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The effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) exposure on hepatic 
pyruvate carboxylase (PC) gene expression were investigated in C57BL/6J Ah" male 
mice. A dose-dependent reduction of PC levels and activity occurred in animals given a 
single intraperitoneal dose of TCDD in a corn oil carrier. The dose ranged from 1 to 
75 ug/kg body weight and the analysis performed 8 days postinjection. At the 
maximum TCDD level investigated, a 10-fold reduction in PC activity occurred. At 
doses beyond those required to initiate a reduction in PC, a lactate dehydrogenase 
isozyme patterns shift is observed. This is accompanied by increases in blood lactic 
acid levels. Northern blot analysis on RNA extracts from hepatic tissues indicated that 
at 8 days post TCDD treatment, a dose-dependent reduction of hepatic mRNA levels 
occurs. 
The aryl hydrocarbon receptor (AhR) is believed to mediate all responses to 
TCDD. Liganded AhR and the aryl hydrocarbon receptor nuclear translocator (ARNT) 
protein form a heterodimeric transcription factor which interacts with dioxin response 
elements (DREs). These are found in enhancer/promoter regions of many genes that 
Redacted for Privacyrespond transcriptionally to TCDD exposure. Cloning and sequencing a region 
approximately 1.4 kb upstream of the PC translational start site revealed an untranslated 
leader sequence of 124 nucleotides starting with adenosine. Primary structural analysis 
of the upstream region revealed an 1nr element in place of a TATA element. Additional 
transcription factor elements were identified including: Spl, GCF, UBP-1, GRE, CREB, 
NF-1, HNF-4, TFII-I and E-boxes; DRE elements were notably lacking. A tandem 
series of 10 evenly spaced E-boxes, which bind ARNT homodimers, are each 
juxtaposed to a TFII-I element, possibly forming composite elements. Tertiary structure 
analysis revealed the positioning of nine composite elements displayed as a trio of 
phased elements. 
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Chapter 1 
Introduction 
1.1 Statement of Problem and Thesis Topic 
The chlorinated dibenzo-p-dioxin family of compounds are unwanted 
environmental contaminants of industry. Formed as by-products, these halogenated 
aromatic compounds are produced during chlorinated phenoxy herbicide manufacturing, 
pulp and paper bleaching, metallurgy, and municipal and hospital incineration (Safe and 
Hutzinger and references therein, 1990). Of the 75 possible congeners, the tetrachloro 
molecule with chlorine atoms laterally located at positions 2,3,7 and 8 (TCDD) is the 
most potent (Schwetz et al., 1973). TCDD gained notoriety and the public's interest as 
a result of environmental disasters at places such as Love Canal, New York; Times 
Beach, Missouri; Alsea, Oregon; Pensicola Florida; and the herbicide, Agent Orange, 
used in Operation Ranch Hand during the Vietnam conflict. A long environmental half 
life of 0.5 to greater than 10 years (di Domencio et aL, 1980) coupled with the extreme 
toxicity observed in some laboratory animals (Schwetz et al., 1973) has promoted 
extensive investigation focusing on the mechanism(s) accounting for TCDD toxicity. 
Intoxication with a sufficient dose of TCDD produces a plethora of end points 
including carcinogenesis, teratogenesis, immunotoxicity, reproductive toxicity, and 
death (reviewed in DeVito and Birnbaum, 1994). It is of interest to note that the lethal 
toxicity of TCDD is unique among toxic compounds. Unlike the generally quick 
lethality of most toxic compounds, TCDD induced death in laboratory animals occurs 
days or even weeks after exposure (Grieg et al., 1973; Gupta et al., 1973). Another 2 
unique aspect of TCDD lethality is the variation in LD50 observed among various 
animal species. Values range from 0.6 ug TCDD/kg body weight for male guinea pigs 
(Schwetz et al., 1973) to greater than 7200 ug TCDD/kg body weight for Hans Wister 
rats (Pohjanvirta et al., 1993). Given the multifarious effects of TCDD exposure, a 
common underlying mechanism for death has remained illusive. However, one 
common theme evident in all animals exposed to a sufficient dose of TCDD is a wasting 
syndrome exemplified by a prominent loss in body weight within days of exposure 
(Harris et aL, 1973; Olson et al., 1980). The causative factors of the wasting syndrome 
are not known, but a number of metabolic pathways are impacted (Jones et al., 1987; 
Weber et al., 1987a; Lentnek et al., 1991; Birnbaum et al., 1990). It has been proposed 
that acute toxicity of TCDD is a result of inhibition of glucocorticoid-dependent 
enzymes, in particular, the gluconeogenic enzyme phosphoenolpyruvate carboxylase 
(PEPCK) (Weber et al., 1992; Stahl et al., 1993). 
The mitochondrial enzyme pyruvate carboxylase (PC) plays a pivotal role in 
gluconeogenesis and the citric acid cycle. Through the ATP-dependent carboxylation of 
pyruvate by PC, oxaloacetate enters the citric acid cycle. In gluconeogenesis, PC 
synthesized oxaloacetate carbon units are converted to malate by mitochondrial malate 
dehydrogenase (MDH). The malate is subsequently shunted across mitochondrial 
membranes to the cytoplasm where cytosolic MDH converts the malate back to 
oxaloacetate. Exergonic decarboxylation by PEPCK produces phosphoenolpyruvate 
from oxaloacetate for use in gluconeogenic or glycolytic pathways of intermediary 
metabolism. Distribution of PC catalyzed oxaloacetate is approximately equivalent 
between the citric acid cycle and gluconeogenesis (Martin et al., 1993). 
The critical role of PC in intermediary metabolism becomes evident in humans 
deficient in this enzyme. Humans with compromised PC activity die in utero or shortly 
after birth (Robinson et al., 1984; Rutledge et al., 1989). Symptoms associated with PC 
deficiency include metabolic acidosis due to the accumulation of lactate and elevated 3 
levels of pyruvate and alanine (Robinson et aL, 1984; Rutledge et al., 1989). In rats 
exposed to TCDD, a reduction in PC activity occurs (McKim et al., 1991; Weber et al., 
1991a). With these observations in mind, TCDD-induced reductions in PC activity 
may, by itself, produce death in animals and be particularly hazardous to a fetus. If 
reductions in PC activity contribute significantly to TCDD toxicity, the reduction in PC 
activity should occur in species other than rat. Moreover, one would expect the 
response to be dose dependent. 
The studies presented in this thesis investigate the alterations in hepatic PC gene 
expression in C57BL/6J (AhbTh) male mice exposed to TCDD. Questions addressed 
include: 1) What changes occur in PC levels and activity upon TCDD exposure in a 
species other than rat; 2) Are any changes at the protein level correlated with expression 
of mRNA transcriptional activity; 3) What possible protein-DNA interactions regulate 
PC transcription and how might TCDD exposure impact these processes; 4) Could 
TCDD exposure alter MDH activity such that the flux of carbon units originating from 
PC activity is impaired and become unavailable for gluconeogenesis; 5) As with human 
deficient in PC, does lactate acidosis occur and, if so, are changes in lactate 
dehydrogenase activity associated with increases in lactate levels. 
1.2 Research Approach 
To investigate the impact of TCDD exposure on hepatic PC, C57BL/6J (Ahb/b) 
male mice were exposed to a single intraperitoneal (i.p.) injection of 50 ug TCDD/kg 
body weight in a corn oil carrier. This dosing regimen was based on the studies by 
McKim et al. (1991) in which the effects of TCDD on the enzymes acetyl CoA 
carboxylase and PC in rats were investigated. Western and Northern blotting 
techniques were used to investigate changes in PC protein and mRNA expression, 
respectively. PC activity was determined using the spectrophotometric assay described 
by Berndt et al. (1978). Various PCR and restriction endonuclease technologies were 4 
used to isolate and amplify from genomic DNA the 5' untranslated leader sequence of 
the PC gene plus approximately 1.3 kb of nucleotide sequence upstream of the gene. 
Molecular biology techniques were used to insert the isolated DNA fragment into a 
phagmid vector followed by transformation into a bacterial host for further 
amplification and sequencing. Polyacrylamide-7M urea sequencing gels were used to 
verify the transcriptional start site of hepatic PC. 
Following sequencing and identification of putative transcription factor binding 
sites, transient transfection into Hepa 1c1c7 cell cultures using a luciferase reporter 
system were performed to functionally characterize the 1.3 kb fragment immediately 
upstream of the PC gene. Transiently transfected cells were exposed to 10 nM TCDD 
suspended in a dimethyl sulfoxide (DMSO) carrier for 48 hours. This was followed by 
luminometer monitoring of luciferase activity. Additional co-transfections with an aryl­
hydrocarbon receptor nuclear translocator (ARNT) encoding plasmid followed by 
exposure to TCDD were also done. The co-transfections were designed to investigate 
the possibility that multiple E-box elements, identified within the 1.3 kb upstream 
fragment, influence the regulation of PC. ARNT has been reported to form 
heterodimers that bind to E-box elements (Sogawa et al., 1995; Antonsson et al., 1995). 
ARNT also interacts with the TCDD-liganded aryl-hydrocarbon receptor (AhR), 
forming a heterodimer complex capable of binding to specific DNA regulatory elements 
and modulating gene transcription. The liganded AhR-ARNT heterodimer complex is 
believed to mediate all responses associated with exposure to TCDD and comparable 
congeners. 
In addition to investigations of the effects of TCDD on PC gene expression, 
studies of hepatic MDH and LDH activity were completed. Protein extracts were 
electrophoresed on non-denaturing polyacrylamide gels followed by activity based 
staining (Thorne et al., 1962). Blood was also collected from TCDD exposed animals 
and the sera analyzed for lactate levels. 5 
1.3 Goals and Objectives 
The underlying events which yield the diverse and multifaceted effects of TCDD 
on animal physiology has eluded researchers. Included in these effects is the universal 
weight lose experienced by laboratory animals exposed to high doses of TCDD, i.e. the 
wasting syndrome. Previous studies have suggested exposure to TCDD impacts a 
number of metabolic pathways which may ultimately contribute to the wasting 
syndrome (Jones et aL, 1987; Weber et al., 1987a; Lentnek et al., 1991; Birnbaum et 
al., 1990). However, the causative factors of the wasting syndrome are not fully 
understood. It is worth noting that developing an understanding of the mechanism(s) 
involved in TCDD mediated wasting in animals may have far reaching consequences 
including understanding human disease such as the wasting experienced by those with 
acquired immunodeficiency syndrome (Grunfeld and Kotler, 1992). 
PC plays a pivotal role in carbon unit flux through the metabolic pathways 
involved in gluconeogenesis, lipid synthesis, and the citric acid cycle. Positioned at the 
crossroads of intermediary metabolism, alterations in PC expression may have the 
potential of contributing to the wasting experienced by TCDD exposed laboratory 
animals. Studies by McKim et al. (1991) and Weber et al. (1991a) have shown-rats 
exposed to TCDD manifest a reduction in PC activity. The aim of this thesis is to 
further advance the understanding of TCDD toxicity by gaining insight into the 
regulatory mechanisms associated with PC expression and to investigate possible 
mechanisms by which TCDD may influence control of expression. 
The chapters within this thesis each address specific topics. Chapter 2 contains a 
general review of TCDD, PC, and the proposed model that was the catalyst for this 
thesis. The materials and methods used to investigate the questions proposed in section 
1.1 are reviewed in Chapter 3. Chapter 4 presents the results of the experimentation 
describe in the previous chapter. Chapter 5 includes a discussion and analysis of the 6 
results. In addition, models suggesting mechanisms for TCDD induced alterations of 
PC expression are presented. The final chapter presents an overall summary of the 
thesis and conclusions derived from the research therein. 7 
Chapter 2 
Literature Review 
2.1 2,3,7,8-Tetrachlorodibenzo-p-dioxin (TCDD) 
2.1.1 Chemical Properties of TCDD 
The chlorinated dibenzo-p-dioxin family of compounds are comprised of two 
benzene rings linked together by two oxygen bridges (Figure 2.1). Halogenation of the 
two rings can range from 1 to 8 chlorine atoms with a total of 75 possible congeners. 
The chlorine atoms of TCDD are spatially arranged on the benzene ring to form an 
overall planer molecule. The physiochemical properties of TCDD are indicative of the 
molecule's stability which is reflected in its long environmental half life of up to ten 
years (di Domencio et al. 1980). Characteristics which contribute to TCDD's stability 
in the environment include a low vapor pressure of 1-2 X 10-7 Pascals at 25° C (Schroy 
et al., 1985; Podoll et al., 1986) and a thermal stability such that temperatures of greater 
than 800° C are required for complete degradation (Kearney et al., 1973; Stehl et aL, 
1973). Another TCDD chemical property which generates concern is its 
hydrophobicity. The octanol-water coefficient of TCDD is approximately 9 X 105 to 
4 X 106, i.e. log K0 of 5.95 to 6.64 (Marple et al., 1986a; Jackson et al., 1993). This 
corresponds to a water solubility of approximately 8 to 19 ng/liter at room temperature 
(Adams and Blaine, 1986; Marple et al., 1986b). The low water solubility of TCDD 
raises concern because this property allows TCDD to accumulate and biomagnify in 
trophic systems. Biomagnification impacts humans ultimately through diet. Located at 
the top of the food chain, humans consume meat and milk of herbivores, fish, and 
plants. In the industrialized countries, it is thought that exposure to chlorinated 
dibenzo-p-dioxins, including TCDD, is largely through food consumption (Fuerst et al., 
1991). 8 
Figure 2.1. The structure of 2,3,7,8-tetrachlorodibenzo-p-dioxin. 9 
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Figure 2.1. 10 
2.1.2 Sources of TCDD 
The formation of the chlorinated dibenzo-p-dioxins is an unwanted by-product 
of industry. Overall, four major industrial sources account for most of the TCDD 
released into the environment. These sources are: 1) chemical manufacturing using 
chlorine-based chemistry; 2) chlorine bleaching of pulp and paper; 3) hospital and 
municipal incineration; and 4) metals processing. An underlying similarity among all of 
these sources is the interaction of chlorine with an aromatic carbon source. 
TCDD was first identified in 1957 as a contaminant produced during 2,4,5­
trichlorophenol (TCP) synthesis (Kimmig and Schulz, 1957). TCP is used in the 
synthesis of various industrial chemicals. Notable TCDD-tainted compounds now 
banned in the U.S. include the phenoxy herbicide 2,4,5-trichlorophenoxyacetic acid and 
the antibacterial agent hexachlorophene (Rappe et al., 1979). Synthesis of TCP 
involves hydrolysis of 1,2,4,5-tetrachlorobenzene using a solvent of ethylene glycol 
containing sodium hydroxide and reaction temperatures of 180° C. During synthesis, 
the condensation of a pair of 2,4,5-trichlorophenate reaction intermediates form trace 
amounts of TCDD. If the reaction vessel solvent is distilled off, an exothermic reaction 
driven by decomposition of sodium- 2- hydroxyethoxide (NaOCH2CH2OH) raises the 
reaction temperature to approximately 410° C (Milnes, 1971). The increase in 
temperature concomitantly increases the formation of TCDD (Hay, 1979). Left 
unchecked, the run away exothermic reaction leads ultimately to massive pressure 
build-up in the reaction vessel. To advert explosions, reaction vessels are fitted with 
pressure relief valves to vent off the pressure build-up. Unfortunately, the contents of 
the reaction vessel may also vent out into the surrounding atmosphere. This scenario 
occurred on July 10, 1976 in a trichlorophenol plant at Seveso, Italy, in which 300-2000 
grams of TCDD was released from a reaction vessel and contaminated 2.8 km2 of 
surrounding countryside (reviewed in Pohjanvirta and Tuomisto, 1994). 11 
The bleaching of pulp and paper allows for the interaction of chlorine with the 
aromatic-rich lignin within wood (Hrutfiord and Negri, 1992) to form chlorinated 
dibenzo-p-dioxins and chlorinated dibenzofurans. Both TCDD and its tetrachlorinated 
furan counterpart have been detected in parts per trillion concentrations in wood pulp, 
waste effluent and sludge (Amendola et al., 1989; Swanson and Rappe, 1988; Clement 
et aL, 1989; Rappe et al., 1987). As a consequence, detectable levels of TCDD have 
been documented in fish downstream of effluent releases (USEPA, 1987). 
Bioaccumulation of polychlorinated dioxins, furans and biphenyls in fish are of concern 
because their consumption by subsistence fisherman may place these people at risk. For 
example, in 1994 the state of Maine advised fisherman to eat no more than two meals a 
year of fish taken from the Penobscot, Androscoggin, and Kennebec Rivers due to high 
TCDD concentrations in the fish (MDEP, 1994). TCDD can also be detected in 
finished paper products including, newsprint, laboratory filter paper, coffee filters, 
cosmetic tissue and recycled paper (Beck et al., 1988). Interestingly, recycled paper 
contains the highest overall concentration of TCDD. 
Carbon and hydrogen containing wastes, if burned efficiently, form carbon 
dioxide and water with concomitant release of energy. If chlorine is present, hydrogen 
chloride gas is formed. However, incineration is usually not completely efficient, 
thereby allowing the formation of various organochlorine products. In 1977, Olie et al. 
detected trace amounts of chlorodibenzo-p-dioxins and chlorodibenzofurans in fly ash 
and flue gas from municipal incinerators in the Netherlands. Subsequent studies of 
municipal incinerators thoughout the world produced similar results (Rappe et al. ,1987; 
Tiernan et al., 1983; Crummett and Townsend, 1984; Hutzinger and Blumich, 1985). 
Profile analysis of chlorinated dibenzo-p-dioxins and dibenzofurans from a typical 
municipal waste incinerator shows the tetrachlorinated dibenzo-p-dioxin isomers 
comprise approximately 2% of the total (Zook and Rappe, 1994). Concentrations of 
TCDD from the flue gases of municipal waste incinerators have been measured at 12 
0.05-0.07 ng/m3 (Nottrodt and Ballschmiter, 1986). Vogg and Stieglitz (1986) 
demonstrated that exposing fly ash to temperatures up to 300° C increased TCDD 
emission by 2.5 fold. Increasing temperatures to 600° C reduced concentrations to 
below 0.1 ng/g fly ash. These results demonstrate the thermal stability of TCDD. 
Medical waste from hospital contains approximately two to four times the 
chlorine content of municipal waste incinerators. The typical chlorine content of 
medical waste ranges from 1.1 to 2.1% while municipal solid waste content is 0.50% 
(Randell and Shoraka-Blair, 1994). This is indicative of the extensive use of PVC 
plastics and saline solutions used daily in hospital operating rooms, examination rooms, 
and patient care rooms. These observations led Brown et al. (1990) to conclude that the 
higher levels of polychlorinated dibenzo-p-dioxins and dibenzofurans in clinical waste 
incinerator fly ash when compared to municipal waste ash residues was a consequence 
of the health care environment. The waste combinations from these various areas 
within hospitals result in a heterogeneous mixture. This heterogeneity may contribute 
to the wide range of chlorinated dibenzo-p-dioxins and chlorinated dibenzofurans 
concentrations detected in incinerator stack gas. Concentrations ranged from 0.1 to 
48,572 ng/dry standard cubic meter (Rigo et al., 1995). It is worth noting the work of 
Lindner et al. (1990) which showed chlorinated dibenzo-p-dioxins and dibenzo furans 
emissions can be reduced by 95% using a trio of wet scrubbers. 
Metal processing also contributes to the formation of chlorinated dibenzo-p­
dioxins and dibenzofurans. For example, samples of ambient air (Christmann et al., 
1989), cow's milk and human blood taken in the vicinity of a copper reclamation plant 
in Austria contained elevated levels of chlorinated dibenzo-p-dioxins and dibenzofurans 
including TCDD (Riss et al, 1990). The source of chlorine in the reclamation process 
is in the form of PVC plastic which coats copper wires and cords. Scrap metal 
processing of steel also forms chlorinated dibenzo-p-dioxins and dibenzofurans 13 
(Tysklind et al., 1989). In addition to chlorine containing plastics, as found in copper 
reclamation, chlorine containing cutting oils used in processing the steel also contribute 
to the formation of chlorinated aromatic compounds (Tysklind et al., 1989; Marklund et 
al., 1986). 
Polychlorinated dibenzo-p-dioxins and dibenzofurans can also be formed in the 
production of metals. In the refining of nickel, chlorine leaching processes are used in 
the purification process. Similarly, purification of magnesium involves a chlorination 
step. Oehme et al. (1989) proposed heavy metals such as nickel, cobalt, lead, and 
copper may act as catalysts during high temperature processing to form chlorinated 
dibenzofurans and dibenzo-p-dioxins. 
Although TCDD is formed in trace amounts in the processes described above, it 
is only one constituent in a complex mixture that may included combinations of the 
various congeners of chlorinated dibenzo-p-dioxins, dibenzofurans, biphenyls, phenols, 
and tetraphenyls. Many of these compounds do not have as an extensive information 
database as TCDD; therefore, their contribution to risk must be estimated As such, it is 
often difficult to assess the risk posed by complex mixtures of chlorinated aromatic 
environmental contaminants. To evaluate complex mixtures of polyhalogenated 
aromatic hydrocarbons, toxic equivalent factors (TEF) were developed. TEFs are 
measures of the relative potency of a compound compared to the toxicity of a 
prototypical compound for which there is a significant database and an understanding of 
the mechanism of toxicity. The wealth of data, extreme potency, and understanding of 
the aryl-hydrocarbon receptor pathway (AhR) (see section 2.1.4) mechanism of TCDD 
toxicity qualifies it for the prototypical compound. For the TEF methodology to be 
applicable, a compound must produce a similar spectrum of toxicity to TCDD via the 
AhR independent of the endpoint studied. Furthermore, the toxic effects of the 
compounds must be additive (DeVito and Birnbaum, 1994). 14 
The TEF methodology is involved in establishing the daily acceptable dose for 
TCDD equivalent exposure. The EPA has established the "acceptable" daily dose of 
TCDD equivalents to be 0.0064 pg/kg/day (Vanden Heuvel and Lucier, 1993). This 
limit is well below the estimated exposure to people in industrialized nations of 
1-3 pg/kg/day (Fuerst et al., 1991). However, the low level set by the EPA is not agreed 
upon by other governmental and state agencies in the U.S. as well as regulatory 
agencies throughout the world. For example, the U.S. CDC and FDA proposed safe 
levels of exposure 4-8 fold higher at 0.0276 and 0.0572 pg/kg/day, respectively 
(Vanden Heuvel and Lucier, 1993). The Washington State Department of Health 
proposes 20-80 pg/kg/day as acceptable levels of exposure even though such exposure 
is 12,500 times the level considered safe by the USEPA (Webster and Commoner, 
1994). Other governments from around the world and the World Health Organization 
place acceptable levels of exposure between 1 and 10 pg/kg/day (Webster and 
Commoner, 1994; Vanden Heuvel and Lucier, 1993). The controversy of acceptable 
dose centers around the models used in determining risk and acceptable doses. As 
technology and research tools improve, thereby advancing the understanding of 
carcinogenesis mechanisms subsequent to polyhalogenated aromatic hydrocarbon 
exposure, a more unified consensus regarding acceptable daily doses should materialize. 
2.1.3 TCDD Toxicity 
The toxicity of TCDD is independent of the route and rate of exposure; rather 
toxicity is manifest as a consequence of body burden (DeVito and Birnbaum, 1994). 
Body burdens in mammals are impacted by the long half life of TCDD in exposed 
animals. For example, the half life of TCDD in mice and rats is 10-15 days (Birnbaum, 
1986; Gasiewicz and Rucci, 1984) and 12-31 days (Pohjanvirta et al., 1990a; Rose et al. 
1976), respectively. The half life for TCDD in humans, however, is substantially 
longer. Estimates place the half life at 5-10 years (Poiger and Schlatter, 1986; 15 
Pirkle et al., 1989; Van den Berg and Poiger, 1989). A study which exemplifies the 
persistence of TCDD within the body involves detection of elevated TCDD levels in 
adipose tissue from workers exposed to TCDD in an industrial accident at the BASF 
factory, Ludwigshafen, Germany. Tissue from 6 workers contained TCDD levels 
ranging from 11-141 ppt thirty-two years post exposure (Schecter and Ryan, 1988). 
Chlorinated dibenzo-p-dioxin and dibenzofuran TEQ tissue burdens in the general U.S. 
population include 52 ppt in blood plasma, 29 ppt in adipose tissue, and 28 ppt in breast 
milk (reviewed in Schecter, 1994). These burdens in a 70 kg human with 20% body fat 
equates to approximately 10.4 ng/kg overall body weight. It is of interest to note these 
concentrations are just 4 fold lower than the 40 ng TCDD/kg concentration needed to 
increase sac fry mortality in lake trout eggs (Spitsbergen et al., 1991). Lake trout fry are 
regarded as the fish species most sensitive to TCDD during the early developmental 
stage. Although adult humans are considered more resistant, the possibility that human 
body burdens may be approaching thresh hold levels that could impact development can 
not be lightly dismissed. 
The majority of toxic effects precipitated by TCDD exposure can be placed into 
four broad categories: 1) carcinogenesis, 2) developmental toxicity and teratogenicity, 
3) reproductive toxicity, and 4) immunotoxicity. A few endpoints, such as chloracne 
and the wasting syndrome, do not appear to fit into these four general categories. To 
fully appreciate the diversity of TCDD toxicity, a short discussion of each endpoint is 
warranted. 
2.1.3.1 Carcinogenesis 
In the multistage model for carcinogenesis, several steps are believed necessary 
for cancer to occur. In the first step, termed initiation, a permanent alteration in DNA 
occurs. For example, in chemical carcinogenesis, adduction of activated xeno-molecules 
to various sites on adenosine or guanosine bases can, if not repaired prior to cell 16 
division, result in permanent DNA transitions or transversions. Compounds capable of 
producing these permanent changes are termed initiators. The second step, 
proliferation, may occur after an extended period of time. During this phase of the 
multistage model, clonal proliferation of the altered cell is stimulated, usually by 
exposure to a second xeno compound(s) termed promoters. The final step in the 
multistage model is progression involving further cellular alterations and increased 
cellular division. 
TCDD is a potent carcinogen, as demonstrated by its ability to produce lung and 
liver tumors at doses low as 0.001 ug/kg/day in male B6C3F1 mice (reviewed in Huff, 
1992). In multistage models, TCDD can act as a potent tumor promoter in liver (Pitot et 
al., 1980; Pitot et al., 1987) and skin (Poland et al., 1982). The potency of TCDD to 
function as a promoter is evident when compared to the prototypic promoting agent 
12- O- tetradecanoylphorbol -13- acetate; TCDD is 2-3 orders of magnitude more potent 
(Poland et al., 1982). Chlorinated dibenzo-p-dioxins and dibenzofurans are not 
genotoxic as these compounds do not form DNA adducts (Wassom et al., 1978). As 
such, these compounds, including TCDD, are not classified as initiators. Nevertheless, 
TCDD is an extremely potent transspecies, transstrain, transsex, transsite complete 
carcinogen capable of causing tumors independent of any prior exposure to genotoxic 
compounds (Huff, 1992; Huff et aL, 1994). 
Epidemiological data from industrial workers exposed to TCDD indicates an 
overall increase in cancer mortality (Fingerhut et al., 1991; Manz et al., 1991). 
Moreover, studies of the general population exposed to TCDD subsequent to the Seveso 
explosion link exposure to multi-site tumor formation (Bertazzi et al., 1993). However, 
since human exposure to TCDD is usually in combination with several other 
compounds within a complex mixture, questions have arisen whether the sarcomas and 
lymphomas reported in the epidemiologic studies are due strictly to exposure to TCDD 
and its related congeners (Johnson, 1993). 17 
2.1.3.2 Developmental Toxicity 
The developmental toxicity of TCDD is divided into three distinct categories: 
1) death/growth/clinical signs, 2) structural malformations, 3) functional alterations. 
Studies using fish, birds, and laboratory mammals provide insight to the sensitivity of 
developing organisms to exposure from TCDD and related congeners. In fish, sac fry 
mortality occurs at a much lower dose compared to adult animals. For example, the 
LD50 of juvenile rainbow trout is 10 ug/kg body weight while sac fry have an LD50 of 
0.4 ug/kg egg weight (Walker et al., 1991; Kleeman et al., 1988). Similarly, the 
chicken embryo is more sensitive to TCDD exposure compared to adults. Adult 
chickens have an LD50 of 25-50 ug/kg body weight while the embryo LD50 is 
0.25 ug/kg egg weight (Grieg et al., 1973; Allred and Strange, 1977). Likewise, in 
mammalian laboratory species the developing fetus is more sensitive to TCDD. The 
LD50 in Sprague Dawley rats is 25-60 ug/kg body weight (Beatty et al., 1978) while a 
cumulative maternal dose of 5 ug/kg body weight results in a 41% prenatal mortality 
rate (Sparschu et al., 1971). A cumulative TCDD maternal dose of 18 ug/kg body 
weight causes a 58% prenatal mortality loss in the Golden Syrian hamster (Olson and 
McGarrigle, 1992) which is substantially lower than the single LD50 TCDD dose 
ranging from 1157-5051 ug/kg body weight (Olson et al., 1980; Henck et al., 1981). It 
is worth noting the similarity in cumulative TCDD dose needed to cause prenatal 
mortality in these species compared to the dose needed for maternal lethality. This 
similarity is also carried to primates where a cumulative maternal dose of 5 ug 
TCDD/kg body weight in rhesus monkeys results in 100% prenatal mortality (McNulty, 
1984). It is noteworthy that, unlike adult TCDD induced mortality in which age does 
not play a role, prenatal mortality due to maternal exposure is temporally dependent, i.e. 
exposure to TCDD must occur early in development, usually during organogenesis 
which occurs between gestation days 6-15 for laboratory animals (Peterson et al., 1993). 18 
Based on such evidence, it is reasonable to suggest that the TCDD dose required for 
prenatal toxicity or mortality in developing humans may be much lower than the TCDD 
dose necessary to expedite maternal toxicity. 
Clinical signs of gestational exposure to TCDD in laboratory species include 
thymic hypoplasia, subcutaneous edema, and decreased prenatal growth (Couture, et al., 
1990). Other species specific signs includes cleft palate formation in mice (Courtney 
and Moore, 1971; Moore et al., 1973), extra ribs in rabbits (Giavini et al., 1982), and 
intestinal hemorrhage in rats (Sparschu et al., 1971; Khera and Ruddick, 1973). 
Clinical signs of developmental exposure to TCDD in fish include edema, hemorrhages, 
and arrested growth (Walker et al., 1991a,b; Helder, 1980, 1981; Spitsbergen et al., 
1991; Wisk and Cooper, 1990). In birds, exposure to TCDD or TCDD-like compounds 
in developing embryos produce species specific pericardial and subcutaneous edema, 
liver lesions, microophthalmia, beak deformities, cardiovascular malformations, and 
altered lymphoid development in the thymus and bursa of Fabricius (Brunstrom and 
Andersson, 1988; Brunstrom and Damerud, 1983; Brunstrom and Lund, 1988; Cheung 
et al., 1981; Nikolaidis et al., 1988a; Nikolaidis et al., 1988b; Nikolaidis et al., 1990; 
Riflind et al., 1985). 
It is difficult to assess the developmental toxicity TCDD has on humans as 
exposure is usually in the form of complex mixtures of chlorinated dibenzo-p-dioxins, 
dibenzofurans, biphenyls and other aromatic compounds. However, the potential for 
TCDD to impact development can be inferred from the Yusho and Yu-Cheng rice oil 
poisoning incidents. In each of these poisonings, humans consumed rice oil tainted with 
Kanechlor-400, a polychlorinated biphenyl used as a heat-transfer medium in processing 
of the rice oil. In addition to various chlorinated biphenyl isomers, polychlorinated 
dibenzofurans and polychlorinated quarterphenyls were also detected in the rice oils 
(Masuda et al., 1994; Hsu et al., 1994). These compounds, like TCDD, have the ability 
to interact with the Ah receptor, though not with as high of affinity. It is generally 19 
accepted that the toxicity of TCDD is mediated through the Ah receptor (section 2.1.4). 
The commonality of Ah receptor involvement suggests the developmental effects 
experienced by children exposed in utero to contaminated rice oil very well could be 
produced by TCDD exposure. 
In the Yu-Cheng exposure, a high incidence of perinatal mortality occurred in 
exposed pregnant women who themselves survived (Hsu et al., 1985). Other outcomes 
displayed as a result of transplacental exposure in both Yusho and Yu-Cheng incidences 
include structural malformations, organ system dysfunction, and growth retardation. 
Exposed Yusho infants exhibited the structural malformation, rocker bottom heel 
(Yamashita and Hayashi, 1985). Yu-Cheng children exposed transplacentally 
experienced neurobehavioral abnormalities and delays in attaining developmental 
milestones (Rogan et al., 1988). Many children exposed in utero displayed an 
ectodermal dysplasia, characterized by hyperpigmentation of the skin, mucous 
membranes, fingernails and toenails, hypersecretion of the meibomian glands, 
conjunctivitis, gingival hyperplasia, and erupted teeth in neonates (Yamashita and 
Hayashi, 1985; Lan et al., 1989). 
Studies of children exposed transplacentally to TCDD and other compounds 
subsequent to the explosion at the Seveso TCP plant are not as clear as the Yusho/ 
Yu-Cheng incidents. Bertazzi and di Domencio have reviewed the impact upon humans 
of exposure to chemical fallout of the Seveso accident (1994). Three studies 
investigated possible increases in spontaneous abortions. Although only one study 
indicated a slight increase, all three studies were criticized for poor data quality and 
possible bias. Investigations using tissues from induced and spontaneous abortions 
indicated no mutagenic, teratogenic or fetogenic effects, but this work was criticized for 
using incomplete fetal tissues for examination. In a second study, 15,000 births 
comprising TCDD-exposed and nonexposed women suggested the frequency of 
developmental defects in the exposed population was not significantly higher. As with 20 
the first study, this work came under scrutiny. Criticism of the study centered on the 
observation that the number of infants investigated was too small to detect very rare 
developmental defects. Even though the Seveso studies were not conclusive, the effects 
observed in the Yusho and Yu-Cheng rice oil contamination, in conjunction with 
developmental alterations seen in animal species exposed to various chlorinated 
dibenzo-p-dioxins, strongly suggest maternal exposure to TCDD may negatively 
influence human development. Furthermore, the similar mechanism of action involving 
Ah receptor interactions with chlorinated dibenzo-p-dioxins, dibenzofurans, and 
biphenyls gives more weight to the notion that TCDD alters development. 
Structural malformations, or teratogenic responses, due to transplacental 
exposure of TCDD and related compounds result from three processes: 1) altered 
cellular proliferation, 2) metaplasia, and 3) modified terminal differentiation (Poland 
and Knutson, 1982). These processes can contribute to structural malformations 
individually or together. The best characterized examples for involvement of these 
mechanisms in teratogenic effects subsequent to TCDD exposure are cleft palate and 
hydronephrosis in mice. During development, palatal shelves are brought into 
juxtaposition, followed by the transformation of the medial edge epithelium into 
mesenchyme. Subsequent to this transformation, the palatal shelves fuse to form one 
tissue which separates the oral cavity from the sinus cavity. In palatal shelve explants 
exposed to TCDD, the transformation of medial edge epithelium into mesenchyme does 
not occur, but instead forms stratified squamous epithelium (Abbott et al., 1989; Abbott 
and Birnbaum, 1990; Abbott and Birnbaum, 1991). These changes are indicative of a 
teratogenic response due to metaplasia and modified terminal differentiation. Of further 
interest is the observation that the medial epithelium originates from ectoderm. As 
such, one would expect infants suffering from ectodermal dysplasia to exhibit cleft 
palate. However, infants exposed to TCDD and related compounds have no defects of 
the palate (Mastroiacova et al., 1988; Stockbauer et al., 1988). Furthermore, for rats to 21 
display clefting, TCDD doses which cause high incidences of prenatal mortality are 
necessary (Schwetz et al., 1973). Abbott et al. (1989) demonstrated embryonic mouse 
palate in vitro cultures were 200 times more sensitive to TCDD than palate cultures of 
rat or human. Such results suggest palate clefting as a consequence of TCDD exposure 
is species specific. 
TCDD induced hydronephrosis is a consequence of obstruction of the 
developing ureter due to hyperplasia of the luminal epithelium, thereby causing back 
pressure which damages the renal papilla (Abbott et al., 1987). This teratogenic 
response differs from clefting of the palate in that altered cellular proliferation, not 
metaplasia and modified terminal differentiation, produces this structural malformation. 
Hydronephrosis is the most sensitive developmental response to TCDD exposure in 
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mice. A dose of 1X10 M TCDD in vitro is sufficient to produces epithelial cell 
hyperplasia (Abbott and Birnbaum, 1990). Hydronephrosis, like palate clefting, does 
not appear in infants exposed transplacentally to TCDD. 
Normal male development of reproductive organs and sexual imprinting 
depends on the release of androgens at critical times in development and after birth. 
The postnatal effects of transplacental exposure to TCDD impacts the developing male 
reproductive tract in many ways. Mably and associates have published several studies 
regarding the various impacts of TCDD on the developing male reproductive tract in 
rats (Mably et al., 1991; Mably et al., 1992a, 1992b, 1992c). The developing male 
fetuses from pregnant rats given a single dose of 1 ug TCDD/ kg body weight on 
gestation day 15 displayed reduced plasma testosterone levels on gestation days 17-19, 
a time in development in which a testosterone surge normally occurs. Furthermore rat 
pups normally experience another testosterone surge 2 hours after birth. The pups 
transplacentally exposed to TCDD did not experience this androgen spike until 4 hours 22 
after birth. TCDD exposed pups were also 10-15% lighter in weight and consumed 
10-20% less food. However, these alteration in weight and food consumption were 
overcome by adulthood. 
Mably's group also demonstrated the ability of TCDD exposure to impact 
androgen dependent development in rats at a single maternal dose exposure of 
0.16 ug/kg followed by subsequent lactational exposure. Developmental alterations 
include a 21% reduction in anogential distance, up to a 1.7 day delay in testis descent, a 
56% decrease in seminal vesicle weight, and a 53% reduction in ventral prostate weight. 
Based on these lines of evidence, Mably suggests that in utero and lactational exposure 
to TCDD alters androgen status during development which remains into adulthood. 
Mably's work also identified decreased spermatogenesis as the most sensitive 
response to transplacental TCDD exposure in developing reproductive tracts of male 
rats. A single maternal dose of 0.064 ug TCDD/kg body weight on gestation day 15 
followed by lactational exposure resulted in a significant reduction in epididymis and 
cauda epididymis weight, seminiferous tubule diameter, daily sperm production rate, 
and sperm per cauda epididymis. A maternal dose of 0.40 ug TCDD/kg also resulted in 
decreased testis weight and plasma follicle stimulating hormone. The daily sperm 
production in rats will reach a peak when the animals are 100-125 days old. Rats 
exposed maternally to TCDD require a longer time to reach maximum sperm 
production; however, at a maternal dose of 1 ug TCDD/kg decreased sperm production 
is evident in animals 300 days old. These data are suggestive of a permanent alteration 
in spermatogenesis at this dose. Mechanism(s) by which maternal and lactational 
exposure to TCDD alters spermatogenesis include: 1) intervention in spermatocyte 
meiosis, 2) degeneration of cells preventing the differentiation of leptotene 
spermatocytes into terminal stage spermatids, and 3) reduction in the number of 
supporting Satoh cells (Orth et al., 1988). It is worth noting that even with the 
decrease in spermatogenesis, reduced fertility in male rats or their offspring was not 23 
evident (Mably et al., 1991; Mably et al., 1992c). This is attributed to the ability of 
normal rats to produce and ejaculate 10 times the necessary sperm for fertilization. 
However, in humans no excess of sperm is present in the ejaculate, i.e. only sufficient 
sperm for fertilization is released (Working, 1988). This observation, along with the rat 
data discussed above and evidence suggesting that human sperm counts have dropped 
approximately 50% over the last 30 years (Sharpe and Skakkeback, 1993), hints that the 
potential for TCDD exposure to further alter human spermatogenesis could have 
tremendous reproductive consequences. 
Mably's group also determine that transplacental and lactation exposure of male 
rat pups to TCDD altered their sexual behavior. In animals exposed to a maternal dose 
of 0.16 ug TCDD/kg, demasculinization in sexual behavior occurs as evident in reduced 
copulatory rates as well as latencies in mounting and ejaculation. Concomitant with the 
decrease in male sexual behavior was an increase in feminine behavior as exemplified 
by increased lordosis frequencies and intensities. 
Prenatal and lactational exposure to TCDD also affects female development. 
Gray and Ostby (1995) treated pregnant Long Evans and Holtzman rats on gestation 
days 8 or 15 with a single dose of 1 ug TCDD/ kg body weight. The offspring 
experienced a delay in puberty, partial clefting of the phallus, and the formation of a 
thread of tissue across the vaginal opening thereby partially occluding the opening. The 
changes in external genitalia is suggested by Gray and Ostby to be an estrogen-like 
effect of TCDD because similar changes are seen upon exposure to the synthetic 
estrogens RU2858 (Vannier and Raynaud, 1980) and diethylstilbestrol (Voherr et al., 
1979). This observation is of interest, as TCDD exposure can also result in 
antiestrogenic effects. For example, female mice exposed to TCDD display decreases 
in uterine weight as a consequence of TCDD antagonizing the ability of 1713-estradiol to 
increase uterine weight (Gallo et al., 1986). 24 
In addition to genital changes, the female offspring experienced alterations in the 
estrous cycle with up to 47% of the animals displaying constant estrous. Other changes 
in TCDD exposed offspring included reduced ovarian, body, and brain weights. Uterine 
lesions were also evident including cystic hyperplasia of the endometrium and the rare 
endometrial squamous cell carcinoma. 
Exposure to TCDD in utero can also create neurobehavioral effects. Primate 
studies were performed in which gestating and lactating monkeys were exposed to 5 or 
25 ppt TCDD in the diet (Bowman et al., 1989a). The offspring of exposed animals 
displayed no changes in reflexes, visual exploration, locomotion, or fine motor controls. 
However, the cognitive function of object learning was impaired (Schantz and Bowman, 
1989). In addition, social interactions between mother and offspring were altered 
(Schantz et al., 1986). 
The possibility of developmental neurobehavioral effects in humans as a 
consequence of maternal exposure to TCDD are unknown. Notwithstanding, children 
of the Yu-Cheng rice oil incident who were transplacentally exposed to polychlorinated 
biphenyls and dibenzofurans displayed developmental or psychomotor delays, speech 
problems, and lowered IQ scores (Rogan et al., 1988). Furthermore, these children 
were hyperactive with behavioral and habit problems (Chen et al., 1992). Given these 
observations and the commonality of the Ah receptor pathway for TCDD, planar 
biphenyls, and chlorinated dibenzofurans, the potential for TCDD to impact 
neurobehavioral development warrants consideration. On the other hand, the ability of 
the non-TCDD like compounds contained within the milieu of chemicals usually found 
in conjunction with TCDD to impact mental development cannot be dismissed. 
2.1.3.3 Reproductive Toxicity 
The effects TCDD exposure has on reproductive toxicity is strikingly similar to 
the developmental effects seen in transplacentally exposed adult male animals including 25 
lowered plasma androgen concentrations, decreased testis and accessory sex organ 
weights, reduced spermatogenesis, and altered testicular morphology (Kociba et al., 
1976; Van Miller et al., 1977; McConnell et al., 1978; Chahoud et al., 1989). However, 
greater doses of TCDD are required to elicit these responses. For example, a dose of 
3 ug TCDD/kg body weight in adult rats caused reductions in spermatogenesis and 
altered testicular morphology (Chahoud et al., 1989) while animals exposed 
transplacentally to 0.064 ug TCDD/kg on gestation day 15 displayed similar reductions 
in spermatogenesis (Mably et al., 1991; Mably et al., 1992c). Kociba et al. (1976) used 
a dosing regimen of 1 ug TCDD/kg/day, 5 days a week, for 13 weeks resulting in a 
cumulative dose of 20 ug TCDD/ kg body weight. The result of this regimen was a 
reduction in weight of the ventral prostate and cauda epididymis. Similar effects are 
seen in animals exposed in utero from a single maternal dose of 0.064 ug TCDD/kg 
(Mably et al., 1991). 
Alterations in the male reproductive system are thought to be in part the 
consequence of altered androgen status. Alteration in androgen status is manifested as 
reductions in plasma testosterone, unaltered plasma leutinizing hormone, and no change 
in the clearance of androgens and leutinizing hormones (Moore et al., 1985; Moore et 
al., 1989; Mebus et al., 1987; Moore et al., 1988; Bookstaff et al., 1990). The 
mechanism behind alteration androgen status is due to the inhibition of the mobilization 
of cholesterol in the testis for testosterone synthesis (Moore et al., 1991), thereby 
resulting in the reduction of plasma testosterone levels. In addition, release of 
leutinizing hormone from the hypothalamus/pituitary axis to stimulate testosterone 
synthesis does not occur (Moore et al., 1989). The inhibition of the release of 
leutinizing hormone is due to enhanced feedback inhibition as an outcome due to the 
TCDD enhanced potency of testosterone, dihyroxytestosterone, and 17B-estradiol 
(Bookstaff et al., 1990). 26 
The female reproductive system is also altered by exposure to TCDD. Studies 
using rats and monkeys reveal exposure to TCDD resulted in decreased fertility, 
reduced litter size, and the inability to carry pregnancies to term. In a three-generation 
study, Murray et al. (1979) exposed rats to various daily doses of TCDD up to 
0.1 ug/kg/day. At the highest daily dose (0.1 ug/kg/day), litter size and fertility was 
reduced. Interestingly, subsequent generations displayed reduced litter size and fertility 
at daily doses of TCDD 10 fold less than the first generation. The impact TCDD has on 
spontaneous abortions was investigated using rhesus monkey exposed to TCDD in the 
diet for up to 9 months. Animals exposed to 25, 50, or 500 ppt TCDD had difficulties 
in conceiving and carrying the fetus to term (Barsotti et al., 1979; Bowman et al., 
1989b; Schantz et al., 1979). Furthermore, spontaneous abortions were more prevalent 
when TCDD exposure occurred early in the first trimester of pregnancies. McNulty 
(1984) observed that a single dose of 1 ug TCDD/kg on gestation days 25, 30, 35 or 40 
resulted in an 83% spontaneous abortion rate with gestation days 25 and 30 the most 
sensitive. 
Estrogens are involved in uterine development, regulation of estrous, and 
maintenance of pregnancy. Progesterone is involved in the preparation of the uterus for 
implantation and nourishment of the embryo. Exposure to TCDD interferes with the 
action of estrogens; therefore, TCDD is considered an antiestrogen. Work by Barsotti 
et al. (1979) indicated female rhesus monkeys exposed to 500 ppt TCDD for up to nine 
months show decreases in plasma estrogen and progesterone levels with concomitant 
anovulatory menstrual cycles and infertility. In vitro studies with MCF7 cells derived 
from a human breast adenocarcinoma indicate exposure to TCDD enhances metabolism 
of 1713-estradiol 100 fold (Spink et al., 1990). Conversely, pregnant rats exposed to 
TCDD maintain serum 1713-estradiol concentrations (Shiverick and Muther, 1983). A 
similar effect is also observed in CD-1 mice (DeVito et al., 1992). The above 
observations indicate the antiestrogenic effect of TCDD in rats and mice entails more 27 
than alterations in circulating estrogen levels. Instead, the antiestrogenic effect of 
TCDD is resultant of decreases in uterine estrogen receptors (Romkes and Safe, 1988; 
De Vito et al., 1992). Other antiestrogenic effects subsequent to TCDD exposure to 
female rats include decreases in uterus weight, uterine peroxidase activity, and uterus 
progesterone receptor concentration (Safe et al., 1991). 
2.1.3.4 Immunotoxicity 
The ability of TCDD exposure to suppress immune function is manifest by 
increased susceptibility in rodents to various bacterial, viral, and parasitic infectious 
agents as well as neoplastic disease. For example, exposure of 28 day old male 
C57BL/6 mice to a cumulative dose of 4 ug TCDD/kg body weight over a 4 week time 
period and subsequent challenge with the gram negative bacteria Salmonella bern result 
in increased mortality and reduced time to death (Thigpen et al., 1975). Additional 
studies by Vos et al. (1978) and Thomas and Hinsdill (1979) used either bacterial 
endotoxin from Escherichia colt or Salmonella typhimurium to challenge TCDD 
exposed male Swiss mice or the offspring of Swiss-Webster mice. Both studies 
demonstrated increased mortality due to endotoxin, indicating TCDD enhances 
susceptibility to gram negative bacteria endotoxin content. However, the presence of 
endotoxin is not a requirement for the increased susceptibility as the gram positive 
bacterium Streptococcus pneumoniae, which lacks endotoxin, also increases mortality 
in TCDD exposed mice (White et al., 1986). 
The ability of TCDD to increase susceptibility to bacterial challenge is evident; 
however, variations in exposure conditions such as dose and route of exposure, single 
versus multiple dosages, animal age, strain, and sex, produce conflicting results. Such 
observations are seen in various studies investigating the ability of TCDD to increase 
the susceptibility of mice to challenge with Listeria monocytogenes. Work by Hinsdill 
et al. (1980) demonstrated increased mortality in Swiss Webster mice fed a diet of 28 
50 ppb TCDD and exposed intravenously to Listeria. Investigations by Luster et al. 
(1980a,b) used the offspring of B6C3F1 mice transplacentally exposed to a maternal 
dose of 5.0 ug TCDD/kg body weight at gestation day 14 followed by postnatal 
exposure at days 1, 7, and 14. At 8 weeks of age, these animals, when challenged with 
Listeria, displayed increased mortality. Conversely, animals exposed orally to a single 
dose of 10 ug TCDD/kg did not show an increase in mortality to Listeria challenge 7 
days post-exposure (House et al., 1990). 
Alterations in susceptibility to viral challenge also is impacted by TCDD. 
Exposure to 0.1 ug TCDD/kg increased mortality in mice exposed to influenza 
AfTaiwan/1/64 (H2N2) virus (House et al., 1990). Clark et al. (1983) demonstrated that 
C57BL/6 mice exposed orally to 0.04 ug TCDD/kg once a week for 4 weeks displayed 
increased mortality when challenged with Herpes simplex type II strain 333 virus. 
However, not all viral challenges are impacted by TCDD challenge. Thigpen et al. 
(1975) demonstrated TCDD exposure did not alter the time to death response to 
Herpesvirus suis. 
The ability of an organism to fend off parasitic attack is also impacted by 
exposure to TCDD. Luebke et al. (1993) demonstrated TCDD exposure increased 
susceptibility to Trichinella spiralis. A single oral dose of 10 ug TCDD/kg to young 
B6C3F1 mice decreased resistance to Plasmodium yoelii., a non-lethal murine malarial 
parasite (Tucker et al., 1986). 
The innate division of the immune system is capable of recognizing malignant 
changes on the surface of cells and removing the effected cells by inducing apoptosis. 
Exposure to TCDD alters the ability to control tumor formation. An example of this 
form of immunosuppression is evident by the increased incidences of tumors in mice 
pups exposed to TCDD in utero and postnatally followed by implantation of polyoma 
virus-induced tumors (Luster et al., 1980a). 29 
Although evidence abounds demonstrating the capacity of TCDD to affect host 
resistance to disease, studies investigating the ability of TCDD to impact specific 
components of the immune system have produced mixed results. The complexity of the 
immune system contributes to the difficulties encountered in investigating the 
immunotoxicity of chemicals. Evaluations of chemical mediated immune system 
dysfunction must take into consideration the period of time which occurs between 
antigen exposure and response. Furthermore, the immune system continues to develop 
after birth in animals and to a lesser degree in humans. As such, investigations need to 
encompass multiple time points and be cognizant of the functional parameters of the 
immune system. To fully appreciate the intricacy of the immune system and the 
formidable task faced by investigators in understanding the mechanisms involved in 
TCDD-mediated immunotoxicity, a short overview of the immune system follows. 
The immune system and its ability to protect the body from infectious disease 
results from the complex interplay between the tissues, cells, and soluble mediators 
which comprise this organ system. The organs of this system are classified into three 
groups. The first group, or primary group, includes the bone marrow and thymus. 
Within the bone marrow resides the stem cell from which the various cellular 
components of the immune system originate, e.g. macrophages, T lymphocytes, and B 
lymphocytes. The thymus provides an environment for T-cell precursors to mature and 
are programmed to distinguish self from nonself. The secondary group of organs 
include the spleen and lymph nodes. The spleen filters foreign antigens, cellular debris, 
and dead cells from the blood circulation. The lymph nodes perform a similar role by 
filtering antigens from the interstitial fluid surrounding the tissues of the body. The 
tertiary group of organs includes the peripheral lymphoid tissues associated with skin, 
mucosal lamina propria, gut, bronchial tissue, and cells lining the genitourinary tract. It 
is at these various sites that immunologic and immunoregulatory functions by memory 
and effector cells occur. 30 
Immunity in mammals is manifest in two forms, innate immunity and acquired 
immunity. Innate immunity is nonspecific and without immunologic memory. The 
physical barrier of the skin, lysozyme containing mucous in the respiratory tract, 
varying pH in the digestive tract, and reflex functions such as coughing and sneezing are 
part of this type of immunity. The cellular components of innate immunity include 
polymorphonuclear cells, monocyte/macrophage cells, and natural killer cells. 
Polymorphonuclear cells are motile phagocytic cells capable of passing through blood 
vessel membranes and are considered a primary line of defense against infectious 
agents. Monocyte/macrophages are phagocytic cells located in all tissues, particularly 
in the liver, lung, spleen, kidney, and brain. Natural killer cells recognize viral or 
malignant changes on cell surfaces and through perforins and enzymatic proteins are 
able to induce apoptosis in the affected cell. 
The innate immunity class also has soluble mediators including cytokines, 
complement, acute phase proteins, and interferon a/f3. Upon infection, the 
monocyte/macrophages release cytokines into the bloodstream. The response, termed 
the acute phase response, includes fever and increases in serum proteins such as 
amyloid A, amyloid P, and C-reactive protein. These serum proteins, in a process 
termed opsonization, subsequently bind bacteria facilitating the binding of complement 
and ultimately culminating in engulfment by phagocytic cells. The complement system 
consists of approximately 30 serum proteins which participate in the inflammatory 
response as well as opsonization. 
Should the defenses of innate immunity prove unable to overcome infection, the 
acquired immunity function is activated. This branch of immunity is distinguished from 
innate immunity by the characteristics of specificity and memory. In addition, acquired 
immunity is subdivided into cell-mediated immunity and humoral immunity. The major 
difference between cell-mediated immunity and humoral immunity is the requirement of 
antigen-specific antibody production in the later. 31 
The cellular components of acquired immunity include antigen-presenting cells, 
B cells, and T cells which communicate and coordinate their activities through various 
soluble cytokine mediator molecules. Antigen-presenting cells take up and process 
antigens with subsequent incorporation into the major histocompatibility complex 
followed by transportation of the complex to the cell surface for interaction with 
lymphocytes. Antigen-presenting cells include macrophages, follicular dendritic cells, 
Langerhans dendritic cells, and B cells. In addition to functioning as antigen presenting 
cells, B cells, can, upon antigen exposure, differentiate into memory cells or antibody-
forming cells. B cells are located in the lymph nodes, spleen and peripheral blood. 
Immature T cells undergo a rigorous selection process during their tenure in the thymus 
to eliminate any autoreactive cells. The cells then further differentiate into cytolytic 
cells, suppressor cells, or helper cells. 
The cell mediated subdivision of acquired immunity is further divided into cell-
mediated cytotoxicity and delayed-type hypersensitivity. Cell mediated cytolytic T 
cells recognize target cells through major histocompatibility complex class I or antigens 
associated with self major histocompatibility complex class I. The cytolytic T cell 
releases perforins and enzymatic proteins which induces cellular apoptosis in the target 
cell. In delayed-type sensitivity, a hapten crosses the epidermis, complexes with a 
carrier protein, and is processed by Langerhans-dendritic cells. The dendritic cells 
migrate to lymph nodes and present the processed antigen to T cells which proliferate 
and generate memory T cells. Upon second contact to the hapten, the memory T cells 
are activated and release cytokines to induce proliferation and the expression of 
adhesion molecules on the surface of specific cells in the dermis. Following 
proliferation, T cells make their way from the lymph node to the general circulation 
where they are attached to the site of antigen exposure via the adhesion molecules and 32 
chemotactic cytokines. The T cells subsequently release proinflammatory cytokines 
which attract additional T cells and macrophages followed by inflammation of the 
antigen exposed area. 
Humoral immunity involves uptake and processing of the antigen presenting 
cells, usually macrophages, however B cells can also process and present antigen. The 
T cells are presented the processed antigen as well as exposed to interlukin 1 secreted by 
the antigen presenting cells, thereby activating the T cells. The activated T cells 
proliferate as well as release cytokines to further regulate the response. The activated T 
cells interact with B cells either directly or via cytokines followed by the proliferation 
and differentiation of B cells into antibody forming cells or memory B cells. The 
released antigen-specific antibodies interact with their respective antigen to facilitate 
their efficient removal. The complete process of humoral immunity response requires 3 
to 5 days following the first exposure to the antigen. Additional challenges by the same 
antigen will activate memory B cells and elicit a rapid and intense response. 
The immunotoxic effects of TCDD on cell-mediated immunity were first 
documented in 1972 by Buu-HoI et al. as an involution of the thymus. The thymus 
provides an environment for the maturation of T cells, especially during prenatal and 
postnatal development; however, the function of the thymus in adult immunity is 
uncertain. The critical need for thymic function during development is evident from 
studies demonstrating neonatal thymectomy dramatically compromises T cell numbers 
and function as well as potentiates a lethal wasting (Benjamini and Leskowitz, 1991). 
Although the mechanisms for thymic involution are not completely understood, cell 
culture studies indicated exposure to TCDD results in the differentiation of the thymic 
epithelium (Greenlee et al., 1985). Consequently, the necessary factors for T cell 
maturation become unavailable. Additional in vivo studies revealed TCDD exposure 
also reduces thymocyte proliferation (Lundberg et al., 1990). The consequences of 
prenatal and postnatal thymic involution mediated by TCDD are manifested as 33 
immunity suppression at lower doses of TCDD when compared to adults (Luster et al., 
1980a; Vos and Moore, 1974; Faith and Moore, 1977). Furthermore, these effectsare 
due to alterations of T-cell mediated immunity. 
Investigations of alterations of T cell function in response to TCDD exposure 
have produced interesting, and sometimes conflicting results. Studies by Clark et al. 
(1981) indicated that C57BL/6 mice exposed to doses of TCDD as low as 0.004 ug 
TCDD/kg experienced a specific reduction in the generation of the cytolytic T cell 
response without any alterations of the cellularity of the spleen or lymph nodes. It was 
subsequently suggested that TCDD induced a population of suppressor cells which 
inhibit the proliferation of cytolytic T cells. This study caused controversy because the 
results could not be duplicated by other laboratories. Furthermore, other studies have 
shown no increases in suppressor cell activity in the peripheral lymphoid tissue in 
TCDD exposed mice (Dooley et al., 1990). Addition work by Dooley and Holsapple 
(1988) and Dooley et al. (1990) used either in vivo exposure to TCDD followed by 
in vitro challenge to spleen cells with P815 mastocytoma cells or in vivo exposure to 
TCDD followed by in vivo challenge to P815 mastocytoma cells. The in vitro challenge 
studies revealed a nondose dependent reduction in lytic units from spleenocyte cultures 
isolated from female B6C3F1 mice exposed to cumulative doses of either 0.5, 5.0, or 
50 ug TCDD/kg. These results contrast with the in vivo challenge studies in which only 
the 50 ug TCDD/kg dose displayed any significant reduction in lytic units. 
Helper T cell function is also effected by TCDD exposure. Tomar and Kerkvliet 
(1991), using spleen cells cultures from C57BL/6(B6) female mice primed with sheep 
red blood cell and exposed to 5 ug TCDD/kg, demonstrated a reduced response to sheep 
red blood cells conjugated to the hapten trinitrophenyl-benzenesulfonate. This response 
was indicative of reduced helper T cell activity of helper T cells. In vitro studies using 
the sheep red blood cell antigen assay, a humoral response requiring helper T cell 34 
involvement, and thymocytes from B6 mice treated with 50 ug TCDD/kg demonstrated 
alterations in the ability to mount an anti-sheep red blood cell response (Lundberg et al., 
1990). 
Studies using polychlorinated biphenyl exposed mice challenged with P815 
mastocytoma cells indicate alterations in cytokines such as interlukins 2, 4, 6, 10, and 
interferon y secreted by regulatory T cells (DeKrey et al., 1993; Steppan et al., 1993). 
Such alterations in cytokine signaling may impact T cell function. Since many, if not 
all, the polychlorinated biphenyls and chlorinated dibenzo-p-dioxins effects are 
mediated via the Ah receptor, it is reasonable to conclude that TCDD should alter 
cytokine levels as well. However, in ex vivo studies employing T cells from TCDD 
treated mice, levels of interlukin 2 were not impacted (Clark et al., 1983). 
Exposure to TCDD also affects B cells and alters the antibody response. Studies 
suggest that TCDD exposure prevents B cells from differentiating into antibody 
producing cells (Holsapple et al., 1986; Tucker et al., 1986). Additional evidence that 
TCDD targets B cells is evident from exposure studies demonstrating the similarity in 
suppression of the following humoral responses: the polyclonal response to 
lipopolysaccharide, the T cell independent responses to trinitrophenyl-haptenated 
lipopolysaccharide and dinitrophenyl-haptenated ficoll, and the T-cell dependent 
response to sheep red blood cells (Dooley and Holsapple, 1988; Chastain and Pazdernik, 
1985). In addition, Chastain and Pazdernik (1985) revealed that TCDD exposure had a 
greater impacted on the immature B cells within the bone marrow compared to the 
mature cells of the spleen. Subsequent work by Dooley et al. (1990) demonstrated that 
alterations in the humoral immune response was not a sequelae due to the actions of 
suppressor T cells. Other evidence indicating TCDD alters B cell differentiation is seen 
in the suppression of immunoglobin M secretion in B cells activated by anti­
immunoglobin and T-cell replacing factor (Luster et al., 1988). 35 
The macrophages of the immune system, unlike the B and T cells, are not 
affected by exposure to TCDD. Studies using B6C3F1 (C57BL/6 x C3H) mice exposed 
to 10 ug TCDD/kg indicated no significant changes in macrophage functional 
parameters as demonstrated by their ability to induce cytostasis of MBL-2 tumor cells, 
cause the cytolysis of P815 tumor cells, and engulf fluorescent microspheres by 
phagocytosis (House et al., 1990). In addition to macrophages, natural killer cell 
function is also unaffected by TCDD exposure (House et aL, 1990; Mantovani et al., 
1980). 
Studies of humans exposed to TCDD in Times Beach, Missouri; Seveso, Italy, 
and from an industrial accident at a British 2,4,5-trichlorophenoxyacetic acid 
manufacturing plant have revealed no clear pattern as to the effects of TCDD exposure 
on the immune system. A study of 41 Times Beach, Missouri residents, with adipose 
tissues concentrations of TCDD as high as 750 ppt, displayed increases in their total 
T-cell numbers (Webb et al., 1989). In addition, proliferative responses to concanavalin 
A, phytohemagglutinin, pokeweed mitogen, or tetanus toxoid and the cytotoxic T cell 
response were not evident. Furthermore, no subject experienced any detrimental 
clinical disease. These observations are in contrast to a study of residents of the Quail 
Run Mobile Home Park, Gray Summit, Missouri, an exposed area with soil 
concentrations of TCDD as high as 1100 ppb. These individuals experienced a decrease 
in T3, T11, and CD4 T cell numbers as well as decreases in the delayed type 
hypersensitivity response (Hoffman et al., 1986). Intriguingly, a follow-up study in 
1988 revealed no alterations in the delayed-type hypersensitivity response (Evans et al., 
1988). 
A study of 44 children exposed to TCDD from a TCP plant explosion in Seveso, 
Italy, performed 3 years after exposure, revealed no alterations in complement proteins 
or serum immunoglobin or responses to T and B cell mitogens (Pocchiari et al., 1979). 
In contrast to these observations, a different cohort of children were examined 6 years 36 
after the accident. Here elevated levels of complement protein, increased peripheral 
blood lymphocytes and proliferative response were evident (Tognoni and Bonaccorsi, 
1982). It is interesting to note that chloracne in the exposed children of the later study 
correlated with the results as compared to the first study in which only 20 of the 44 
individuals displayed signs of chloracne. 
In 1961, workers were exposed to chlorinated dibenzo-p-dioxins in an explosion 
at a 2,3,5-trichlorophenoxyacetic acid manufacturing plant in England. A study of 18 
exposed individuals, 8 with chloracne, 17 years post exposure revealed B and T cell 
numbers were unaltered; however, natural killer cell numbers were elevated (Jennings et 
al., 1988). 
2.1.3.5 Chloracne 
Although controversy and uncertainty surrounds many of the proposed human 
endpoints resultant from TCDD exposure, chloracne is the most obvious and undeniable 
sign of exposure to polyhalogenated hydrocarbons. Originally observed in 1897 
(Bettmann, 1901), Herxheimer (1901) incorrectly proposed that exposure to chlorine 
gas was the etiologic agent and proposed the term chloracne, a truncated version of 
chlorine acne. In 1918, exposure to chlorinated naphthalenes resulted in an outbreak of 
chloracne (reviewed in Webster and Commoner, 1994) implicating halogenated 
aromatic compounds as the causative source of chloracne. In 1957, Kimmig and Schulz 
identified exposure to TCDD as a cause of chloracne. 
Chloracne results from the overactive sebaceous glands producing vast excesses 
of keratin. Although best associated with human exposure, chloracne-like lesions also 
occur with rhesus monkeys, hairless mice, and on the inner surface of rabbit ears 
(reviewed in Crow, 1978). The clinical signs of chloracne have been reviewed by Crow 
(1978). Exposure to sufficient concentrations of chloracnegenic compounds, such as 
TCDD, can result in the formation of comedones accompanied by small pale yellow 37 
cysts, papules, and pustules. The skin of the face is notably sensitive especially around 
the eyes and behind the ears. Other areas of the body, thought to be dependent on the 
chemical dose, are also effected beginning with the remainder of the face followed 
sequentially by the neck, shoulders, genitalia, chest, and lower trunk. In extreme cases, 
legs, feet, and hands are also effected. Some cases experience hyperpigmentation of the 
skin while an unfortunate few have had their entire body covered with sharp horny 
spines likened by Crow as those of a nutmeg grater. Mild cases of chloracne last only a 
few months while severe cases will experience skin lesions for years after exposure 
(Crow, 1978; Reggiani, 1980, 1978; Suskind and Hertzberg, 1984). Remarkably, one 
study reported a persistence of lesions 26 years post exposure (Moses et al., 1984). The 
endpoint of chloracne is permanent scarring of the skin which, at times, can be quite 
disfiguring. Although chloracne is a positive indicator of TCDD exposure, the lack of 
this disorder does not eliminate the possibility of exposure. 
2.1.3.6 The Wasting Syndrome 
All laboratory animals exposed to a sufficient dose of TCDD undergo a lethal 
wasting characterized by a lose in muscle mass and adipose tissue (Max and Silbergeld, 
1987; Peterson et at, 1984). Mice experience an increase in body weight prior to death 
due to acites and subcutaneous edema (Kelling et al., 1985). Those exposed to a high 
sublethal dose experience stunted growth (Seefeld et al., 1984a). In addition, 
adipocytes exposed to TCDD in vitro (Phillips et al., 1995) or in vivo (Brodie et al., 
1996) do not differentiate. Given the observation that TCDD exposure causes severe 
wasting in adipose cells, it is not unreasonable to consider the inhibition of cell 
differentiation as a factor involved in wasting, thereby possibly interfering with the 
cells' lipid storage and releasing ability. 
Onset of hypophagia subsequent to exposure is thought to be the primary factor 
underlying the wasting syndrome (Seefeld and Peterson, 1983; Seefeld et al., 1984b; 38 
Potter et al., 1986a; Kelling et al., 1985; Christian et aL, 1986a). Refusal of feed in 
TCDD exposed rats has been proposed by Rozman et al. (1991) to be a consequence of 
the reduction of tryptophan 2,3-dioxygenase activity followed by the elevation of 
tryptophan. It is also interesting to note that rats exposed to TCDD spill more of their 
feed in a dose-dependent manner compared to controls (Seefeld et aL, 1984b). 
The exact mechanism(s) which contribute to the wasting syndrome are not 
known. Various studies have investigated the possibility of impaired nutrient uptake, 
energy expenditure, changes in intermediary metabolism, and alterations of the set point 
for body weight as contributing factors. Work by Seefeld and Peterson (1984) and 
Potter et aL, 1986a) indicated that nutrient absorption is unaffected by TCDD exposure. 
As such, the lack of nutrients due to the impairment of food absorption does not 
contribute to TCDD-mediated wasting. 
Studies of the effect of TCDD on energy expenditure explored the possibility of 
changes in basal metabolic rate, locomotion, and nonshivering thermogenesis. Basal 
metabolic rates in TCDD exposed rats are decreased in a time and dose dependent 
manner (Seefeld et al., 1984b; Potter et al., 1986a,b; Rozman and Greim, 1986a). 
Likewise, a similar reduction was also evident in the pair-fed controls (Potter et al., 
1986a,b). This observation would suggest the change in basal metabolic rates is not a 
direct consequence of TCDD exposure and does not contribute to the wasting 
syndrome. 
Investigations of changes in interscapular brown adipose tissue, the primary 
tissue for nonshivering thermogenesis, in TCDD exposed rats revealed morphological 
changes such as lipid depletion, mitochondrial swelling, and enhanced lysosomal 
activity ( Rozman et al., 1986a,b; 1987). Although morphologic changes were evident, 
thermogenic activity remained unchanged (Weber et al., 1987b). Even in light of the 
morphologic alterations, exposure to TCDD does not appear to impact thermogenesis 
nor contribute significantly to the wasting syndrome. 39 
Work by Tuomisto et al. (1993) investigated changes in motor activity of Long-
Evans and the H/W strain of Wister rats exposed to TCDD. The Long-Evans rat is a 
TCDD susceptible strain and the Han/Wister strain is quite resistant. Motor activity of 
the Long-Evans rats was reduced in both the experimental and the pair-fed controls. On 
the other hand, the Han/Wister strain was unaffected. These results would indicate 
exposure to TCDD dose not directly induce energy expenditure through locomotion, 
thereby not contributing to the wasting syndrome. 
Intermediary metabolism pathways are able to utilize ingested and stored 
carbohydrates and lipids as well as various endogenous metabolites for energy 
production. In addition to energy production, intermediary metabolic pathways are also 
involved in the synthesis and storage of lipids in adipose cells and carbohydrates in the 
form of glycogen. As such, one can envision the impact of altering the equilibrium 
between the pathways of intermediary metabolism as possibly being manifested in the 
form of metabolic wasting. Exposure to TCDD appears to alter the flux and utilization 
of carbohydrates and lipids, although results of various studies are contradictory. 
Several examples are presented in the following paragraphs to illustrate several TCDD-
mediated alterations in lipid and carbohydrate metabolism. 
Increases in lipid utilization are evident in the form of decreased respiratory 
quotients in TCDD exposed rats fed a high carbohydrate diet (Potter et al., 1986a; Muzi 
et al., 1989). Furthermore, TCDD treated rats given [14C]palmitic acid resulted in 
increased exhalation of 14CO2 (Rozman and Greim, 1986b). Also, lethally exposed rats 
mobilize peripheral adipose lipids (Pohjanvirta et al., 1990b). In contrast to the above 
studies, investigations using other strains of rats indicated lipid oxidation is either 
reduced or not effected. Male Sprague-Dawley rats exposed to 75 ug TCDD/kg 
experienced reduced fatty acid 13-oxidation (Christian et al., 1986b) while 0-oxidation in 
Fischer 344 male rats exposed to 160 ug TCDD/kg was not altered (Tomaszewski et al., 
1988). Wister rats exposed to TCDD also do not display alterations in 13-oxidation; 40 
however, lipid-derived acetyl CoA in exposed animals is diverted from the citric acid 
cycle to the ketogenic pathway ( Lakshman et al., 1991). On the other hand, glycerol 
derived carbon units, formed subsequent to the hydrolysis of triacylglycerols, are not 
significantly diverted to the ketogenic pathway or the citric acid cycle (Lakshman et al., 
1991). 
Serum lipids also vary between TCDD exposed animals. Rats, guinea pigs, and 
rabbits experience hypertriglyceridemia (Gasiewicz and Neal et al., 1979; Swift et al., 
1981; Brewster et al., 1988; Schiller et al., 1985; Christian et al., 1986b). These 
observations are in contrast to C57BL/6 mice which experience hypotriglyceridemia 
(Chapman and Schiller, 1985). Free fatty acids in serum also vary among strains of rats 
and the dose of TCDD exposure. A lethal dose of 50 ug TCDD/kg given to Long-Evans 
rats increased serum free fatty acids while a nonlethal dose of 5 ug TCDD/kg did not 
alter levels. Similarly, nonlethal exposures of TCDD to Han/Wister, Sprague-Dawley, 
and Fischer rats did not alter serum free fatty acid levels (Pohjanvirta et al., 1989; 
Schiller et al., 1985; Christain et al., 1986b). In contrast to these observations, Wistar 
rats nonlethally exposed to TCDD display increased serum free fatty acids (Lakshman 
et al., 1991). 
Fatly acid synthesis is also impacted by TCDD exposure and, like n- oxidation 
and serum lipids, differences exist between strains of animals. Sprague-Dawley rats 
exposed to 125 ug TCDD/kg experienced increased hepatic fatty acid synthesis (Gorski 
et al., 1988). Conversely, in Wister rats exposed to 50 ug TCDD/kg, fatty acid 
synthesis capabilities are impaired due in part to the reduced activity of acetyl­
coenzyme A carboxylase (McKim et aL, 1991). 
The contrasts in lipid metabolism subsequent to TCDD exposure upon various 
laboratory animals and strains complicates the search for an underlying mechanism(s) 
involved in the mediation of these changes. It is not inconceivable for slight variations 
in lipid metabolism to normally occur between different strains of animals which, upon 41 
exposure to TCDD, are dramatically enhanced, reduced, or rerouted thereby producing 
the contrasts seen among animal strains. Nevertheless, the final outcome is the same, a 
decline in body weight due in part to rapid lose of adipose stores which occurs as a 
sequelae to high dose exposure to TCDD. 
Carbohydrate metabolism is also effected by exposure to TCDD. Weber et al. 
(1987a) demonstrated that the elimination of [14C]glucose derived radioactivity was 
reduced in Sprague-Dawley rats exposed to 125 ug TCDD/kg. Subsequent studies by 
Gorski et al. (1990) proposed that the reduced conversion of [14C]alanine to 
[14C]glucose in TCDD exposed rats indicated a reduction in gluconeogenesis. 
Subsequent studies by Rozman and colleagues have demonstrated the TCDD induced 
reduction of activity and mRNA levels of the hepatic gluconeogenic enzyme 
phosphoenolpyruvate carboxykinase (PEPCK) in Sprague-Dawley rats (Weber et al., 
1991a,b, 1992; Stahl et al., 1993). Additional studies in TCDD in C57BL/6J and 
DBA/2J strains of mice also have revealed a reduction in hepatic PEPCK activity. 
(Smith and Rozman, 1993; Weber et al., 1995). It is interesting to note that TCDD-
induced changes in hepatic PEPCK appear to be a tissue specific event. In addition to 
liver, kidney tissue also possesses relatively high levels of PEPCK, for this tissue also is 
also a major site for gluconeogenesis. However, kidney PEPCK activity is unchanged 
in TCDD exposed animals (Weber et al., 1995). On the other hand, in Sprague-Dawley 
rats exposed to 30 or 60 ug TCDD/kg, a slow, but steady increase of kidney PEPCK 
activity occurs until day 16 post exposure, followed by a decline to near normal levels 
by day 32 (Viluksela et al., 1995). Furthermore, in the same study, brown adipose 
PEPCK activity in these animals were also transiently increased, peaking at day 4 post 
exposure followed by a decline to near normal levels by day 32. It is noteworthy to 
point out that the dose-dependent decrease in hepatic PEPCK activity remains 
suppressed throughout the time course. 42 
Other critical enzymes in carbohydrate metabolism have also been investigated 
to determine the impact TCDD exposure may have upon them. Pyruvate kinase, a rate 
limiting enzyme in glycolysis, is not effected in TCDD exposed rats (Weber et al., 
1991a). Glucose-6-phosphatase, a dephosphorylating enzyme needed for release of 
glucose from cells, activity is reduced in C57BL/6J and DBA/2J male mice exposed to 
> 75 ug/ kg and > 375 ug/ kg TCDD, respectively (Weber et al., 1995). Reductions in 
glucose-6-phosphatase activity also occurs in Sprague-Dawley rats exposed to TCDD, 
however the dose dependency is variable (Weber, et al. 1991a,b). The activity of 
pyruvate carboxylase, an enzyme which provides metabolites for gluconeogenesis and 
the citric acid cycle, is also reduced in Wister and Sprague-Dawley rats exposed to 
TCDD (McKim et al., 1991; Weber et al., 1991a, 1992). It is of interest to note the 
commonality in the reduction of pyruvate carboxylase activity compared to the contrast 
in fatty acid synthesis, i.e. stimulated in Sprague-Dawley rats and reduced in Wistar 
rats. 
A quite intriguing hypothesis was proposed by Seefeld et al. (1984b) to explain 
the hypophagia and weight lost that occurs after an acute exposure to TCDD. An 
animal's body weight is regulated by what Seefeld's group termed an internal set point. 
Throughout an animals life, its weight is adjusted to this set point through either 
increased or decreased food consumption. Exposure to TCDD lowers the internal set 
point thereby causing the animal to reduce its food intake in an attempt to match the 
new set point. Seefeld's group based this hypothesis on two lines of evidence: 1) Rats 
exposed to a nonlethal dose of TCDD initially experience reduced food intake and 
weight loss followed by an increase interest in food consumption approaching near 
normal levels. However, the animals never fully regained their original weight and did 
not undergo hyperphagia in an attempt to increase their weight for the duration of the 
study, i.e. 5 weeks. 2) The animals only consumed the necessary amount of food to 
maintain the new lower weight. 43 
The ability of TCDD to alter the activity and expression of critical rate limiting 
enzymes involved in intermediary metabolism may alter the metabolic flux through the 
various pathways and contribute to the wasting syndrome. To what degree these 
enzymatic changes contribute to metabolic wasting is uncertain as the underlying 
mechanisms for TCDD-induced wasting is still unknown. Furthermore, one should 
consider the possibility of changes in the internal set point along with alterations in the 
flux through the metabolic pathways functioning in an agonistic manner to enhance 
metabolic wasting subsequent to TCDD exposure. 
Humans exposed to TCDD do not appear to experience the lethal wasting 
observed in exposed laboratory animals. However, it is worth noting that exposed 
individuals in the Yusho and Yu-Cheng rice oil poisoning incidences experienced 
prolonged suppressions of appetite (Urabe et al., 1979; Lii and Wu, 1985). Even though 
no humans have perished from TCDD induced wasting, this does not imply that humans 
cannot succumb to the wasting syndrome. Rather, it may indicate that humans to date 
have not been exposed to a sufficient dose to elicit the wasting response seen in animals. 
2.1.4 The Aryl-Hydrocarbon Receptor (AhR) 
The AhR is a ligand-dependent transcription factor which is believed to mediate 
all the detrimental effects of TCDD exposure. Originally discovered and characterized 
in cytosolic fractions of murine liver tissue (Poland et al., 1976), the AhR functions in a 
manner similar to the steroid hormone receptors in which the liganded receptor binds to 
DNA regulatory elements of various genes to regulate transcription. However, cloning 
and sequence analysis of the AhR revealed the lack of a zinc finger motif, a 
characteristic associated with the receptors of the steroid superfamily (Burbach et al., 
1992; Ema et al., 1992). Analysis of the C57BL/6 murine AhR revealed a molecule 
with a molecular mass of approximately 95 kDa (Poland and Glover, 1987; Prokipcak 
and Okey, 1990). Amino acid sequencing revealed the AhR is comprised of three 44 
distinct domains (Burbach et al., 1992; Ema et al., 1992). A basic helix-loop-helix 
domain is present near the amino terminus of the molecule. The basic portion is 
involved in DNA binding while the helix-loop-helix motif is for the dimerization with 
other proteins. The second region, termed the PAS domain due to it high homology to 
segments from the PER and SIM proteins of Drosphila melanogaster, contains two 
direct repeats of approximately 50 amino acids. It is believed that the repeat nearest the 
carboxy terminus, termed the PAS B repeat, is involved in ligand binding as well as 
heterodimerization with other proteins. The final domain, positioned near the carboxy 
terminus is a glutamine-rich region which is thought be able to interact with other 
transcription factors with a similar domain. Such protein-protein interactions may assist 
in the regulation of transcriptional activity. 
The unliganded AhR is located in the cytosolic fractions of tissue homogenates 
(Okey et al., 1980; Cuthill et al., 1987). Immunofluorescence microscopy techniques 
further verified the localization of unliganded AhR to the cytoplasm in Hepa 1c1c7 cell 
cultures (Pollenz et al., 1994). In contrast to Hepa 1c1c7 cell cultures, the AhR of 
untreated mice are found in both the nuclear and cytoplasmic compartments (Abbott et 
al., 1994; Abbott et al., 1993). The purpose for the localization of the AhR in both 
compartments is uncertain, although it is suggested that this observation may be due to 
binding of a yet unknown endogenous ligand or ligand-independent nuclear targeting 
(Hopkinson, 1995). 
The unliganded cytosolic AhR is part of a 280 kDa, multiprotein complex 
(Denison et al., 1986; Cuthill et al., 1987) comprised, in addition to the AhR, of two 
molecules of heat shock 90 proteins (Perdew, 1988; Denis et al., 1988) and a third 
protein designated p50 (Perdew, 1992) (Figure 2.2). The heat shock 90 proteins are 
protein products of different genes (Perdew et al., 1993) which bind to the PAS B 
domain of the AhR, overlapping the ligand binding site (Whitelaw et al., 1993). 
Binding of this pair of proteins to the AhR may maintain a configuration which allows 45 
for ligand binding and may also prevent binding of the unliganded AhR to DNA 
(Pongratz et al., 1992). Upon binding of ligand, the heat shock proteins are released. 
The p50 protein has not been fully characterized; however, Matsumura (1994) has 
proposed an intriguing function based on the following observations: 1) TCDD 
exposure increases c-fos, jun B, and jun D levels of mRNA in C4 cells which lack the 
aryl hydrocarbon receptor nuclear translocator (ARNT) protein necessary for the 
interaction of liganded AhR with DNA; 2) Exposure of C4 cells to TCDD also 
increased calcium ion influx within 5 minutes of exposure, too rapidly for de novo 
synthesis of proteins through the induction of gene transcription by nuclear receptor 
binding mechanisms; 3) Various protein kinase inhibitors can eliminate certain effects 
subsequent to TCDD exposure; 4) Heat shock 90 proteins, along with heat shock 50 
and 70 protein, are involved with pp60src translocation, folding, and membrane 
insertion. pp60sre. Proteins are tyrosine kinases involved in the signal transduction of 
various pathways. Matsumura suggests that the cytosolic AhR complex may also 
include the pp60src protein in association with the p50 protein. Upon binding of TCDD 
to the AhR, the heat shock protein and p50 with its associated pp6Osrc are released, 
allowing for the activation of the kinase activity of pp6Osrc followed by activation of 
various signaling pathways in a rapid and efficient manner. Thus exposure to TCDD 
could, in addition to altering gene expression through AhR interaction at the genomic 
level, alter phosphorylation signaling pathways resulting in responses which occur 
minutes after exposure. Further investigations by Enan and Matsumura (1995) have 
demonstrated TCDD-induced increases in tyrosine kinase activity independent of de 
novo protein synthesis. 
As previously mentioned, the ligand binding site of the AhR is located within 
the PAS-B domain. Sulfhydryl groups within this domain are necessary for ligand 
binding (Denison et al., 1987). Upon binding, the associated heat shock proteins and 
protein p50 are released and the liganded AhR is translocated to the nucleus in what is 46 
Figure 2.2. The AhR pathway for gene induction, e.g. cytochrome P-450 1A1 gene 
expression. The hydrophobicity of TCDD allows it to enter the cell via simple 
diffusion. Upon binding the AhR, a pair of heat shock 90 proteins and protein p50 are 
released. The liganded receptor forms a heterodimeric complex with the ARNT protein. 
The heterodimer complex subsequently interacts with a specific DNA cis-element 
designated as dioxin response element (DRE). In the cytochrome P-450 I Al gene, 
binding of the liganded AhR-ARNT complex enhances transcription of mRNA. 
TCDD; a = Ah receptor;  = ARNT;  = heat shock protein 90; v = protein p50. 47 
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thought to be an energy-dependent process (Okey et al., 1980) (Figure 2.2). Before 
DNA binding can occur, the liganded AhR forms heterodimers ina 1:1 ratio with 
ARNT, a ligand-independent basic helix-loop-helix transcription factor (Hoffman et al., 
1991). Originally, ARNT was proposed to facilitate nuclear translocation; however, 
studies with ARNT-deficient Hepa cell cultures revealed liganded AhR translocates to 
the nucleus even in the absence of ARNT (Pollenz et al., 1994). As such, the role 
ARNT plays in nuclear translocation is in question. Nevertheless, liganded AhR must 
form a heterodimer with ARNT prior to binding to DNA (Reyes, 1992). In addition 
ARNT must be phosphorylated for dimerization to occur (Berghard et al., 1993). 
Furthermore, phosphorylation of the AhR appears necessary for DNA binding. The 
liganded AhR/ARNT heterodimer binds in the major groove of DNA (Shen and 
Whitlock, 1989; Neuhold et al., 1989) to a regulatory element termed the dioxin 
response element (DRE) or xenobiotic response element (XRE) containing the core 
nucleotide sequence 5' TA/TGCGTG 3' (Denison et al., 1988, 1989; Saatcioglu et al., 
1990; Hapgood et al., 1989). DREs function as enhancer elements which are usually 
positioned upstream of the transcriptional start site of a gene in an orientation 
independent fashion and alter transcriptional activity. The best characterized example 
of TCDD liganded AhR/ARNT heterodimer interactions with DREs to alter 
transcriptional regulation of a gene is the upregulation of the cytochrome P-450 1A1 
gene (reviewed in Whitlock, 1990, 1993). 
The ability of the AhR to bind ligand is not equal among the various species and 
strains of laboratory animals. Murine studies using DBA/2J and C57BL/6J strains of 
animals have shown that the affinity of the DBA/2J AhR for TCDD is approximately 
tenfold lower than the AhR of the C57BL/6J animals (Okey et aL, 1989). This is 
notably similar to the observation that a tenfold higher concentration of TCDD is 
required for the DBA/2J mouse strain to mirror the aryl hydrocarbon hydroxylase 
activity of TCDD exposed C57BL/6J mice (Poland et al., 1974). In 1972, Thomas et al. 49 
surveyed 21 inbred strains of mice for the inducibility of hepatic aryl hydrocarbon 
hydroxylase activity by 3-methylcholanthrene. The DBA/2 strain, with a allele labeled 
Ahhn , was chosen as the prototypical nonresponsive strain because of the near zero 
inducibility of aryl hydrocarbon hydroxylase activity upon exposure to 3-methyl­
cholanthrene. Conversely C57 BL/6J mice, possessing an allele labeled Ahhi was 
selected as the prototypical inducible mouse strain due to the high inducibility of aryl 
hydrocarbon hydroxylase activity upon exposure to 3-methylcholanthrene. Cross 
breeding between the DBA/2J and C57BL/6J strains indicated inducibility segregated as 
a single autosomal gene. Subsequent to these studies, Green and the Committee on 
Standardized Genetic Nomenclature for Mice (1973), proposed renaming the Ahhi allele 
Ahb and the Ahhn allele Ahd. Further characterization of the Ah alleles in several mouse 
strains revealed that a single Ahd allele with a molecular weight of approximately 
104,000 exists in 18 strains of mice (Poland and Glover, 1990). On the other hand, up 
to three allelic variations of the Ahb allele have been characterized from various strains 
of mice. These variants include: 1) Ahb-1 allele which encodes a high affinity, heat-
stable receptor with a molecular weight of approximately 95,000; 2) Ahb-2 allele 
encoding a high affinity, heat-labile receptor with a molecular weight of approximately 
104,000; 3) Ahb-3 allele that encodes a high affinity receptor of intermediate heat 
lability and a molecular weight nearing 105,000. Sequence analysis of the Ahd and 
Ahb-1 alleles revealed that the Ahd allele varies from the Ahb-1 allele by four amino 
acids, one which occurs within the PAS-B ligand binding domain (Chang 1993). 
Furthermore, the Ahd allele encodes a receptor with an additional 43 amino acids at the 
carboxy terminus. Studies by Ema et al. (1994) indicate that the amino acid difference 
in the PAS B ligand binding site and the additional amino acids at the carboxy terminus 
both contribute to the reduced affinity of the Ahd AhR for TCDD. 
Humans appear to be rather insensitive to TCDD exposure compared to 
laboratory species. Comparisons between the human AhR and AhRs from murine 50 
C57BL /6J and DBA/2J reveals similarities and differences exist. Human AhR was first 
isolated from placental tissues (Manchester et al., 1987) in concentrations similar to that 
found in murine hepatic tissues, i.e. approximately 100 fmol/mg of protein (Poland et 
al., 1986). Human placental AhR, without bound ligand, appears to be more stable than 
rat AhR; however, once liganded, the human AhR is less stable than its rodent 
counterpart (Nakai and Bunce, 1995). The molecular mass of human AhR is 
approximately 106-110 kDa (Poland and Glover, 1987; Harper et al., 1991; Wang et al., 
1991). It did not go unnoticed that the molecular mass of the human AhR is similar to 
that of the Ahd encoded protein of the insensitive DBA/2J mouse strain. Whether this 
similarity is of consequence is uncertain. The binding affinity of the human AhR for 
TCDD falls in between the DBA/2J and C57BL/6J mouse strains. The Kd for the 
human Ala ranges from 3 to 15 nM (Manchester et al., 1987) while the Kd values for 
TCDD binding to the C57BL/6J and DBA/2J AhRs are approximately 1 nM (Okey, 
1992) and 16 nM (Okey et aL, 1989), respectively. Such evidence would suggest that 
human sensitivity to TCDD is intermediate to that of the prototypical sensitive and 
insensitive murine strains. Whether this conclusion is reasonable is yet to be 
determined. 
2.2 Pyruvate Carboxylase (PC) 
Originally isolated from chicken liver mitochondria in 1960 (Utter and Keech, 
1960), PC (E.C. 6.4.1.1) was subsequently isolated from other vertebrates, invertebrates 
fungi, and bacteria (reviewed in Wallace, 1985). More recently, PC has also been 
discovered in both monocot and dicot plants (Wurtele and Nikolau, 1990). A biotin-
containing enzyme, PC belongs to the group of biotin-dependent carboxylases, namely, 
acetyl CoA carboxylase (EC 6.4.1.2), 3-methylcrotonyl CoA carboxylase (EC 6.4.1.4), 
and propionyl CoA carboxylase (EC 6.4.1.3). In physiological environments, 
mammalian PC occurs as a tetramer. Each monomer consists of a single polypeptide 51 
chain with a molecular weight of approximately 120 kDa (reviewed in Wallace and 
Easterbrook-Smith, 1985). The native tetrameric PC complex forms a tetrahedron 
(Mayer et al., 1980) with the active site located within a cleft running the length of the 
long axis of each monomer (Johannssen et al., 1983). The active site is thought to be 
composed of two separate subsites which interact through a biotin cofactor. The biotin 
molecule is tethered to a lysine residue by an s amide bond (Rylatt et al. 1977) resulting 
in a carrier molecule atop a 14A flexible arm. It has been proposed that the biotin is 
carboxylated by the first subunit in an ATP-dependent process, followed by a 
translocation of the carboxylated biotin to the second subunit and transfer of the 
carboxy group to pyruvate forming oxaloacetate (reviewed in Keech and Attwood, 
1985). Therefore, the overall reaction is actually made up of two partial reactions: 
(1) MgATP + HCO3- + PC-Biotin a MgADP + Pi + PC- Biotin -0O2­
(2) PC-Biotin-0O2- + Pyruvate a PC-Biotin + Oxaloacetate 
The cofactor acetyl CoA is also involved in the reaction by acting as an allosteric 
activator. In addition, various studies have suggested that acetyl CoA performs an 
additional duel role in facilitating the carboxylation of pyruvate by PC. Studies of 
chicken liver PC indicate that acetyl CoA stabilizes the quaternary structure of the 
molecule (Mayer et al., 1980). Additional work by Wallace et al. (1985) suggests that 
acetyl CoA is involved in the carboxylation of the PC biotin cofactor. In addition, 
Mg2+ ion in excess to that complexed with ATP is also required for functional PC 
(Keech and Barritt, 1967). Work by Bais and Keech (1972) indicated binding of Mg2+ 
ion induced a conformational change in PC. Subsequent work by Goodall et al. (1981) 
demonstrated that Mg2+ retains and stabilizes the carboxybiotin intermediate in the first 
subsite by 10 fold. The stabilization of carboxybiotin by Mg2+ is critical, for if the 
carboxybiotin is allowed to move to the second subsite prior to pyruvate binding, the 
carboxy group will rapidly react with the surrounding water in the active site to reform 
HCO3- (Easterbrook-Smith et al., 1976). 52 
Two kinetic mechanisms for the carboxylation of pyruvate by PC have been 
proposed, however controversy still exists as to which mechanism more accurately 
describes the enzymatic kinetics. The non-classical ping pong mechanism (Barden et 
al., 1972) proposed that the two subsites are separated within the active site linked 
together by the lysine bound biotin carrier molecule in which reaction (1) proceeds to a 
rapid equilibrium at the first subsite followed by the binding and subsequent 
carboxylation of pyruvate to oxaloacetate in reaction (2) at the second subsite. The 
second mechanism proposed is a sequential mechanism (Warren and Tipton, 1974) 
which differs from the first in that all of the metabolites involved in the reaction, i.e. 
Mg2+, MgATP, HCO3-, and pyruvate, must sequentially bind to the enzyme subunits in 
the order listed before reaction (1) and (2) can proceed. 
Pyruvate carboxylase is an intermediary metabolism enzyme which performs an 
anaplerotic role in the citric acid cycle and provides carbon units for gluconeogenesis. 
(Figure 2.3). Increased PC activity, signaled by changes in acetyl CoA levels, 
replenishes the oxaloacetate carbon units of the citric acid cycle as it is drawn off for 
other biosynthetic processes such as gluconeogenesis, amino acid synthesis, e.g. 
aspartate, or as citrate for fatty acid or neurotransmitter synthesis. To provide substrate 
for gluconeogenesis, a cytosolic pathway, oxaloacetate carbon units must be shunted 
across the mitochondrial membranes in the form of malate. The inner mitochondrial 
membrane is impermeable to oxaloacetate. Mitochondrial malate dehydrogenase 
reduces oxaloacetate to malate, thereby allowing the carbon units of oxaloacetate to 
cross the mitochondrial membranes. Once in the cytoplasm, the transported malate is 
oxidized to oxaloacetate by cytosolic malate dehydrogenase, thereby providing a 
substrate for phosphoenolpyruvate carboxykinase (PEPCK), a rate limiting enzyme in 
gluconeogenesis. The distribution of oxaloacetate between the citric acid cycle and 
gluconeogenesis is approximately equal (Martin et al., 1993). 53 
Figure 2.3,. The intermediary metabolism pathways involving PC. PC catalyzes the 
ATP-dependent carboxylation of pyruvate to form oxaloacetate. Oxaloacetate can 
subsequently be used to anaplerotically replenish carbon units for the citric acid cycle. 
The citric acid cycle produces reducing equivalents in the form of reduced 
nicotinamide-adenine dinucleotide and flavin-adenine dinucleotide which are oxidized 
in the oxidative phosphorylation pathway to ultimately produce ATP. Oxaloacetate 
carbon units are also used as a precursor for the cytosolic gluconeogenic pathway. 
Transport to the cytosol involves reduction to malate by mitochondrial malate 
dehydrogenase followed by oxidation to oxaloacetate in the cytosol by cytosolic malate 
dehydrogenase. Mitochondria! Inner Membrane 
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During mammalian development, PC levels and activity are quite low (Chang, 
1977; Yeung et aL, 1967). This observation is reasonable, for the developing fetus 
obtains its nutrition maternally and would not require high rates of flux through the 
intermediary metabolism pathways. As parturition approaches, the levels and activity 
of hepatic PC begin to rapidly increase and continues to do so, reaching a maximum 
approximately 5 days after birth followed by a slow two to three fold decline over the 
next thirty days to adult levels. One could presume that this increase in PC protein and 
activity over adult levels may occur to "prime" the intermediary metabolism pathways 
thereby enhancing flux through gluconeogenesis to provide high levels of carbohydrates 
for energy until the newborn can obtain external sources of energy via suckling or food. 
This line of reasoning is evident in the observation that increases in neonatal PC 
levels/activity correlates well with an increase rate of [14C]HCO3- fixation in 
mitochondria (Chlebowski et al., 1979; Snell, 1974) indicating increases in intermediary 
metabolism including gluconeogenesis (recall approximately half of the flux through 
PC is used in gluconeogenesis). In addition, PC levels/activity in premature animals 
remains low up to 3 days after birth and are these animals are typically hypoglycemic 
(Rolph and Jones, 1981; Robinson and Oei, 1976; Chang, 1977). Further evidence 
indicating the critical need for PC activity is readily apparent from the observation that 
humans afflicted with PC deficiency usually die in utero or shortly after birth (Robinson 
et al., 1984; Rutledge et al., 1989; Van Coster et al., 1991). 
Gorski et al. (1990), Weber et al. (1992), and Stahl et al. (1993) have suggested 
that impairment of gluconeogenesis plays an important role in the lethal action of 
TCDD in rats. They report reduced activities for PC and PEPCK, both key enzymes in 
gluconeogenesis, but have suggested that PEPCK inhibition may be a critical factor in 
acute TCDD-induced lethality (Weber et al., 1991b). However, considering PC's 
critical role in intermediary metabolism, as evident by the nearly inevitable premature 
death of PC deficient individuals, as well as the observation that TCDD exposed rats 56 
displayed reductions in PC activity (Weber et al., 1991a,1992; McKim et al., 1991), it is 
reasonable to conclude that TCDD-induced reductions in PC activity may also be a 
primary contributor in TCDD metabolic toxicity. A reduction in PC levels/activity 
would lessen the availability of oxaloacetate substrate for PEPCK and consequently 
gluconeogenesis. Furthermore, lowered PC activity/levels would compromise 
anaplerotic replenishment of oxaloacetate for the citric acid cycle. The possible 
outcome would be lowered production of NADH and FADH2 reducing equivalents with 
subsequent reduction in the flux through the oxidative phosphorylation pathway thereby 
impacting the production of ATP (Figure 2.4). As oxaloacetate carbon units for 
gluconeogenesis must be transported across the mitochondrial membrane as malate, the 
possibility of TCDD altering the activity of either mitochondrial or cytosolic malate 
dehydrogenase could also contribute to the metabolic toxicity of TCDD. The 
intervention of PC activity due to the exposure of TCDD in rats as well as the possible 
impact a reduction in PC may cause to the energy status of an organism (Figure 2.4) 
were the catalyst for the research presented in this thesis. 57 
Figure 2.4. Schematic drawing of the proposed disruption of gluconeogenesis and the 
citric acid cycle concomitant to TCDD exposure. Reduction of PC activity 
level/activity would contribute to a drain of mitochondrial oxaloacetate carbon units in 
the mitochondria. Consequently, impairment of the citric acid cycle would compromise 
the organism's capacity to produce reducing equivalents (NADH and FADH2 ) for the 
respiratory chain and, subsequently, reduce ATP production. The reduction of 
mitochondrial oxaloacetate would impact cytosolic oxaloacetate levels due a reduced 
flux through the malate dehydrogenase (MDH) shunt. Oxaloacetate carbon units for 
gluconeogenesis must be transported across the mitochondrial membrane as malate; as 
such, the possibility of TCDD altering the activity of either mitochondrial and cytosolic 
malate dehydrogenase could also contribute to disruption of gluconeogenesis. Reduced 
cytosolic oxaloacetate would impair gluconeogenesis due to lowered substrate 
availability for phosphoenolpyruvate carboxykinase (PEPCK). Disruption of 
gluconeogenesis is further enhanced by the TCDD-mediated reduction of PEPCK 
activity/levels. 58 
Figure 2.4. 59 
Chapter 3 
Materials and Methods 
3.1. Protein Studies 
3.1.1 Preparation of TCDD for Injection 
Crystallized TCDD (99% pure) was generously provided by Stephen Safe 
(Texas A&M University, College Station, TX). A TCDD stock solution was prepared 
by solubilizing the TCDD crystals in 10 mL of corn oil for 24 hours. The concentration 
of the TCDD stock solution (0.102 mg/mL) was confirmed by mass spectrometry (OSU 
Environmental Health Sciences Center Mass Spectrometry facilities). 
3.1.2 Animals 
Seven-week old C57BL/6J Ahb/b male mice weighing 19-25 grams purchased 
from Jackson Laboratory (Bar Harbor, MA) were housed in polycarbonate cages lined 
with paper towels. Animals were maintained on Teklad Rodent Diet (Harlan Teklad, 
Madison, WI). The mice were held in a room at 22°C, 40-65% humidity, and a 12 hour 
light/day cycle was implemented. The room was maintained as a clean room with 
double entry. Shoe coverings, lab coats, and masks were required for admittance. 
Animal cages were positioned on a rack facing a laminar flow system. 
3.1.3 TCDD Treatment 
Following 3 days of an ad libitum feeding, animals were separated by weight 
and divided into three matched weight groups of nine. In each group of 9, 3 were fed ad 
libitum, 3 were pair-fed based on experimental animal feed consumption, and 3 animals 
from each group were injected i.p. with 1, 10, 20, 50, or 75 ug TCDD/kg body weight. 
The animals were maintained on a pair-feeding program for 8 days. The pair-fed 60 
controls were injected i.p. with corn oil only. The corn oil carrier dose was 4 mL/kg 
body weight. Each mouse received approximately 100 uL of corn oil. Mice fed ad 
libitum were not injected with corn oil. Animal weight and food consumption were 
monitored daily for all groups. 
3.1.4 Protein Extraction 
Mice were sacrificed via CO2 asphyxiation. Livers were quickly excised, 
separated from gall bladders, rinsed with 0.9% ice-cold saline and weighed followed by 
perfusion with 0.9% chilled saline to remove blood. The tissues were minced with a 
razor blade and placed in three volumes (w/v) ice-cold homogenization buffer (Tris-
HCL, 20 mM, pH 7.4; mannitol, 0.3 M; EDTA, 2 mM; dithiothreitol, 1 mM; and 
4- (2- aminoethyl)- benzene sulfonyl fluoride, 0.2 mM. Cell disruption was accomplished 
using a 30 mL Potter-Elvehjem tissue homogenizer (glass on Teflon) at 4°C; this was 
followed by centrifugation at 29,000 x g for 10 minutes at 4°C. The lipid layer of the 
supernatant was removed and the remaining supernatant was subjected to centrifugation 
at 368,000 x g for 45 minutes at 4°C. The supernatant was concentrated using an 
Amicon (Beverly, MA) centriprep concentrator (30 kDa exclusion limit). The retentate 
was made to 10% glycerol, divided into small portions, and stored at -85°C. Protein 
concentration of the retentate was determined as described by Bradford (1976), using a 
bovine serum albumin standard. 
3.1.5 Western Blotting 
Proteins extracts (150 ug) were separated by sodium dodecyl sulfate poly­
acrylamide gel electrophoresis (SDS-PAGE) as previously described (Hames, 1990). 
Following electrophoresis, the gel was equilibrated in transfer buffer (25 mM Tris and 
192 mM glycine, pH 8.3) for 25 minutes at room temperature to remove excess SDS 
and swell the gel. Zeta probe membrane (BioRad, Richmond, CA) was bathed in 61 
transfer buffer for 15 minutes. Transfer of proteins onto the Zeta probe membrane was 
done overnight at 5V constant voltage and at 4°C with a Genie Blotter (Idea Scientific, 
Minneapolis, MN). Incubation and development of the blot was completed as described 
by McKim et al. (1991). 
3.1.6 Enzyme Assays 
The PC activity was measured using the method of Berndt et al. (1978). The 
method is indirect and measures the formation of citrate as the result of PC mediated 
formation of oxaloacetate. Coenzyme A (CoASH), ATP, citrate synthase (EC 4.1.3.7), 
phosphotransacetylase (EC 2.3.1.8), acetylphosphate (K-Li salt), and pyruvate were 
obtained from Boehringer Mannheim (Indianapolis, IN). Protein extracts (150 ug) were 
combined with 600 uL of 167 mM Tris-HC1, pH 8.0, containing pyruvate, 2 umol; ATP, 
1 umol; MgC12, 5 umol; KHCO3, 15 umol; acetyl phosphate, 5 umol; CoASH, 
0.5 umol; citrate synthase 2 U, and phosphotransacetylase, 10 U. The mixture was 
incubated 30 minutes at 37°C, thereby forming citrate. Avidin inhibition (1 U) of 
pyruvate carboxylase was used in assay controls to correct for any non-PC-mediated 
production of citrate. 
Citrate levels were determined as described by Mollering (1985). Lactate 
dehydrogenase (LDH) (EC 1.1.1.27), malate dehydrogenase (MDH) (EC 1.1.1.37), 
citrate lyase (EC 4.1.3.6), and reduced nicotinamide-adenine dinucleotide (NADH) were 
purchased from Boehringer Mannheim (Indianapolis, IN). The following reagents were 
pipetted into a 3 mL quartz cuvette: 1.00 mL glycylglycine/ZnC12 buffer (160 mM 
glycylglycine; 0.19 mM ZnC12); 100 uL 0.32 mM NADH; 1.80 mL H2O; 200 uL 
citrate-containing sample solution; and 20 uL of MDH/LDH solution (3.8 U/mL MDH; 
8.8 U/mL LDH). The resultant solution was mixed via inversion and allowed to stand 
for 5 minutes at ambient temperature followed by measurement of spectrophotometric 
absorbance at 340nm. This process removes any excess pyruvate or unreacted 62 
oxaloacetate within the citrate-containing solution. Twenty uL of citrate lyase solution 
(260U/L) was added to the cuvette with subsequent mixing of the solution via inversion. 
The resultant solution was allowed to stand for 10 minutes at ambient temperature 
followed by recording of the spectrophotometric absorbance at 340nm. The difference 
in the two absorbance measurements were subsequently used in the determination of 
citrate concentration. 
For LDH activity assays, protein extracts (75 ug) were subjected to native 
protein polyacrylamide gel electrophoresis, as previously described (Hames, 1990). 
Activity was determined by the modified activity-based staining described by Thorne et 
al. (1962). In this assay phenazine methosulfate shuttles electrons from NADH, formed 
as LDH oxidizes lactate to pyruvate, to nitroblue tetrazolium, resulting in a purple 
formazan precipitate in the gel. This same method, with substrate changes, was 
employed to visualize malate dehydrogenase. The staining intensity in these activity-
based assays, in the presence of saturating substrate concentrations, is directly 
proportional to enzyme activity. 
3.1.7 Lactate Assay 
Blood was collected immediately after sacrifice from the heart chambers of 
control, 20, 50, and 75 ug TCDD/kg treated mice. Each dose was pooled in iced 
Vacutainer tubes containing sodium fluoride to inhibit LDH and potassium oxalate to 
prevent coagulation. Samples were centrifuged for 10 minutes at 400 x g and serum 
lactate levels determined using a Lactate Kit (No. 735) and Lactate Standard from 
Sigma (St. Louis, MO). There were three mice in each dose group. Measurements were 
made in triplicate. 63 
3.2 mRNA Studies 
3.2.1 Preparation of 12P- Labeled Oligonucleotide Probes 
To analyze PC mRNA levels, a 39-base oligonucleotide probe designated 
MPC-1 was synthesized by the Center for Gene Research and Biotechnology, Oregon 
State University. The probe sequence: 5'-CAT GTC CTT GGT AAC ATG AAC CPT 
TCG GAT AGT GCC CTC-3' is complementary to nucleotides +3560 to +3598 of 
mouse pyruvate carboxylase cDNA (Zhang et al., 1993). This sequence was utilized 
because it is unique to PC when compared to other biotin-containing enzymes (e.g., 
acetyl CoA carboxylase, 3-methylcrotonyl CoA carboxylase, and propionyl CoA 
carboxylase). A Gen Bank database search revealed no significant homology between 
this sequence and other known sequences. Another 15-base oligonucleotide probe 
designated 1406R was utilized to determine the abundance of the 18S ribosomal RNA 
for normalization of the RNA load on membrane blots. The probe sequence: 5'-ACG 
GGC GGT GTG TRC-3' is complementary to nucleotides +1406 to +1392 of 
Escherichia coli 16S rRNA. This is a unique universal sequence found in all 
prokaryotic and eukaryotic organism's small subunit rRNAs (Pace et al. 1988). 
Following synthesis, both probes were purified with C-18 Sep-Pak cartridges. 
Probes were 5' end-radiolabeled to a specific activity of approximately 5 X 108 cpm/ug 
with y[3211 ATP (6000 Ci/mmol, New England Nuclear, Boston, MA) (Sgaramella and 
Khorana 1972). The labeled oligonucleotides were separated from free y[32P] ATP by 
P2 gel chromatography. 
3.2.2 Cellular RNA Preparation and Northern Blot Analysis 
Total RNA was extracted from liver samples with guanidinium thiocyanate­
phenol-chloroform according to the method of Chomczynski and Sacchi (1986). Liver 
samples were homogenized with a polytron at 1/2 maximum speed for 10 seconds while 64 
placed on ice. RNA concentration was determined spectrophotometrically at an 
absorbance of 260nm (1 O.D.  40 ug). An A260/A280 nm ratio was used to assess the 
protein content of the sample. Total RNA was analyzed for integrity on a 2.2 M 
formaldehyde-containing agarose gel. The quality of extracted RNA samples was 
examined using ethidium bromide staining of the agarose gel to verify the 28S and 18S 
bands and their intensity. Gels were washed overnight to remove the formaldehyde in 
doubly distilled H2O. The RNA was subsequently transferred overnight to a Zeta-probe 
membrane (BioRad, Richmond, CA). RNA was immobilized by baking the membrane 
for 1 hour under vacuum at 80°C. The baked membrane was prehybridized for 1 hour at 
55°C in hybridization buffer (0.5X SSC, 3.5% SDS,  125 mM phosphate buffer). 
Following prehybridization, the immobilized RNA was hybridized for 18 hours to the 
5' [32P1 end labeled oligonucleotide probes. Following hybridization, the membrane 
was washed 4 times in washing buffer (2X SSC, 0.1% SDS) at 55°C and wrapped in 
Saran Wrap. Autoradiography was accomplished with Dupont Cronex Plus intensifying 
screens and Kodak X-Ompt film at -90°C. Typical exposure times were 0.5 to 4 days. 
Quantitation of RNA signals was accomplished via scanning densitometry. A 
Molecular Dynamics (Sunnyvale, CA) scanning system and analytical software was 
employed for this purpose. Using the software default settings, the data from 
autoradiographs are reported as image density units. 
3.3. PC Gene Verification and Sequencing of Upstream PC Regulatory Region 
3.3.1 Isolation of Genomic DNA 
Total genomic DNA from livers of untreated C57BL/6J Ahbib male mice was 
isolated with Gentra Systems (Minneapolis, MN) PuregeneTM DNA Isolation Kit as 
directed. DNA concentration was determined spectrophotometrically at an absorbance 65 
of 260nm (1 0.D  50 ug). An A260/A280 nm ratio was used to assess the protein 
content of the sample. DNA solutions were divided into small aliquots and stored 
at -20°C. 
3.3.2 PC Gene Cloning 
To identify and separate the PC gene from total genomic DNA, PCR techniques 
were used. Primers IPCR3 (5'-CAG AGG TGA GAT TGC CAT CCG-3') and PC3 (5'­
GGT GAG ACG TGA GCG AAG TTG-3') were synthesized by The Center for Gene 
Research and Technology, Oregon State University. Primer IPCR3 is homologous to 
PC gene cDNA (Zhang et al. 1993) coding nucleotide sequence +231 to +252 and PC3 
is complementary to coding nucleotide sequence +956 to +976. Thermal cycling 
parameters are shown in Table 3.1. PCR products were subjected to endonuclease 
restriction enzyme digestion. The digest was resolved on a 1% agarose 45 mM Tris­
borate-1 mM EDTA (TBE) horizontal gel. The fragments were visualized by ethidium 
bromide staining. Restriction mapping was used to verify amplification of the PC gene 
from total genomic DNA. 
3.3.3 Isolation of PC Regulatory Sequences Using Vectorette PCR 
Ten ug of genomic DNA was digested with the restriction endonuclease enzyme 
Sau3A1 for 3.5 hours at 37°C. A 0.5 ug aliquot was electrophoresed on a 1% horizontal 
agarose TBE gel to verify complete digestion. Three vectorette oligonucleotides as 
described by Riley et al. (1990) were synthesized by the Center for Gene Research and 
Biotechnology, Oregon State University and designated Bubble Top, Bubble Bottom, 
and Primer Bottom (Figure 3.1a). A fourth oligonucleotide designated IPCR5B with 
the sequence 5'-GAT CCA CAG GCA GTA ACT GCT CCA CCC GA G-3' was also 
synthesized. This oligo is complementary to nucleotide sequence +20 to +49 of the PC 
cDNA sequence reported by Zhang et al.(1993). Annealing of Bubble Top and 66 
Table 3.1. Thermocycling parameters for PCR amplification of the murine hepatic PC 
gene from genomic DNA. 
Cycles  Step  Temperature  Time 
Denature  94°C  1 minute 
3  Anneal  61°C  45 seconds 
Extension  70°C  2 minutes 
Denature  94°C  1 minute 
30  Anneal  61°C  30 seconds 
Extension  70°C  2 minutes 
1  Extension  70°C  10 minutes 67 
Figure 3.1. Vectorette PCR amplification of the PC upstream region. (a) The Bubble 
Top and Bubble Bottom oligonucleotides have complimentarity along 12 nucleotides at 
each end (underlined). The remaining nucleotides of each oligonucleotide lack 
complimentarity. The 5' end (in bold) of Bubble Top possesses a nucleotide tail 
capable of annealing to restriction enzyme Sau3A1 digested genomic DNA fragments. 
Primer Bottom is an oligonucleotide homologous to the noncomplimentary region of 
bubble bottom. Ten ug of Bubble Top and 10 ug of Bubble Bottom oligonucleotides 
were annealed at 60°C for 30 minutes and cooled slowly to ambient temperature. 
(b) The annealed vectorette was combined with 2 ug of Sau3A1 restriction enzyme 
digested DNA (.T.Z) and ligated together using T4 DNA ligase (Life Technologies, 
Grand Island, NY) overnight at 16°C. During the first round of PCR cycling, the 
genomic and orientation specific oligonucleotide (IPCR5B =27) anneals to its genomic 
complementary sequence and a new strand of DNA (--) is synthesized. This strand is 
complementary to genomic DNA and the Bubble Bottom oligonucleotide. In the 
second round of PCR cycling, Bubble Primer oligonucleotide  anneals to its 
complement and a strand of DNA ( ) complementary to the strand produced in the 
first PCR cycle is synthesized. Subsequent PCR cycling further amplifies the DNA 
sequences synthesized during the first and second PCR cycles. Primer 
Bubble Top 
RE  Bottom 
Site 
Bubble Bottom 
Bubble Top = 5'-GATCGAAGGAGAGGACGCTGTCTGTCGAAGGTAAGGAACGGACGAGAGAAGGGAGAG-3' 
Bubble Bottom = 3'- CTTCCTCTCCTGTCGCTAAGAGCATGCTTGCCAATGCTAAGCTCTTCCCTCTC-5' 
Primer Bottom= 3'-TCGCTAAGAGCATGCTTGCCAATGCTAAGC-5' 69 
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Figure 3.1b. 70 
Bubble Bottom oligonucleotides to form the bubble vectorette and ligation of the 
vectorette to Sau3A1 digested mouse genomic DNA followed the method of Allen et al. 
(1994). Vectorette PCR amplification (Figure 3.1b) was performed using a 
modification of the hot start method described by Allen et al.(1994). Briefly, 50 ng of 
vectorette ligated genomic DNA was diluted with doubly distilled H2O to a final 
volume of 50 uL in 0.5 mL thin-walled PCR reaction tubes. The vectorette DNA was 
denatured at 94°C for 3 minutes then held at 80°C using a Perkin-Elmer 480 Thermal 
Cycler. PCR buffer, 40 uL at 2X concentration (Life Technologies, Grand Island, NY), 
containing 100 pmol each of Primer Bottom and IPCR5 primers with dNTPs and MgC12 
at final concentrations of 0.2 mM and 2 mM respectively, were added to the denatured 
DNA solution. An additional 10 uL of 2X PCR buffer containing 5U Taq DNA 
Polymerase (Life Technologies, Grand Island, NY) was added to the DNA-primer 
solution. PCR cycling was performed using the parameters shown in Table 3.2. The 
PCR amplification mixtures were electrophoretically analyzed on 1% TBE horizontal 
agarose gels and bands were visualized by ethidium bromide staining. Isolation of 
approximately 600 bases of the PC regulatory region was achieved using vectorette 
PCR technology. 
3.3.4 Purification and Cloning of Vectorette PCR Products 
To separate successful amplification products away from excess dNTPs, 
primers, and incomplete PCR products, reactions were combined and gel purified using 
a 3% low melt agarose gel containing ethidium bromide. Zones containing DNA were 
excised from the gel, put into 1.5 mL microfuge tubes, and placed in a 650C water bath 
to liquefy the agarose. The material was extracted with equal volumes of 65°C phenol, 
vortexed, then placed on ice. Following centrifugation at 12,000 x g, the aqueous layers 71 
Table 3.2. Thermocycling parameters for vectorette PCR amplification of the upstream 
region of the murine hepatic PC gene from genomic DNA. 
Cycles  Step  Temperature  Time 
Denature  94°C  1 minute 
3  Anneal  66°C  45 seconds 
Extension  72°C  2 minutes 
Denature  94°C  1 minute 
30  Anneal  66°C  30 seconds 
Extension  72°C  2 minutes 
1  Extension  72°C  10 minutes 72 
were transferred to new tubes and extracted once with phenol/chloroform/isoamyl 
alcohol (50:49:1) and transferred to a new tube. The organic layer was backextracted 
with an equal volume of 10 mM Tris-1 mM EDTA buffer, pH 7.8 (TE). The aqueous 
solutions were combined with the extracted aqueous solutions. Solutions were brought 
to 0.8 M LiC1 and the PCR products precipitated with 2.5 volumes 95% ethanol. 
Pelleted by centrifugation, samples were washed twice with 70% ethanol, air dried and 
resuspended in TE buffer. DNA concentration was determined spectrophotometrically 
at 260nm. 
Purified PCR fragments were blunt ended with Klenow fragment (Promega, 
Madison, WS) and ligated into PBS phagmids (Strategene, La Jolla, CA) with T4 DNA 
ligase (New England Biolabs, Beverly, MA). XL1 MRF' Blue Escherichia colt 
(Strategene, La Jolla, CA) were transformed with ligated phagmids using the CaC12­
heat shock method described by Sambrook et al. (1989a). Transformed cells were 
plated onto 100 x 15 mm 5-bromo-4-chloro-3-indoly1-13-D-galactoside (X-gal)-
isopropylthio-P-D-galactoside (IPTG)-Luria-Bertani (LB) agar plates containing 
12.5 ug/mL tetracycline and 60 ug/mL ampicillin. The plates were inverted and 
incubated 16 hours at 37°C. PCR insert containing colonies were identified by blue-
white screening. Select colonies were incubated overnight in LB media containing 12.5 
ug/mL tetracycline and 60 ug/mL ampicillin at 37°C with vigorous shaking (350 r.p.m. 
on a rotary shaker). Phagmids were isolated from the cells (Sambrook et al. 1989b) and 
subjected to restriction enzyme analysis to confirm fragment insertion. Colonies with 
inserts were cultured overnight in LB media containing 12.5 ug/mL tetracycline and 
60 ug/mL ampicillin at 37°C with vigorous shaking (350 r.p.m. on a rotary shaker). 
Phagmids were purified from cellular constituents using Qiagen anion-exchange 
columns and plasmid purification protocols (Qiagen, Chatworth, CA). Sequence 73 
analysis was done by The Center for Gene Research and Biotechnology, Oregon State 
University. Sequencing was performed on a minimum of three separate vectorette PCR 
amplifications. 
3.3.5 Isolation of PC Regulatory Sequences by PCR 
To verify regulatory sequence homology between two strains of C57 mice 
(Ahbib vs. Ahd/d) as well as sequence further into the upstream regulatory region of PC, 
PCR primers used to sequence a portion of the PC regulatory region of congenic 
C57BL/6J Ahdid were used with C57BL/6J Ahbib genomic DNA. The primers, 
synthesized by The Center for Gene Research and Technology, were designated REG5 
(5'-AAC ACC TTC CCA AGA GGC AC -3') and REG3 (5'-TGG AGG GCA AGG 
GTC ATA TT-3'). Thermal cycling parameters are shown in Table 3.3. The PCR 
products were resolved on a 1% agarose TBE horizontal gel and visualized by ethidium 
bromide staining. 
Purification of the desired PCR fragment away from residual primers and dNTPs 
as well as incomplete PCR products was achieved as described in section 3.3.4. 
Purified PCR products were sequenced by the Center for Gene Research and 
Biotechnology, Oregon State University. 
3.3.6 Verification of the PC Transcriptional Start Site 
Total RNA was isolated from normal livers of C57BL/6J Ahbib mice by the 
method of Chomczynski and Sacchi (1986). RNA concentration was determined 
spectrophotometrically using an absorbance of 260nm. An A260/A280 nm ratio was 
used to assess the protein content of the sample. 
An oligonucleotide, designated PCLDR 3B (5'-CT1' GTA CCA GCC AAG 
CAC CTA-3') was synthesized by the Center for Gene Research and Biotechnology, 
Oregon State University. This oligonucleotide is complimentary to the PC 5' noncoding 74 
Table 3.3. Thermocycling parameters for PCR amplification used in verifying hepatic 
PC gene regulatory region sequence homology between C57(Ahb/b) and C57(Ahd/d) 
mice. 
Cycles  Step  Temperature  Time 
Denature  94°C  45 seconds 
3  Anneal  61°C  45 seconds 
Extension  70°C  1.5 minutes 
Denature  94°C  45 seconds 
30  Anneal  61°C  30 seconds 
Extension  70°C  1.5 minutes 
1  Extension  70°C  10 minutes 75 
nucleotide leader region +79 to +100 as indicated by Zhang et. al (1993). The 
oligonucleotide was radiolabeled at its 5' terminus using 7[32P]ATP as detailed by 
Sambrook et al. (1989c). Total RNA samples of 50, 25 and 10 ug were incubated with 
1 X 105 cpm of PCLDR 3B (specific activity approximately 2.6 X 107 cpm/ug) at 30°C 
for 13 hours. This was followed by reverse transcriptase primer extension using 
Moloney Murine Leukemia Virus (MMLV) reverse transcriptase (Epicentre 
Technologies, Madison, WI) and dNTPs (Life Technologies, Grand Island, NY) as 
directed by Sambrook et al.(1989d). The resulting RNA/DNA hybrids were incubated 
for 30 min. at 37°C with 5 ng of DNase-free RNase It TM Ribonuclease Cocktail 
(Strategene, La Jolla, CA). The mixture was brought to 0.1 M NaC1, extracted with an 
equal volume of phenol:chloroform, and the radiolabeled cDNA precipitated with 2.5 
volumes of 100% ethanol. The radiolabeled cDNA was recovered by centrifugation at 
12,000 x g, washed with 70% ethanol, air dried, and resuspended in 80% formamide gel 
electrophoresis loading buffer. 
To verify the PC transcriptional start site, a sequencing ladder was made from a 
phagmid clone containing the PC leader sequence and adjoining upstream regulatory 
region. The phagmid was alkali denatured with 0.4 N NaOH as previously described by 
Epicentre Technologies (Madison, WI). The oligonucleotide PCLDR 3B was 
radiolabeled at its 5' terminus to a specific activity of approximately 2.6 X 107 cpm/ug 
as detailed by Sambrook et al. (1989c) using y[32P]ATP. The radiolabeled 
oligonucleotide was annealed to its complementary sequence in the denatured phagmid 
followed by nucleotide extension sequencing using an IsoThermTM DNA Sequencing 
Kit (Epicentre Technologies, Madison, WI) as directed. 
The sequencing ladder reactions and the radiolabeled cDNA were electro­
phoresed through a 6% polyacrylamide-7M urea sequencing gel. Following electro­
phoresis, the gel was bathed in a 12% acetic acid-10% methanol solution for 15 minutes 76 
then transferred to 3MM Whatman paper and dried for 2 hours at 80°C. The dried gel 
was wrapped in Saran Wrap and exposed with Dupont Cronex Plus intensifying screens 
for 36 hours to Kodak X-Ompt film at ambient temperature. 
3.4 Plasmid Preparation and Transient Transfection Assays 
3.4.1 Plasmid Preparation 
To study the utility of multiple E-Box-sequences contained within the PC 
regulatory region, a luciferase reporter construct containing the regulatory sequence, 
exon 1, and portions of intron 1 of the PC gene (Ryu 1996), was truncated using PCR. 
A luciferase reporter construct containing the upstream regulatory region and 5' 
noncoding nucleotides through +65 of the PC gene was made as described in the 
following paragraphs. 
PCR primers, designated IPCR5 (5'-GGC AGT AAC TGC TCC ACC CGA 
G-3') and LUC-1 (5'- GAG ATC TGC GAT CTA AGT AAG-3') were synthesized by 
the Center for Gene Research and Technology, Oregon State University. IPCR5 is 
complimentary to the PC 5' noncoding nucleotide sequence +44 to +65. LUC-1 has 
homology to nucleotide sequence +35 to +51 of the pGL3 luciferase basic reporter 
vector (Promega, Madison, WI). Nucleotide sequences +1 to +58 of pGL3 encompass 
the multiple cloning site. PCR amplification and cycling was achieved using 
eLONGaseTM enzyme mix (Life Technologies, Grand Island, NY) as directed. PCR 
products were combined and chloroform extracted followed by ethanol precipitation. 
DNA was collected by centrifugation at 12,000 x g at 4°C. The pellets were washed 
with 70% ethanol, air dried and resuspended in TE buffer, pH 7.8. DNA concentration 
was determined spectrophotometrically at 260nm. 
PCR fragments were blunt ended with Klenow fragment (Promega, Madison, 
WS) and ligated with T4 DNA Ligase (Life Technologies, Grand Island, NY) to 77 
recircularize the truncated constructs. The constructs were introduced into XL1-MRF' 
Blue Escherichia coli (Strategene, La Jolla, CA) using CaC12-heat shock transformation 
methods (Sambrook et al. 1989a). The transformed bacterial cells were plated onto 
100 x 10 mm LB agar plates containing 12.5 ug/mL tetracycline and 60 ug/mL 
ampicillin. The plates were inverted and incubated 16 hours at 37°C. Select colonies 
were incubated overnight in LB media containing 12.5 ug/mL tetracycline and 
60 ug/mL ampicillin at 37°C with vigorous shaking (350 r.p.m. on a rotary shaker). 
Plasmids were isolated from the cells (Sambrook et al. 1989b) and subjected to 
restriction enzyme analysis to confirm fragment insertion. To produce large quantities 
of plasmid, a colony with the appropriate insert was cultured overnight in 500 mL LB 
media containing 12.5 ug/mL tetracycline and 60 ug/mL ampicillin at 37°C with 
vigorous shaking (350 r.p.m. on a rotary shaker). Plasmids were purified away from 
cellular constituents using a BIGGER prepTM Plasmid DNA Preparation Kit (5 Prime to 
3 Prime, Boulder, CO). Plasmid concentration was determined spectrophotometrically 
at 260nm. 
A plasmid encoding ARNT, pBM5/Neo/M1-1, was a generous gift from Dr. 
Oliver Hankinson, UCLA, CA. Expression of the ARNT transcript is under the control 
of cytomegalovirus promoter and enhancer regions. The plasmid was propagated using 
CaC12-heat shock transformation methods (Sambrook et al. 1989a) into XLI MRF' Blue 
Escherichia coli (Strategene, La Jolla, CA). Transformed cells were plated onto 
100 x 10 LB plates containing 12.5 ug/mL tetracycline and 40 ug/mL kanamycin, 
inverted and incubated overnight at 37°C. Colonies were selected and plasmids were 
prepared from the cells (Sambrook et al., 1989b). Plasmid insertions were verified by 
restriction endonuclease digestion. A colony was cultured overnight in 500 mL of LB 
media containing 12.5 ug/mL tetracycline and 40 ug/mL kanamycin at 37°C with 78 
vigorous shaking (350 r.p.m. on a rotary shaker). Plasmids were purified as described 
in the previous paragraph and concentration was determined spectrophotometrically at 
260nm. 
3.4.2 Transient Transfection Assays 
Hepa 1c1c7 cells were a generous gift from Dr. James Whitlock, Stanford 
University, CA. Cultures were grown to 80-90% confluency in 75 cm2 flasks 
containing Minimal Essential Media Eagle, Alpha Modification (Sigma, St. Louis, 
MO), 10% fetal bovine serum (Hyclone, Logan, Utah), 100U/mL of penicillin, and 
100 ug/mL streptomycin (Sigma, St. Louis, MO). Cells were trypsinized and seeded 
into 25 cm2 flasks at a density of 8 x 105 cells per flask. Following a 24 hour 
incubation at 37°C, 5% CO2, the cells were transfected for 3 hours in serum-free, 
antibiotic free media using equal concentration ratios of CLONfectinTM, a cationic 
amphiphile (Clontech, Palo Alto, CA), and the following plasmids: 1) the PC regulatory 
region-luciferase reporter construct alone or in conjunction with pBM5/NEO/M1-1 
ARNT plasmid; 2) the pGL3 basic luciferase reporter vector; and 3) a murine 
dihydrofolate reductase (DHFR) promoter region-luciferase reporter construct. The 
murine DHFR promoter region (-270 to +20) has high promoter activity and was used 
as a positive control to verify transfection into Hepa lcl c7 cells occurs. Transfection 
reactions were performed a minimum of four times. Post-transfection procedures 
entailed removal of the transfecting media, washing with Dulbeccos Phosphate Buffered 
Saline, and addition of Minimal Essential Media Eagle, Alpha Modification, containing 
10% fetal bovine serum, 100U/mL penicillin, and 100 ug/mL streptomycin. The cell 
cultures were trypsinized and split evenly between two 35 mm culture dishes. TCDD 
(Midwest Research Institute, Kansas City, MO) suspended in DMSO, was added to 
10 nM final concentration in one culture dish. The other culture dish served as the 
control. 79 
Following incubation for 48 hours at 37°C, 5% CO2, cultures were placed on 
ice. The chilled culture media was removed and the cells were washed twice with 
chilled Dulbeccos Phosphate Buffered Saline. Ice cold 1X lysis buffer (Promega, 
Madison, WI) was overlaid onto the washed cells and the cells were scrapped free of the 
dishes. The lysate solution was placed in microfuge tubes and stored at -80°C 
overnight. Cellular lysates were allowed to come to ambient temperature, vortexed, and 
the cellular debris removed by centrifugation at 12,000 x g. The supernatants 
containing luciferase were combined for each corresponding transfection. The 
luciferase activity was measured as directed (Promega, Madison, WI) using a LKB 
Wallac model 1250 luminometer. 80 
Chapter 4 
Results 
4.1 Protein Studies 
Livers from TCDD-treated animals were visually enlarged and displayed 
reticulation when compared to controls. Body weight to liver weight ratios for TCDD-
treated mice over the dose range investigated were 0.082 + 0.004 and 0.059 + 0.003 for 
pair fed control animals. These observations are consistent with previously reported 
hepatomegaly and fat disposition in the liver of animals subjected to TCDD exposure 
(McKim et al. 1991, Christian et al. 1986b). 
Western blot analysis employing avidin peroxidase visualization (Figure 4.1) 
reveals a reduction in PC protein levels as a function of increasing TCDD dose (lanes 4 
through 8 with TCDD doses of 1, 10, 20, 50, and 75 ug/kg body weight, respectively). 
Lanes 2 and 3 display an interesting phenomena. The PC protein level in control 
animals manifest a notable elevation when compared to ad libitum animals not receiving 
i.p. injections of corn oil (lane 2). This induction of PC was observed at comparable 
levels in control animals sacrificed 14 days postinjection (data not shown). It is worth 
noting that induction of PC is a consequence of caloric restriction in pair-fed control 
animals whose experimental counterparts undergo reduced food consumption (Roy et 
al., submitted). TCDD blocks this induction, which is an early response, and reduces 
PC levels in a dose dependent manner. 
If PC protein levels are reduced as a function of dose, the specific activity of the 
enzyme in the protein extracts would also be expected to be reduced in a dose dependent 
manner. Enzymatic activity analysis of PC, shown in Figure 4.2, demonstrates a dose 
dependent reduction in activity that closely follows the reduction of PC levels shown in 
Figure 4.1. Reduction in activity to 32% of control for the 1 ug/kg body weight dose 81 
Figure 4.1. Western blot analysis of hepatic pyruvate carboxylase from C57BL/6J male 
mice. Lane 1 is E. coli (3 galactosidase biotinylated standard (116,250 Da). Lanes 2 
through 8 are ad libitum, corn oil control, 1, 10, 20, 50, and 75 ug TCDD/kg body 
weight, respectively. Protein (150 ug per lane) was loaded onto 10 x 10 x 0.08 cm SDS­
polyacrylamide gels (3.5% stacking, 6% resolving) and separated at 150V constant 
voltage for 2 hours at ambient temperature. Protein was transferred onto Zeta probe 
membrane with 5 V constant voltage at 4° C for 16 hours. Visualization was by avidin­
peroxidase staining with 4-chloro-l-napthol. 82 
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Figure 4.2. Hepatic pyruvate carboxylase enzyme activity. Protein extracts (150 ug) 
were used to determine activity as described in Chapter 3. Enzyme activity in hepatic 
protein extracts from treated mice (1, 10, 20, 50, and 75 ug TCDD/kg) is represented as 
percent of control with control denoted as 0 on the abscissa. Cross bars show the 
maximum and minimum values obtained in replicate samples using a minimum of six 
mice per dose. 84 
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Figure 4.2. 85 
illustrates the sensitivity of PC activity in response to TCDD intoxication. Exposure to 
10, 20, 50, and 75 ug TCDD/kg body weight lowers PC activity to approximately 9% of 
control activity at the 75 ug/kg body weight dose. 
As a result of PC level reduction, one might expect an accumulation of pyruvate. 
Pyruvate, if not utilized in the citric acid cycle, may accumulate and be removed via 
lactate dehydrogenase (LDH). This would account for the emergence of lactate acidosis 
in human PC deficiency syndrome (Robinson, et aL, 1984 and Rutledge et al. 1989). 
To evaluate this pathway, liver protein extracts were separated on nondenaturing 
polyacrylamide gels and an activity-based stain was employed to visualize LDH in the 
gel. Figure 4.3 shows a typical separation of protein samples from animals given 
TCDD, corn oil only and animals that fed ad libitum animals which received no 
treatment. A clear dose-dependent shift in isozyme patterns in treated animals can be 
seen at dosages 20, 50, 75 ug/kg ( lanes 3 through 5). The shift is not apparent at the 
lowest dose where PC level depression effects occur, i.e. 1 ug/kg body weight (lane 4; 
Figure 4.1). When compared with the reduction of PC levels and enzymatic activity, 
the isozyme shift occurs at a point where PC levels and specific activity are very low, 
i.e. at doses of 20, 50, and 75 ug TCDD/kg body weight. 
An excess of pyruvate due to inhibition of PC and change in LDH isozyme 
patterns /activity could enhance conversion of pyruvate to lactate. Excess pyruvate in 
the liver may also confound the Cori Cycle, which uses hepatic LDH to convert lactate 
formed in the extremity muscles to pyruvate. The end result would be an excess of 
blood lactate levels. Figure 4.4 shows that when measured, there is an increase in serum 
lactate levels as a function of TCDD exposure. 
To determine the impact of PC reduction and LDH isozyme shifts on transport 
of oxaloacetate carbon for gluconeogenesis, the LDH activity assay was modified to 
monitor changes in MDH activity. Exposure to TCDD does not alter MDH levels 
(Figure 4.5). 86 
Figure 4.3. Activity-based staining for lactate dehydrogenase. Lanes 1 through 5 are 
separations of hepatic protein extracts from treated mice (1, 10, 20, 50, and 75  ug 
TCDD/kg, respectively). Lanes 6 through 8 are hepatic extracts from corn oil controls; 
lane 9, ad libitum. Samples (75 ug per lane) of protein were loaded onto a 10 x 10 x 
0.08 cm nondenaturing polyacrylamide gel (7.5%) and separated at 150 V for 1.5. 
hours. Color development was performed as described in Chapter 3. F
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Figure 4.4. Regression analysis of blood lactate levels. Cardiac blood samples from 
control, 20, 50, and 75 ug TCDD/kg treated C57BL/6J male mice were obtained 
immediately after CO2 asphyxiation. Three mice for each group were used. Lactate 
levels were determined as described in Chapter 3. Assays were done in triplicate and 
averaged to produce the graph. The R2 for the regression analysis is 0.97. 89
 90 
Figure 4.5. Activity-based staining for malate dehydrogenase. Lane 1 is cytosolic 
porcine malate dehydrogenase standard purchased from Sigma, St. Louis, MO. Lanes 2 
through 5 are separations of hepatic protein extracts from corn oil control and TCDD 
treated mice (control, 20, 50, and 75 ug TCDD/kg, respectively). Samples (75 ug of 
protein per lane) were loaded onto a 10 x 10 x 0.08 cm nondenaturing polyacrylamide 
gel (10%) and separated at 150 V at 4° C for 2.75 hours. Color development was 
performed as described in Chapter 3. 91 
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4.2 mRNA Studies 
Northern blot analysis was used to monitor hepatic PC mRNA levels inresponse 
to TCDD exposure. To establish the utility of using DNA probes MPC-1 (PC mRNA 
specific) and 1406 R (ribosomal 18S rRNA specific) in this study, concentration-
response experiments for PC and 18S rRNA using 12.5, 25, and 50 ug of total RNA 
were undertaken Pan et aL, 1996). Conditions were found that produced a linear and 
specific response for PC mRNA. In subsequent work, 50 ug of total RNA was routinely 
processed for Northern blot analysis of experimental tissue samples. 
Hepatic PC mRNA levels in response to various levels of TCDD is shown in 
figure 4.6. To illustrate the impact of lowered Ah receptor affinity for TCDD on PC 
mRNA expression, the PC mRNA response to 50 and 75 ug TCDD/kg body weight 
doses in the congenic Ahdid mice possessing low affinity receptors for TCDD (Ilian et 
a1 1996) is incorporated into Figure 4.6. Furthermore, PC enzyme activity levels are not 
altered in Ahdid mice at doses lower than 50 ug/kg body weight in these animals (Ryu et 
al., 1995). 18S mRNA abundance was used to normalize the RNA load on the 
membrane by hybridization using the 1406R probe. Exposure of animals to TCDD 
caused reduction in PC mRNA levels in a dose-dependent manner. At 50 and 75 ug 
TCDD/ kg body weight, the response of the Alibib mice are 3 and 10 fold greater than 
that seen in Ahdid mice. The reduction in PC mRNA levels is associated with the 
reduction of PC protein level and activity. 
4.3 Sequencing Studies 
4.3.1 Upstream Sequence Alignment Comparison of Ah 
b/b  and Ah  Mice Strains 
Using PCR techniques, approximately 1.4 kb of a PC specific DNA fragment 
was amplified. The PC DNA includes exon 1 of the PC gene, containing the non-
coding leader sequence, and associated upstream DNA (Figure 4.8). Sequence 93 
figure 4.6. Hepatic PC mRNA reductions in response to TCDD exposure. Animals 
were sacrificed 8 days post i.p. injection with TCDD. Northern blot analysis of RNA 
extracts from control and experimental animals was performed as described in Chapter 
3. The results shown are from an experiment where the number of animals per exposure 
was three. Autoradiographs of blots probed with PC mRNA probe, MPC-1, were 
scanned, and the ratio of image density control values to experimental values on the 
same blot were employed to produce the data for Ahb/b(*) and Ahdid () samples. The 
average for three independent determinations are shown. The R2 for the Ahbib data 
points regression is 0.793. Standard error for the ratios were calculated using error 
propagation analysis as described by Benington (1969). The experiment with Ahdid (,) 
mice are taken from Him, MA, Sparrow, B.R., Ryu, B-W, Selivonchick, D.P., and 
Schaup, H.W. (1996). 94 
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Figure 4.6. 95 
alignment comparisons with the corresponding upstream PC DNA zones obtained from 
congenic Ahd/d mice (Ryu 1996) revealed complete homology between the two strains 
except for one C-T transition at nucleotide -231. The congenic mouse strain was 
produced by backcross/intercross breeding between C57BL/6J and B6ND2N (Ahd) 
N13F13 mice (Poland et al., 1989). These genetic crossings produce a mouse strain 
essentially identical genetically to C57BL/6J Ahb/b mice except they are homozygous 
for the Ahdid allele. The homology between the Ahbib and the Ahdid mice strains for the 
PC regulatory region exemplifies that, in regards to regulation of the PC gene, the 
strains are for all practical purposes identical. 
4.3.2 Mapping of PC Transcriptional Start Site 
When using cDNA libraries to recover specific genes, artifacts due to library 
construction and propagation are of concern (MacKay et. al. 1994). Sequence analysis 
of human PC obtained from cDNA libraries differ in the number of nucleotides 
comprising the 5' untranslated sequence of the gene (MacKay et al., 1994 and Wexler et 
al., 1994). It is worth noting that sequencing of the murine PC gene was done using an 
adipocyte cDNA library (Zhang et al., 1993). With these observations in mind, I felt it 
necessary to verify the transcriptional start site and the overall length of the 5' non-
coding region of the PC gene. 
To locate the transcriptional start site of the PC gene, total RNA and a radio-
labeled probe complementary to the 3' end of the PC gene leader sequence were 
employed with Moloney Murine Leukemia Virus reverse transcriptase in a primer 
extension protocol (Sambrook et al. 1989d). The radiolabeled cDNA produced was 
analyzed using a polyacrylamide-7M urea sequencing gel. A sequencing ladder of 
approximately 460 bases beginning at the 3' terminus of the non-translated sequence of 
the PC gene and continuing toward the upstream regulatory region was simultaneously 96 
electrophoresed. Analysis of autoradiograms of the gels and sequence alignments 
shows the transcriptional start site of PC begins with the purine adenosine followed by a 
124 base leader sequence (Figure 4.7). 
4.3.3 Transcription Factors 
The analysis of the regions proximal and distal to the PC transcriptional start site 
for transcription factor binding sequences was accomplished using SIGNAL SCAN 
analysis software (Prestridge 1991). This analytical tool searches nucleotide sequences 
for known DNA binding protein sequences and cross-references these sites to databases 
(Ghosh, 1991; Wingender, 1988) of known transcription factors and their respective 
binding sites. A complete listing of all the putative transcription factor binding sites 
located using SIGNAL SCAN is presented in the Appendix. The results shown here 
include those transcription factors which may be relevant in the transcriptional 
regulation of hepatic PC (Figure 4.8). 
Assembly of the transcriptional apparatus commences with DNA-protein 
interactions at two possible locations, the TATA element (consensus sequence 
TATAAA) or the initiation response element (Inr) (consensus sequence YAYTCYYY). 
The upstream region of the PC gene lacks a properly positioned TATA element; 
however, a possible Inr sequence is positioned near the transcriptional start site (+3 to 
+10). The nucleotide region immediately upstream of the Inr element (-1 to  "175) is 
GC rich (-55-75%). Such motifs contain various GC elements and are especially 
prevalent in the regulatory regions of housekeeping genes (Wingender, 1993). 
Moreover, these elements may possibly substitute for the TATA element (Wingender, 
1993). Within this region are 8 putative GC elements; three are Sp 1 elements and five 
are GCF factor elements. The Spl transcription factor is a constitutively expressed 
trans-activator of many housekeeping (Wingender, 1993) and glucose metabolism 
genes (Lemaigre and Rousseau, 1994). Transcription factor GCF may act as a 97 
Figure 4.7. Mapping of PC transcriptional start site. Total hepatic RNA was subjected 
to primer extension analysis as detailed in Chapter 3. Radiolabeled cDNA and a 
sequencing ladder (Chapter 3) were loaded onto 210 x 400 x 0.4 mm 6% 
polyacrylamide-7M urea sequencing gel which was preheated to 50°C. Samples were 
electrophoresed at 40 watts constant power (approximately 1700 volts) until the 
bromophenol tracking dye reached the bottom of the gel. Following electrophoresis, the 
gel was bathed in a 12% acetic acid-10% methanol solution for 15 minutes then 
transferred to 3MM Whatman paper and dried for 2 hours at 80°C. The dried gel was 
wrapped in Saran Wrap and exposed with Dupont Cronex Plus intensifying screens for 
36 hours to Kodak X-Ompt film at ambient temperature. The sequencing ladder in the 
autoradiogram shows the antisense strand for a portion of the upstream and noncoding 
exon 1 of the PC gene. The identified sequence ranges from "8 to +39. 98 
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Figure 4.8 DNA sequence of C57BL/6J (Ah") mouse liver pyruvate carboxylase gene 
upstream region (1359 bp) and untranslated exon 1. The sequence was isolated from 
hepatic genomic DNA using PCR technologies described in Chapter 3. Sequencing of 
sense and antisense strands was done at least in duplicate by The Center for Gene 
Research and Biotechnology, Oregon State University. Transcription factor analysis 
was performed using SIGNAL SCAN analysis software (Prestridge 1991). 100 
-1359 AACACCTTCCCAAGAGGCACTGTTGTGAGGAAAGAGGATGGTCACATTA 
- 1310 GATTAGGATGCC	  GGTT'GGGTCCCCITTAGTACCCAAACGAGGA
 
GRE
 
- 1261 ATTCTGGGGGGCTTGGAGGGTACCACACTATTCAGTGCCCACCCAAGGT 
-1212 CTTCCTACCACCCTAGGTGCTCTGCTTCTCTCTICACCTGIACCCCCAGGC
 
E-BOX-1
 
- 1163 TCTATGATACCCCTGI AGCTCTCT I CACCTG IACCCCCAGGCTCTATGATAC
 
TFII-I  I  I  E-BOX
 
-1114 CCCTGIAGCTCTCTI CACCTG IACCCCCAAGCTCTATGATACCCCTG IAGCTC
 
TFII-I ---I  LE -BOX  TF114  '
 
-1065 TCT1CACCTG GCCCCCAAGCTCTATGATACCCCTGIAGCTCTCT CACCTG k
 
I  E-BOX	  TFII-I 
i  L_ E-BOX 
- 1016 CCCCCAGGCTCTATGATACCCCTG KGCTCTCTICACCTG IACCCCCAGGCT 
TFII-I  I-- E-BOX I 
-967 CTATGATACCCCTGIAGCTCTCTI CACCTGIGCCCCCAAGCTCTATGATACC 
TFII-I ---1  I---E-BOX 
- 918 CCTGIAGCTCTCTI CACCTG IACCCCCAGGCTCTATGATACCCCTGIAGCTCT 
TFII-I----I  E-BOX  TFII-I I	 I 
-869 CTICACCTGIACCCCCAGGCTCTATGATACCCCTG IAGCTCTCT CACCTG AC 
1--- E-BOX  TFII I  E-BOX I 1 
-820 CCCCAGGCTCTATGATACCCCTG IAGCTCTCTI CACCTG IGCCCCCAAGCTC 
TFII-II  I-- E-BOX 
-771 TATGATACCCCTGAGCTGTGCAGACGGTTCTGTCCCTTCAGCTTTGAGA 
-722 ATTTGCTGAGACTICAGGTGICAACTTGGTCAACCTTATCACTGGAGTTAT 
E-BOX 
-673 CTCAGACCCTGGAACTCAACACTCCGTTGGCTGTCACAA CATCTG TGGG 
E-BOX 
-624 GCCCTAAGGGGACCCAGTGGGTCCA ICAGC TG ITCCTIGCGGCTGGAT TCT 
GRE 
-575 CTGGICTGATCATGA  1-1 AAAAGTTCCTGAGTGTAGGCCTGTGAGGGCA 
UBP-1 
-526 GTGGGATTCATTCAGTGAGGGAAAGGCTAGATCAGCTATGGAGATGCTT 
-477 AGGAACAAGGTGGTA TGTTCT CTTGTCTG TGACGGCC TTGTCTTGTGTC 
GRE  CREB 
-428 TGGCAGTGCATTGAATTAGGGGAGAGGCTGGTTGCAGCACAGGCCTCCT 
-379 GTGACTGTAGTAGTGAACCAGCCTTCAGGCTAAT GTGACCCTTGCCI CTC 
HNF-4 
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- 330 CATCATGCCTGGCACAGTCCCTACCAAGCAGCCTGTCTAGGTACCATTC 
- 281 TACTITCTGAGTGACATTTTTATGCCTTGAACTTI CAAGI TGI GCAGTATGT 
E-BOX 
- 232 CTAA	  TCCACCACAAAAGTCTG ICAGCTGICTITCTAGCAGGTATTGTCT 
NF-1  E-BOX 
- 183 TGTAATTCTGTGTATTCCTGAGGGCCCAGGGAACAGGCTCTAGGCCACT 
GCF -1  Spl  UBP-1  GCF 
-134 GCTCATCTACTTTCTGCATGACCCACTICCCCGC C 1C TCT rei 'LW CC 
Spl  GCF I 
- 85	  TCCTAGGCAGCCAGTGGCCCATGATGGCCTCAG :ffiff,Keett CGC CCC TT 
Sp1  GCF  L--- GCF I 
- 36 CCCCTGATTTCAGCC TTGGCTACAGCCCAGGCC TCC+1AG ICAGTCTAGITG 
inr ____J 
+13 CTGGAGAACTTTGTATTCTGGGGCCAATGACCTCGGGTGGAGCAGTTAC 
+62 TGCCTGTGGATCCTCTATCACGTCCTCTGTGTGCAGCACACCTAGGTGC 
+111 TTGGCTGGTACAAG 
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transcriptional repressor (Kageyama and Pastan, 1989). The presence of 3 
glucocorticoid response elements (GREs) and 1 cyclic AMP response element (CREB) 
is reasonable, for many enzymes associated with glucose metabolism are hormonally 
regulated. A pair of transcription factor elements, nuclear factor 1 (NF-1) and hepatic 
nuclear factor 4 (HNF-4), which are involved in the regulation of various glycolytic and 
gluconeogenic enzymes are also positioned upstream of the PC transcriptional start site. 
Two untranslated binding protein 1 (UBP-1) elements, bind to a cellular protein capable 
of also binding a TATA element (Kato et al., 1991). A particularly interesting aspect of 
the upstream sequenced region of the PC gene is the presence of 16 E-box elements, 10 
which are juxtaposed to transcription factor II-I (TF II-I) elements. These abutted 
elements are evenly spaced over 364 nucleotides (-1148 to -784). Transcription factor 
II-I facilitates and stabilizes the binding of transcription factor II-D (Roeder, 1991), a 
protein essential for the assembly of the RNA polymerase II preinitiation complex. E-
box elements bind basic helix-loop-helix proteins (Kadesh, 1993) including 
homodimers of ARNT (Sogawa et al.  , 1995; Antonsson et al., 1995). It is also 
interesting to note that no dioxin response elements are found in the sequenced 
upstream region of the PC gene. However, studies have indicated reduction in PC 
expression involve the Ah receptor (Ryu, et al., 1995). As such, the ability of ARNT to 
bind E-box elements as well as form heterodimers with liganded Ah receptors hints of a 
possible mode for altering the expression of PC in TCDD-exposed animals. 
4.4 Transient Transfection Assays 
To investigate the ability of the upstream region of the PC gene to regulate 
transcription, DNA sequence +65 to -1359 was inserted into a luciferase reporter gene 
plasmid (PC-LUC) and transiently transfected into Hepa lc 1 c7 murine hepatoma cells. 
The results shown in Figure 4.9 indicates a modest 3-fold induction in activity (lane 4) 
compared to the activity of a transiently transfected luciferase reporter gene lacking the 103 
upstream PC sequence (lane 1). When transfected cells cultures were exposed to 
10 nM TCDD, the activity of PC-LUC increased 6-fold (lane 5). The increase in 
activity as well as the observation that ARNT homodimers bind E-box elements 
(Sogawa et al., 1995; Antonsson et al., 1995) suggests that alterations in available 
ARNT, due to heterodimer formation with liganded Ah receptor, may impact the 
regulatory activity of the upstream PC sequence in Hepa lc 1 c7 cell cultures. To further 
investigate this possibility, Hepa lc 1 c7 cell cultures were co-transfected with PC-LUC 
and a plasmid encoding ARNT (pBM5/NEO/M1-1), thereby overexpressing ARNT 
protein. The activity of PC-LUC in the co-transfected cultures was reduced by 
approximately 30% when compared to transfections with PC-LUC only (lane 6 vs. lane 
4). When exposed to 10 nM TCDD, activity increased 4-fold compared to unexposed 
co-transfections (lane 7 vs. lane 6). However, the overall increase in activity was 
approximately 48% of the activity observed in TCDD-exposed cell cultures transfected 
with PC-LUC only (lane 7 vs. lane 5). These results suggest that overexpression of 
ARNT protein partially overrides the TCDD-induced increase in PC-LUC activity. In 
addition, the reduced activity observed in unexposed co-transfected cell cultures 
suggests a possible functional role involving ARNT and the E-box elements of the 
upstream region of the PC gene. This is further evident from the observation that 
changes in the activity of TCDD-exposed Hepa lc 1 c7 cell cultures transiently 
transfected with the DHFR-luciferase reporter, which lacks E-box elements, are nominal 
when compared to unexposed cell cultures (lanes 3 and 2, respectively). 104 
Figure 4.9 Transient transfection assay using a luciferase reporter gene. Hepa 1c1c7 
cells were seeded into 25 cm2 flasks at a density of 8 x 105 cells per flask. The cultures 
were transfected with equal concentrations (4 ug) of the PC gene reporter vector PC­
LUC alone (lanes 4 and 5) or in conjunction with the pBM5/NEO/M1-1 ARNT 
expression plasmid (lanes 6 and 7) and equal concentrations of CLONfectinTM 
(Clontech, Palo Alto, CA). Additional cell cultures were transiently transfected with the 
pGL3 basic luciferase reporter vector (lane 1) or the DHFR-luciferase reporter vector 
(up to 8 ug) (lanes 2 and 3) using equal concentrations of CLONfectinTM. Transfected 
cell were equally divided into two 10 x 35 mm cell culture dishes as described in 
Chapter 3. In each experimental group, 1 culture dish was treated with TCDD (10 nM 
final concentration). The other dish served as the control. Each transfection was 
performed at least three times. Cell lysate from each experimental group were 
combined and luciferase activity monitored as described in Chapter 3. L
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Chapter 5 
Discussion 
5.1 Protein Studies 
C57BL/6J Ahbib male mice exposed i.p. to TCDD exhibit a dose-dependent 
reduction of PC levels and enzymatic activity in hepatic protein extracts. This result is 
consistent with an earlier report of a dose-dependent reduction of PC activity in male 
Sprague-Dawley rats (Weber et al., 1991a). In rats, both PEPCK and PC activity levels 
were reduced approximately 50% at the highest dose (125 ug/kg body weight) at 8 days 
post-exposure. Hepatic PC level reduction in C57BL/6J Ahbib mice, however, 
approaches zero relative to pair-fed controls at 8 days post exposure to 75 ug TCDD/kg 
body weight. PC is an essential enzyme in energy metabolism involving the citric acid 
cycle and is critical for gluconeogenesis. Because TCDD produces reductions in PC 
activity at low doses, this may represent a critical response in TCDD-mediated toxicity 
in mice as well as rats. 
In gluconeogenesis, PC-formed oxaloacetate is converted to malate by 
mitochondrial malate dehydrogenase (MDH). The mitochondrial membrane is 
permeable to malate, thereby providing a shunt for oxaloacetate to the cytoplasm. 
Cytosolic MDH converts malate back to oxaloacetate, the precursor for the rate-limiting 
gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK). Activity-based 
staining for MDH in the protein extracts, which include mitochondrial and cytosolic 
MDH, show no activity change in mice given TCDD. Therefore, a substrate for PEPCK 
would be available via this pathway but most likely at greatly reduced levels due to low 
PC activity; PEPCK is down regulated in rats exposed to TCDD (Stahl et al., 1993; 
McKim et al., 1991). This TCDD-mediated response disrupts gluconeogenesis, thereby 
contributing to the metabolic cascade that eventually kills the animal (Weber et al., 107 
1992; Stahl et al., 1993; Weber et al., 1991a). Although gluconeogenesis is a vital 
pathway, not all cells require it. Cells of the Islets of Langerhans, found in the pancreas, 
lack the gluconeogenic enzymes PEPCK (MacDonald and Chang, 1985) and fructose 
1,6-bisphosphatase (MacDonald et al., 1991). Consequently, the islet cells of the 
pancreas cannot carry out gluconeogenesis (MacDonald et al., 1992). It is worth noting 
that islet cells have functional PC which produces oxaloacetate for use in the citric acid 
cycle (MacDonald et al., 1992). On the other hand, in cells that do support 
gluconeogenesis, PC-produced oxaloacetate is the major substrate source for PEPCK. 
The data presented here provides evidence that C57BL/6J male mice treated 
with less than lethal doses of TCDD exhibit a substantial dose-dependent reduction in 
PC levels and activity as well as secondary changes in LDH isozyme activity. The LDH 
complex is a tetramer comprised of combinations of muscle (M) and heart (H) subunits. 
The M4 isozyme optimally converts pyruvate to lactate. In normal rat liver, the LDH 
subunit composition consists of only 2% H type (Fine et al., 1963). The pattern shifts 
observed in response to TCDD exposure are toward a predominantly H isozyme 
composition (Market, 1963). These isozymes have a lower KM for pyruvate and are 
allosterically inhibited by high pyruvate concentrations. The experimentally observed 
isozyme shift most likely reflects a protective response that would reduce the rate of 
lactate production as a consequence of pyruvate accumulation. The accumulation 
would most likely be related to low pyruvate removal rates for PC. Nevertheless, there 
appears to be sufficient pyruvate reduction to lactate to initiate lactate acidosis 
(Figure 4.4). 
Under normal metabolic conditions, the anaerobic metabolism of glucose in 
peripheral tissues such as brain, white skeletal muscle, and intestinal mucosa produce 
lactate through the reduction of pyruvate by LDH (Kreisberg, 1972). The primary fate 
of lactate produced by such peripheral tissues is translocation to the liver followed by 
oxidation to pyruvate via hepatic LDH and the subsequent formation of glucose via 108 
gluconeogenesis (Robinson, 1989). The newly synthesized glucose is transported back 
to the peripheral tissues, thereby completing the Cori cycle. Alterations in the 
metabolic pathways used by this important cycle could influence the normal 
lactate /pyruvate equilibrium ratio of 10:1 ultimately culminating in lactate acidosis. 
Lactate acidosis is characteristic of PC deficiency in humans (Merinero et al., 
1992; Van Coster et al., 1991; Stem, 1994). As of 1991, all of the 34 documented 
individuals suffering from PC deficiency died during the first 4 months of life (Van 
Coster et al., 1991 and references therein). In two remarkable instances, PC deficient 
infants have survived to childhood (Van Coster et al., 1991; Stern, 1994). Both children 
were subjected to periods of elevated lactate levels at least 4 times greater than normal 
and blood pHs ranging from 6.89-6.96. Enzyme analysis of cultured fibroblasts from 
these children revealed PC activities 1.8 and 3% of normal. The serum lactate levels in 
animals given TCDD approach levels two times higher than controls at the highest level 
of TCDD exposure (Figure 4.4). Of greater interest is the observation that reduced PC 
activity in the 75 ug TCDD/kg body weight treatment animals are quite similar to those 
of the PC deficient children, i.e., less than 10% of normal (Figure 4.2). This unique 
correlation of reduced PC levels and increased serum lactate levels between PC 
deficient humans and TCDD exposed mice lends credence to the proposal that TCDD-
mediated reduction in PC and LDH isozyme shifts may produce a major and fatal 
component in TCDD toxicity. 
The potential for reductions in blood pH, as a consequence of increased lactic 
acid levels, may be further enhanced by the acidifying affects of ketone bodies. TCDD 
exposed Wister rats display an increased flux of fatty acid-derived acetyl CoA, normally 
targeted for citric acid cycle and lipid synthesis, to the ketogenic pathway (Lakshman et 
al., 1991). It is noteworthy that the ketogenic pathway serves as an "overflow" for 
acetyl CoA when oxaloacetate levels are low. Depressed oxaloacetate production, as a 109 
consequence of TCDD mediated reductions in PC, may contribute to excess ketone 
body production. As such, the additional ketone burden may further enhance the 
acidotic affects resulting from increased lactic acid levels. 
The impact of diminished PC levels/activity subsequent to TCDD exposure 
could lead to an accumulation of excess pyruvate with the following substrate-mediated 
consequences possibly occurring: (1) Pyruvate accumulation would lead to the 
reconversion of pyruvate to alanine via a transamination reaction ultimately leading to 
an accumulation of this amino acid. An excess of alanine could lead to the inhibition of 
the transaminases, therefore precluding the utilization of aspartic acid and glutamic acid 
as replenishment carbon source in the citric acid cycle. (2) The alteration of substrate 
flow through LDH, as discussed above. (3) A reduction in the flux of carbon units 
through the citric acid cycle. As a result, the capacity of the citric acid cycle to produce 
reducing equivalents for the electron transport system would ultimately impair ATP 
synthesis. It is worth noting that rats exposed to TCDD display an increase in 
circulating blood alanine concentrations (Christian et al., 1986b). Reduced PC levels 
and activity associated with LDH isozyme configuration shifts may be the direct cause 
of elevated lactate levels in the blood as shown in Figure 4.4. This newly formed lactate 
would be added to lactate already present due to the Cori cycle shunting lactate to the 
liver for conversion to pyruvate. Such elevations in lactate would be expected to 
precipitate lactate acidosis as observed here in mice and in humans. 
The reduction of PC levels/activity by TCDD in a fashion similar to that seen in 
PC deficient individuals bring into question the potential damage such compounds 
could produce during development. It is of value to note PC deficient infants exhibit 
severe delays in mental and motor development (Van Coster et al., 1991 and references 
within). Moreover, severe lactic acidosis can manifest various conditions including 
hypoglycemia, seizures, vomiting, ataxia, hyperventilation, myopathy, coma and death 110 
(Stern, 1994 and references within). Transient disruption of programmed gene 
induction/repression may prove to be central to human health issues associated with 
TCDD and related congeners. 
5.2 mRNA Studies 
A wasting syndrome is a ever-present sign of high-dose TCDD intoxication 
(Matsumura, 1983). The molecular events precipitating the wasting syndrome are not 
completely understood. Derailment of gluconeogenesis is thought to play a central role 
in TCDD-induced wasting (Muzi et al., 1989). Inhibition of gluconeogenesis is 
produced by a TCDD-mediated decrease in activities of hepatic gluconeogenic 
enzymes, in particular the activities of PC and phosphoenolpyruvate carboxykinase 
(Muzi et al., 1989; Weber et al., 1991b). The reduction in PC activity is especially 
critical as exemplified by the evidence that PC deficiency is lethal in humans; thus it 
appears that there may be no bypass for this enzymatic reaction in eukaryotes (Rutledge 
et al., 1989; Freytag and Utter, 1983). 
In liver and kidney, PC is an essential enzyme in gluconeogenesis, catalyzing the 
first reaction in the conversion of pyruvate to glucose. Regulation of PC is categorized 
as either short-term or long-term. Short-term regulation of PC centers upon changes in 
substrate concentration, particularly pyruvate (Banitt et al., 1976); product inhibition by 
ADP (McClure and Lardy, 1971); and regulation by a positive effector, acetyl CoA 
(McClure et al., 1971). Long-term regulation of PC involves changes in the 
intracellular concentration of the enzyme regulated at the level of PC mRNA 
transcription (Weinberg and Utter, 1980). TCDD exposure has been reported to 
increase the levels of specific mRNAs such as those coding for some microsomal 
enzymes or to decrease the levels of mRNAs such as PEPCK (Conney, 1982; Stahl et 
al., 1993). The study presented here is the first to describe significant reductions in 
hepatic PC mRNA in mice exposed to TCDD. 111 
Mechanistic studies have revealed that TCDD ligands to an intracellular protein, 
the Ah receptor, which then forms a heterodimer with a second intracellular protein, the 
Ah receptor nuclear translocator (ARNT) (Whitlock, 1993). The activated liganded 
receptor complex interacts with a specific DNA element, the dioxin response element 
(DRE), thereby initiating a series of transcriptional events. Comparisons in the 
reduction of hepatic PC mRNA levels in C57BL/6J mice with their congenic 
counterparts, possessing Ah receptors with low affinities for TCDD, reveal that the 
congenic strain is approximately 10-fold less sensitive to TCDD exposure (Ilian et al., 
1996). This correlation supports the hypothesis that the Ah receptor is involved in 
mediating the effect of TCDD on PC mRNA in mouse hepatic tissue. Furthermore, 
Ilian et al. (1996) reported time course studies on TCDD exposed C57/BL6J mice 
which suggest that the decrease in hepatic PC mRNA after TCDD treatment is a result 
of an alteration in PC gene expression as opposed to an increase in PC mRNA turnover. 
The events leading to PC mRNA reductions are not likely to be straightforward. 
PC is a key enzyme which plays a major role in the control of the overall pathway of 
gluconeogenesis from lactate or pyruvate in the liver (Freytag and Utter, 1983). The 
flux through this enzyme is enhanced by hormones that stimulate gluconeogenesis such 
as corticosteroids (Gorski et al., 1988). Based on the observation that elevated plasma 
levels of corticosteroids have been reported in TCDD treated animals (Lin et al., 
1991a), one would expect PC to be upregulated in TCDD-treated animals. To the 
contrary, the data presented here indicates that the PC activity level and mRNA in liver 
is downregulated. TCDD appears to cause the PC gene to become nonresponsive to its 
normal physiological stimuli. 112 
5.3 Sequencing Studies and Transcription Factors 
5.3.1 Upstream Sequence Alignment Comparison of Ahk& and Ahdid Mice Strains 
The C57BL/6J(Ahlilb) mouse strain possess Ah receptors with relatively high 
ligand affinity for TCDD. Conversely, their congenic counterpart, C57BL /6J(Ahdld), 
are bred to carry a B6N Ah locus coding for low ligand affinity Ah receptors. 
Development of the congenic strain of C57BL/6J mice involved a regimen of 
backcross/intercross breeding of C57BL/6J(Ahb/b) mice having high affinity Ah 
receptors with B6ND2N(Ahd)N13F13 mice possessing a locus encoding a low affinity 
Ah receptor for TCDD. The result of this breeding protocol is congenic mice [B6N 
D2N (Ahd) NI3F13B6JN28F28F3], which are homozygous for the Ahd/d allele (Poland 
et al., 1989). The data presented here in conjunction with those of Ryu et al. (1995) and 
Ifian et al. (1996) collectively demonstrate that exposure of both strains to sublethal 
concentrations of TCDD produces a dose-dependent reduction in PC protein 
levels/activity with a concomitant reduction in PC mRNA. Furthermore, the congenic 
Ali" mice require a 60-fold greater dose to produce the same effect observed in Ahbfb 
animals (Ryu et al., 1995; Ifian et al., 1996). This altered response is consistent with 
having low affinity Ah receptors and is usually interpreted to mean that the Ah receptor 
is necessary for the response. However, it is conceivable that this response is the result 
of PC regulatory sequence differences associated with the segregation of a B6ND2N 
PC gene locus along with the AhR locus. If so, the upstream regulatory sequences of 
the PC gene for the congenic Ahdid animals would vary from those of the Ahbfb strain. 
Sequence comparison of approximately 1.3 kb upstream of the transcriptional start site 
reveals both strains have essentially identical regulatory regions (Figure 4.8). These 
data provided evidence that the B6ND2N PC gene locus do not segregate with the Ah 113 
receptor locus. In addition, no upstream dioxin response elements (TA/TGCGTG) were 
present in the upstream PC region in either strain. Nevertheless, the Ah receptor is 
clearly involved in the PC response to TCDD. 
5.3.2 Mapping of PC Transcriptional Start Site 
The transcription of eukaryotic mRNA, unlike prokaryotic mRNA transcription 
which produces mRNA co-linear to that of genomic DNA, results in transcripts 
comprised of coding (exons) and noncoding (introns) sequences. The noncoding introns 
are excised in a precise nucleotide specific manner and the exons are spliced together. 
This exacting process of splicing is accomplished within the nucleus by a complex of 
small nuclear ribonucleoproteins known as the spliceosome. Subsequently, the 
intronless transcript is exported to the cytosol for translation. However, the splicing 
process is not always so direct; some transcripts are spliced in alternative ways to 
produce tissue or developmentally specific proteins. These unique, but related proteins, 
are termed isoforms. An example of an isoform protein synthesized from an 
alternatively spliced transcript is UDP-glucuronyl transferase 1 (UGT1). The 
mammalian UGT1 transcript is formed by the splicing of 6 exons. Five of these exons 
(2-5) are invariant. However, exon 1 is alternatively spliced to the remaining five from 
a pool of six possible exon ones. 
The PC transcript also is subjected to alternative splicing, albeit unique. Studies 
by Jitrapakdee et al. (1996) demonstrated that the single copy rat and human PC gene 
transcript undergoes alternative splicing of the 5' nontranslated region. Furthermore, the 
divergent 5' untranslated regions of the isoform PC mRNA expression is tissue specific. 
Of even further interest, is the observation by Jitrapakdee's group that alternative 
splicing of the 5' untranslated region of transcripts may be a unique trait of biotin 
containing enzymes. A case in point is the biotin containing enzyme, acetyl- CoA 
carboxylase (ACC). Studies of rat and human ACC have shown that the mRNA 114 
transcripts of this gene also are alternatively spliced in the 5' untranslated region (Luo et 
al., 1989; Ha et al., 1994). With these observations in mind, in is not surprising to 
discover that the 5' untranslated region transcriptional start site of the cDNA for mouse 
adipose PC (Zhang et al., 1993) differs from the hepatic PC untranslated region. 
As suggested by Jitrapakdee et al. (1996), the divergence of the 5' untranslated 
region of the PC transcript via alternative splicing may play a role in translational 
regulation. The metabolic demands placed on PC and thus the distribution of PC differs 
among tissues. Activity of PC is greatest in liver and kidney and to a lesser extent 
adipose (Bottger et al., 1969). Other tissues also demonstrate PC activity although at 
substantially lower levels than adipose (Bottger et al., 1969). It is intriguing to consider 
the possibility of the variable length untranslated region of PC in various tissues 
contributing to the diverse degrees of expression seen in tissues through regulation at 
the translational level. 
The metabolic demands on PC in liver are quite different from those of PC in 
adipose. The liver is a diverse organ with multiple functions including, but not limited 
to bile production, metabolism of potentially harmful xenobiotics and metabolic waste 
products for excretion, glycogen storage, oxidation and synthesis of fatty acids, and the 
mainstay production of glucose through gluconeogenesis. The demands placed on this 
organ require a substantial amount of energy, i.e. flux through the citric acid cycle and 
the oxidative phosphorylation pathway to produce reducing equivalents and ATP. On 
the other hand, based on the primary function of lipid storage, the metabolic demands 
placed on PC in adipose tissue would not be as great compared to liver. Thus it stands 
to reason that control of PC may be more tightly regulated in liver tissue than adipose. 
How exactly the differences in the untranslated region between PC in liver and 
adipose tissues may contribute to regulation at the translation level remains to be 
determined. Two possibilities may be worth consideration: (1) Length-dependent 
differences in the formation of secondary stem-and-loop structures in the untranslated 115 
region of the mRNA may alter translational initiation. An example of translational 
regulation by 5' mRNA stem-and-loop/protein interactions occur in the control of 
ferritin gene transcript translation (reviewed in Kozak, 1992). Schulz and Reznikoff 
(1990) demonstrated through alterations of secondary structures in the initiation region 
of the prokaryotic lacZ mRNA variation in translational efficiency of 160-fold. 
Furthermore, in eukaryotic systems, Kozak (1989) made the observation that when a 
strong stem-loop structure occurs at 12 nucleotides from the 5' end of the untranslated 
region a mRNA will not engage the 40 S ribosomal subunit. In addition, strong stem-
loop structures at other positions can prevent the 40 S subunit from unwinding the 
sequence, thus stalling the 40 S subunit (Kozak 1989). (2) The overall length of the 
noncoding leader sequence may allow the loading of extra 40S ribosomal subunits onto 
the sequence, thus increasing protein translation (reviewed in Kozak 1991). 
Another aspect of the untranslated leader region of the C57BL/6J Ahb/b mouse 
PC gene is the lack of a Kozak sequence. The Kozak sequence is a GC rich sequence 
with the consensus GCCA/GCC (Kozak, 1987a) and is associated with optimal, strong 
translational initiation in eukaryotes. To be effective, the Kozak sequence must be 
juxtaposed 5' to the AUG start codon signifying the beginning of protein translation. A 
spatial shift by one nucleotide in either direction eliminates the expediting effect a 
Kozak sequence imposes on translation (Kozak, 1986; Kozak 1987b). The lack of a 
Kozak sequence is not unusual; the rat PC untranslated region also lacks this sequence 
(Jitrapakdee et al., 1996). However, the human untranslated PC isoform transcripts 
have properly orientated Kozak sequences (Jitrapakdee et al., 1996). 
5.3.3 Transcription Factor IID (TF IID) and the Initiation Response Element (Inr) 
TF IID along with several basal transcription factors and RNA polymerase II 
comprise the preinitiation transcriptional complex (PIC) (Kornberg 1996). Several 
subunits, a TATA binding protein (TBP) and multiple TBP-associated factors (TAFs) 116 
make up TF IID (Burley and Roeder 1996). TBP recognizes TATA binding elements 
while TAFs interact with a pyrimidine-rich initiator element (Inr) (Burley and Roeder 
1996; Zawel and Reinberg, 1995 Roeder, 1996). Many constitutively expressed genes 
(housekeeping genes) lack TATA sequences (Boyer et al., 1989; Boyer and Maquat, 
1990). However, TF IID is the only PIC protein intrinsically capable of binding DNA 
elements; therefore, for PIC assembly to occur, TF IID is required. To resolve this 
paradox, many TATA-less housekeeping gene promoters interact with TF IID via the 
TAF recognition of Inr elements. 
Analysis reveals that the PC gene regulatory region contains a TF IID binding 
site; however, this site lacks the proper orientation and is located 22 bases downstream 
of the mapped transcriptional start site. For a TF IID site to be functional, it must be 
located within 30 bases and 5' of the transcriptional start site and have the proper 
orientation (Burley and Roeder 1996). Keeping this observation in mind and 
acknowledging pyruvate carboxylase as a constitutively expressed housekeeping gene, 
the lack of a properly orientated TATA box is not surprising. 
The apparent lack of a functional TATA element and the presence of a 
nucleotide sequence (+3 to +10) with Inr homology (Figure 4.8) suggests that the DNA­
TFIID interaction required for successful assembly of the PIC requires an Inr-TAF 
interaction. Although Inr elements usually include the transcriptional start site within its 
sequence, this element can be distally located (Nakatani et al. 1990). It is also worth 
noting that the transcription initiation site of TATA-less genes typically have 
heterogenicity with initiation occurring at any of several nucleotides within a 30 
nucleotide stretch (Hawkins 1996). With these observations in mind, the location of the 
putative Inr element downstream of the transcriptional start site is an acceptable 
location. 117 
5.3.4 Transcription Factor SP1 
Many housekeeping genes have upstream sequences rich in G+C residues 
(Kageyama and Pastan 1989). Examples of this motif appear to regulate the expression 
of several housekeeping genes including: hamster hydroxymethylglutaryl-coenzyme A 
(HMG CoA) reductase (Reynolds et al. 1984), mouse dihydrofolate reductase (Farnham 
and Schimke, 1985), mouse and human hypoxanthine-guanine phosphoribosyl­
transferase (Patel et al., 1986), mouse and human adenosine deaminase (Ingolia et al., 
1986; Valerio et al., 1985), human phosphoglycerate kinase (Singer-Sam, 1984), human 
epidermal growth factor receptor (Ishii, et al., 1985a), human c-Ha-ras (Ishii et al., 
1985b), and mouse c-Ki-ras (Hoffman et al., 1987). The promoter regions of these 
TATA-less genes have a high G+C content. For example, the HMG CoA reductase 
promoter region has a G+C content of 65% (Reynolds et al., 1984). These G+C rich 
regions frequently contain binding elements for the transcription factor Sp 1 (Boyer and 
Maquat, 1990; Boyer et al., 1989). The G+C content of the putative promoter region of 
the PC gene approaches 80% and contains 3 candidates for Sp 1 elements positioned at 
-45 to -51, -98 to -107, and -100 to -106. Two of the elements overlap and may in 
actuality comprise a single element. 
The orientation independent binding of transcription factor Sp 1 to DNA 
element(s) enhances transcription initiation of RNA polymerase II up to 50-fold 
(Kadonaga 1986). Although binding elements may occur in multiple numbers, binding 
of a single element is sufficient to enhance transcription. However, the most important 
site appears to be 40-70 nucleotides upstream of the transcriptional initiation site 
(Kadonaga 1986). It is worth noting that one of the putative Sp 1 elements of the PC 
gene falls within this range. 118 
5.3.5 Transcription Factor GCF 
The importance of GC-rich sequences in housekeeping gene regulation may 
reflect an adaptation that allows a family of differentially expressed GC site specific 
factors to produce variable responses in a common zone. One element may act in a 
positive manner to increase transcriptional initiation while another may act as a 
transcriptional repressor. Transcription factor GCF may play such a role. Kageyama 
and Pastan (1989) demonstrated GCF mediated repression of chloramphenicol 
acetyltransferase (CAT) reporter plasmid activity. This group used the promoter 
regions of either the epidermal growth factor receptor or a chimeric promoter containing 
the negative regulatory element of the calcium-dependent-protease (CANP) gene and 
the truncated early promoter of the SV40 virus early promoter to regulate the 
transcription of the CAT reporter gene. 
The upstream region of the PC gene contains possibly five GCF factor elements 
located at '19 to -45, -42 to -48, -85 to -91, -88 to -94, and -101 to -107. Four of the 
putative elements overlap in pairs while the remaining element stands alone. It is 
noteworthy and intriguing that the proposed Spl sites are overlapped by three GCF 
elements. One can envision such a motif functioning as a sensitive and competitive 
check and balance mechanism governing the transcription initiation of the PC gene in 
response to various stimuli. Such a role for GCF has been proposed by Kageyama and 
Pastan (1989) as one way to possibly control the overexpression of the cellular 
oncogene encoding epidermal growth factor receptors. 
5.3,6 Untranslated Binding Protein 1 (UBP-1) 
UBP-1 was first described by Wu et al. (1988) as a cellular protein which binds 
to the sequence CTCTCTGG located within the untranslated region of the long terminal 
repeat (LTR) of the human immunodeficiency virus type 1 (HIV-1). Furthermore, 
UBP-1 also appears to have the ability to bind the TATA region of the HIV-1 LTR. 119 
Proteins with multiple DNA binding sites are not unusual as exemplified by the yeast 
HAP proteins (Pfeifer et al., 1987), AP-2 (Mitchell et al., 1987), EBP 20 (Johnson et 
al., 1987) and TF II-I (Roy et al., 1991). Binding of UBP-1 to the TATA region in the 
LTR of HIV-1 displaces or prevents the binding of TF IID to the TATA element, thus 
repressing transcription in vitro (Kato et al., 1991). On the other hand, it has been 
suggested that the CTCTCTGG element contained within the HIV-1 transactivation 
response element and downstream of the transcriptional start site, may play a positive 
role (Jones et al., 1988, Kliewer et aL, 1989). However, UBP-1 alone is not enough to 
illicit the response (Kato et al., 1991); other factor(s) for enhancement are required. 
Such factors may or may not interact directly with UBP-1. 
The upstream region of the PC gene contains two UBP-1 binding elements 
located at nucleotide positions -572 to-579 and -93 to-100. The element nearest to the 
transcriptional start site slightly overlaps a SP1 consensus element and a neighboring 
GCF element. Conversely, the position of the more distal element is at least 12 
nucleotides away from any other known transcription factor element sequence. The 
lack of a properly positioned and orientated TATA element eliminates the possibility of 
interference with TF IID binding as demonstrated with the HIV-1 studies. However, a 
protein-bound UBP-1 element, proximal to the transcriptional start site, interacting 
either positively or negatively with proteins binding to neighboring elements cannot be 
ruled out. Solitary binding of UBP-1 within sequence domains containing CTCTCTGG 
elements apparently does not influence HIV-1 transcriptional initiation in vitro (Kato et 
al., 1991). Until UBP-1 interactions at the cellular level are better understood, the 
possibility of this protein binding to independent cellular elements, such as the distal 
UBP-1 element, and influencing transcriptional regulation should not be dismissed. 120 
5.3.7 Nuclear Factor-1 (NF-1) / TGGCA Protein 
Nagata et al. (1982) isolated and purified NF-1 from HeLa cell extracts and 
demonstrated its ability to stimulate adenovirus DNA replication in vitro. In the same 
year, Nowock and Sippel (1982) isolated the TGGCA protein from chicken ovaduct 
which, in addition to interacting with the adenovirus origin of replication, also binds to 
sequences within the long terminal repeat of the mouse mammary tumor virus (Speck 
and Baltimore, 1987, Miksicek et al., 1987) and the enhancer region of the BK virus 
(Nowock et al., 1985). Comparison of DNA binding consensus sequences and binding 
activities confirm that the mammalian (NF-1) and the avian (TGGCA protein) factors 
are functionally equivalent (Leegwater et al., 1986). As a result, both proteins are 
considered to belong to a family with at least six species of highly conserved DNA 
binding proteins (Rupp and Sippel, 1987). The members of this family form dimers that 
recognize the palindromic sequence T/CGGA/CN5-6GCCAA (Faisst and Meyer, 1992, 
Gil et al., 1988, Gronostajski et al. 1985). 
The sequenced upstream region of the PC gene contains one possible element 
(-229 to -243) with nearly 90% homology to the published consensus sequence 
(TGGCN6TTCAA vs. T/CGGA/CN5-6GCCAA). Consensus sequences are derived 
from analysis of various nucleotide sequences which demonstrate in vitro an affinity for 
a particular DNA binding protein. The nucleotide combination that displays the highest 
affinity for the DNA binding protein is considered the consensus sequence for that 
protein. The sequence need not always be perfect to the consensus element to have 
binding capabilities. For example, a nonperfect sequence in the regulatory region of the 
c-myc gene (Siebenlist et al., 1984) has 93% homology to that of the putative element 
for the PC gene, albeit the in vitro binding affinity is less than that ofa perfect 
consensus sequence. Given the high homology between the c-myc element and the 
putative PC element, this element may play a role PC gene regulation. Furthermore, a 
nonperfect element (TGGCN5TCCAA) very similar to the c-myc and PC element is 121 
located upstream of the phosphoenolpyruvate carboxykinase gene (Quinn et al., 1988, 
Christ et al., 1991), the rate limiting enzyme of gluconeogenesis. In addition, the 
enzyme, 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase, which indirectly 
governs gluconeogenesis through the regulation of fructose-2,6-bisphosphate, contains 
multiple NF-1 elements (Lemaigre et al., 1991). 
With the ability to form heterodimers among family members, the mode of NF-1 
influence upon higher eukaryotic, i.e. mammalian, transcriptional initiation can be quite 
diverse. Proposed modes of action include repression and /or activation, steric 
hindrance action on neighboring factors (Goyal et al., 1990), conveyance of sterol 
sensitivity (Gil et al., 1988), and competition for overlapping sequences (Courtois et al., 
1990). Given the myriad of possible heterodimer combinations and modes of 
regulation, conjecture as to which mode(s) influence transcriptional activity of PC is 
problematic. 
5.3.8 Cyclic AMP Response Element Binding Protein (CREB Element) 
The rapid induction of transcription in response to various metabolic demands 
placed upon an organism involves processes which do not require new protein 
synthesis. Instead, preexisting nuclear proteins undergo covalent modifications, i.e. 
phosphorylation of specific serine, threonine, or tyrosine residues. Such alterations 
influence the affinity of nuclear proteins for DNA and consequently the induction of 
transcription. Nuclear protein phosphorylation and concomitant DNA binding is the 
final step of a cascade process referred to as signal transduction. Signal transduction 
begins with peptide hormones binding specific transmembrane receptors, followed by 
the activation of transducer G proteins. The G proteins interact with adenyl cyclase or 
phospholipase C to produce the second messengers cyclic AMP (cAMP) or inositol 
triphosphate and diacylglycerol, respectively. Protein phosphorylations by specific 
protein kinases are mediated through these second messengers. 122 
The surge in transcriptional initiation resulting from signal transduction is 
dramatic and rapid. For example, cAMP induces transcription of the gluconeogenic 
enzyme PEPCK within 5 minutes (Sasaki et al., 1984). Induction continues to increase 
to a maximal rate 15 fold above basal levels within 30 minutes. This striking induction 
gradually diminishes over 24 hours. 
The cyclic AMP response element (TGACGTCA) was first implicated to play a 
role in the cAMP mediated regulation of the somatostatin gene (Montminy et al., 1986). 
Within a year, Montminy and Bilezikjian (1987) demonstrated the binding of a nuclear 
phosphoprotein to the cAMP response element and labeled it as the CREB protein. 
Yamamoto et al. (1988) further established phosphorylation of CREB via the cAMP­
dependent second messenger pathway augmented the transcriptional efficacy of this 
nuclear factor. 
The upstream region of the PC gene contains one putative CREB site located 
-441 to -448 nucleotides from the transcriptional start site. Although this site has 75% 
homology to the consensus sequence (TGACGGCC vs. TGACGTCA), studies of the 
regulatory region of the vasoactive intestinal peptide gene have shown the TGACG 
portion of the consensus element is critical for biological activity (Fink et al., 1988, 
Tsukada et al., 1987). Moreover, the regulatory region of the human insulin gene also 
contains a divergent CREB element with 75% homology to the consensus sequence 
(Boam et al., 1990). In vitro gel retardation and competition analysis using nuclear 
extracts from various cell lines contain factors which bind to this imperfect element. It 
should be noted that the ability of proteins to interact with the cAMP response element 
appears to depend upon the context of the nucleotides juxtaposed to the cAMP response 
element (Deutsch et al., 1988). Nevertheless, with an intact TGACG region as well as 
the ability of this sequence to bind proteins as demonstrated in the human insulin gene, 
the potential for functionality of the PC sequence appears favorable. Furthermore, 
Zhang et al. (1995) has provided evidence for the involvement of cAMP in the 123 
regulation of PC in 3T3-L1 adipocytes. Also of interest is the observation that the 
regulatory region of the rate limiting gluconeogenic enzyme PEPCK, which uses 
oxaloacetate produced by PC as a substrate, contains a cAMP response element (Short 
et al., 1986, Bokar et al., 1988) which binds CREB (Liu et al., 1991). Of further 
interest is the binding of nuclear factors to a cAMP response element located in the 
lactate dehydrogenase A subunit promoter of the lactate dehydrogenase gene (Kwast-
Welfeld et al., 1989). 
5.3.9 Glucocorticoid Response Element (GRE) 
The glucocorticoids, e.g. cortisol, cortisone, and corticosterone, belong to the 
class of hydrophobic C21-steroids synthesized in the adrenal cortex from a cholesterol 
precursor. Unlike polypeptide hormones which interact with transmembrane receptors, 
the hydrophobic steroid hormones pass through membranes and form ligands with their 
respective intracellular receptors. These ligand-bound receptors then interact with 
specific DNA elements thereby influencing the transcription initiation process. 
Liganded glucocorticoid receptors can stimulate or inhibit transcription. 
Examples of stimulation of transcription include the human metallothionein-IIA gene 
(Karin et al., 1984; Karin and Richards, 1982), the rat 2u globin gene (Chan et al., 
1991), and PEPCK (Sasaki et al., 1984). In addition to the regulation of PEPCK, 
glucocorticoids coordinate the flux of amino acids into the gluconeogenic pathway via 
breakdown of peripheral tissues, particularly muscle and bone (Kraus-Friedmann, 
1984). Transcriptional repression examples include the pro-opiomelaocortin gene of the 
anterior pituitary (Drouin et al., 1989), stromelysin (Frisch and Ruley, 1987), human 
glycoprotein hormone a-subunit (Akerblom et al., 1988), interleukin 113 (Lee et al., 
1988), and prolactin (Adler et al., 1988). 124 
The upstream region of the PC gene contains three possible GREs at sequences 
-457 to-462 (TCTTGT), -590 to -595 (TCCTGT), and -1293 to -1298 (ACAGGA). 
These three sites are, in actuality, GRE half sites. The consensus sequence for the 
complete GRE is GGTACAnnnTGTTCT (Beato, 1989). Binding to the complete 
consensus element involves homodimers or heterodimers of the glucocorticoid receptor 
(Chalepakis et al., 1990) which bind in a cooperative manner, i.e., one receptor of the 
dimer binds to the TGTTCT half site followed by binding of the second receptor 
binding to the GGTACA half site (Tsai et al., 1988). However, monomer binding of 
the glucocorticoid receptor to half sites was suggested as early as 1984 by Scheidereit 
and Beato (1984) and Karin et al. (1984). Chalepakis et al. (1990) confirmed that 
monomers of the glucocorticoid receptor do indeed bind to GRE half sites, albeit with 
less affinity. 
Though binding of monomers of the glucocorticoid receptor to half sites occurs, 
the possibility of the bound monomer binding a second glucocorticoid receptor and 
producing a dimer which binds DNA also deserves consideration (Perlmann et al., 
(1990). The possibility of the putative GRE half sites within the upstream region of the 
PC gene binding glucocorticoid receptor dimers also warrants consideration. Inclusion 
of 9 nucleotides juxtaposed to each of the GRE half sites results in a complete GRE 
element with 50-67% homology to the consensus sequence. When compared to the 
two GREs located in the promoter of the PEPCK gene, which have 50-58% homology 
to the consensus sequence, yet still bind glucocorticoid receptor dimers (Imai et al., 
1990), the binding potential of dimer glucocorticoid receptors to the PC GREs is a 
possibility. 
The position of GREs relative to the transcriptional initiation site of a gene 
appears to influence the ability of glucocorticoid receptor binding to regulate 
transcription. When located within 105 nucleotides of the transcriptional start site, a 
single GRE positioned upstream of the thymidine kinase promoter is sufficient to 125 
activate transcription (Stall le et al., 1987). However, at distances greater than 105 
nucleotides from the transcriptional start site, glucocorticoid receptors must bind to 
multiple GREs before alterations in transcription develop (Stith le et al., 1988). In 
addition, binding to multiple GREs proceeds in an additive fashion with binding to one 
GRE enhancing binding of the next GRE by as much as 100-fold (Tsai et al., 1989). 
The observation that the putative GRE elements upstream of the PC gene are located a 
minimum of 457 nucleotides upstream of the transcriptional start site would suggest 
more than one GRE site would be needed to influence PC transcription. Moreover, 
based on the observations of Tsai et al. and Strahle et al., the presence of multiple GREs 
imply binding may occur in an additive fashion and possibly alter PC transcription 
several fold. 
The spatial positioning of multiple GREs in the enhancer region of genes does 
not appear to influence gene regulation by glucocorticoids. GREs can form clusters 
near the transcriptional start site as exemplified in the long terminal repeat of the murine 
mammary tumor virus (Payvar et al., 1983). Conversely, clusters of GREs are located 
2.5 kb from the tyrosine aminotransferase gene start site (Jantzen et al., 1987). GREs 
can also be scattered individually throughout a gene regulatory region and still influence 
gene regulation. Such a situation occurs with the tryptophan oxygenase (TO) gene. The 
regulatory region of TO contains two GREs; one is located 450 nucleotides from the 
transcriptional start site and the other is positioned 1.2 kb upstream of the start site 
(Danesch et al., 1987). This is of interest because two of the proposed GRE elements in 
the upstream region of the PC gene have spatial positions (-457 and -1253) very similar 
to those of TO (-450 and -1200). 
In addition to interacting synergistically with other bound GREs to regulate 
transcription, bound GREs also interact with several transcription factors in the same 
manner. Schille et al. (1988) observed that a bound GRE interacts synergistically with a 
second GRE as well as with the following bound transcription factor elements: 126 
CAAT-box factor, Spl, octamer transcription factor, CACCC-box, and nuclear factor 1. 
It is also worth noting the mouse mammary tumor virus (MMTV) promoter studies of 
Cording ley et al. (1987) suggest the binding of glucocorticoid receptors to GREs 
facilitates the binding of NF-1, possibly by bound GREs altering nucleosome structure 
thereby exposing the NF-1 element. Such an interaction would imply that the spacing 
between NF-1 and a GRE be within the constraints of a nucleosome core particle, i.e. 
the octet of histone particles containing 146 nucleotides and not including the linker 
histone H1 (Paranjape et al., 1994). The distance between the proposed NF-1 site and 
the nearest putative GRE within the upstream region of PC is 214 nucleotides. 
Consequently, depending upon the spatial positioning of the GRE sequence on the 
nucleosome, the extra 68 nucleotides would presumptively place the NF-1 element 
nucleotide in the linker region between two nucleosomal cores or within the 
neighboring nucleosome. It is interesting to consider what impact the extra nucleotides 
would or would not have on the ability of bound GRE to influence the binding of NF-1 
as seen in the MMTV studies. Nevertheless, the plausibility of synergistic interactions 
between a bound GRE and other GREs and/or with bound NF-1 or Sp 1 within the 
regulatory region of PC has merit. 
Glucocorticoids also play a role in controlling gluconeogenesis during periods of 
starvation. Studies using isolated hepatocytes from starved rats treated with 
dexamethasone, a potent synthetic glucocorticoid, produce increased levels of glucose 
(Jones et al., 1993). Enhanced flux through PC is proposed to be the source of 
increased glucose production via gluconeogenesis. The ability of TCDD to reduced PC 
levels and activity could potentially constrict the flux through PC during times of 
reduced food intake. Laboratory animals exposed to TCDD consume less food 
compared to controls (Kelling et al., 1985; Stahl et al., 1990; Seefeld et al., 1984a,b; 
Potter et al., 1986a,b). It is conceivable that lowered PC levels due to TCDD exposure 
could interfere with the starvation induced activity of PC via glucocorticoids. 127 
Consequently, reduced food consumption, in conjunction the with loss of PC induciblity 
due to TCDD exposure, could exacerbate the wasting syndrome laboratory animals 
experience when exposed to sufficient levels of TCDD. 
5.3.10 Hepatic Nuclear Factor 4 (HNF-4). 
HNF-4 is an orphan receptor, i.e., no ligand has yet been identified, belonging to 
the steroid hormone superfamily (Sladek et al., 1990). Originally identified in crude 
liver extracts as a transcription factor involved in the regulation of transthyretin, a serum 
protein which carries thyroxine and vitamin A, and 1-antitrypsin, a protease inhibitor, 
HNF-4 is also found the in kidney (Costa et al., 1989; Xanthopoulos et al., 1991) and 
intestine (Sladek et al., 1990). No other tissues express HNF-4. 
HNF-4 role in gene transcription is positive regulation. Examples include, but 
are not limited to: 1) increased expression of human apoA-I, a protein involved in 
cholesterol synthesis (Tzameli and Zannis, 1996); 2) apolipoprotein CIII, a lipid binding 
protein involved in triacylglyceride and cholesterol transport in plasma (Mietus-Snyder 
et al., 1992); 3) the hypoxia responsive glycoprotein, erythropoietin (Galson et al., 
1995); 4) the liver-type pyruvate kinase, a phosphorylating protein involved in 
glycolysis (Liu and Towle, 1995); 5) phosphoenolpyruvate carboxykinase, the rate 
limiting enzyme in gluconeogenesis (Hall et al., 1995). The positive influence on 
transcriptional regulation of some genes by HNF-4 is counteracted by hypolipidemic 
drugs/peroxisome proliferators (HD/PP) such as clofibrate and bezAfibrate. For 
example, peroxisome proliferator-activated receptor-retinoic acid X receptor 
heterodimer suppresses the transcription of HNF-4 as well as competes with HNF-4 
binding sites in the promoter regions of transferrin (Hertz et al., 1996) and 
apolipoprotein CIII (Hertz et al., 1995), thereby squelching transcription of these genes. 
The HNF-4 binding element also has the ability to interact with another orphan 
receptor, the chicken ovalbumin upstream promoter transcription factor (COUP-TF), 128 
and influence gene transcription. In genes regulated by elements with the capacity to 
either bind HNF-4 or COUP-TF, HNF-4 binding regulates gene expression in a positive 
manner while COUP-TF is antagonistic, thereby controlling gene expression negatively. 
For example, the transcription activation of erythropoietin (Galson et al., 1995) and 
apolipoprotein CIII (Mietus-Snyder et al., 1992) by HNF-4 is antagonized by the 
binding activities of COUP-TF. An exception to this motif of gene expression is seen in 
studies involving the regulation of PEPCK; both COUP-TF and HNF-4 positively 
modulate the induction of PEPCK transcription by glucocorticoids (Hall et al., 1995; 
Scott et al., 1996). 
The upstream region of the PC gene contains one possible site HNF-4 binding 
site (-334 to '345). Based on the observation that glucocorticoid induced activation of 
PEPCK requires binding of HNF-4, the presence of three putative GREs and a HNF-4 
element in the PC upstream region adds more credence to glucocorticoid involvement in 
the regulation of PC. Furthermore, the possibility of COUP-TF interacting with the 
HNF-4 element to regulate the transcription of PC as seen with PEPCK also deserves 
consideration. 
Although several genes have promoter elements capable of binding both 
COUP-TF and HNF-4, this motif is not universal in all gene promoters capable of 
binding HNF-4. (Hall et al. and references within, 1995). An example of preferential 
binding of HNF-4 over COUP-TF occurs in the promoter region of the 1-antitrypsin 
gene. The possibility of the putative HNF-4 element of PC falling into this category 
should not be overlooked. 
5.3.11 Transcription Factor II-I (TFII-I) 
Transcription factor II-I was first described by Roy et al. (1991) as a factor 
capable of binding the initiation response element (Inr) of the adenovirus major late 
promoter and propagating basal transcription. Inr elements encompass the 129 
transcriptional start site or are located near it. The bound TF II-I facilitates the binding 
of transcription factor IID (TFIID), thereby promoting the subsequent sequential 
assembly of the RNA polymerase II preinitiation complex in TATA less genes (Roeder, 
1991). Similarly, the stabilization of TFIID binding in genes containing a TATA box is 
through interactions with transcription factor IIA (TFIIA). In promoters containing both 
TATA and Inr elements, TFIID may interact with TFIIA, the Inr bound TFII-I, or both 
(Roy et al., 1993a). The stabilization of TFIID by either TFII-I, TFIIA, or in 
combination is paramount for further assembly of the transcriptional preinitiation 
complex, i.e. assembly of the RNA polymerase II transcriptional apparatus cannot begin 
in the absence of stably bound TFIID. 
In addition to binding to Inr elements and stabilizing binding of TFIID, TFII-I 
also has the ability to interact with other DNA sequences and with proteins of the helix­
loop-helix (HLH) family of regulatory proteins. TFII-I binds the pyrimidine rich 
sequence AGCTCTCT of the human immunodeficiency virus-1 promoter region (Roy 
et al., 1991; Roeder, 1991) and the upstream stimulatory factor (USF) (Roy et al., 1991) 
sequence GGCCACGTGACC (Gregor et al., 1990). It is worth noting that the binding 
element of USF contains an E-box motif, i.e., CANNTG. This hexanucleotide sequence 
is a common motif in the binding sites for many HLH proteins. TFII-I also interacts 
cooperatively with USF at the Inr and the USF binding element (Roy et al., 1991). The 
cooperative binding of USF and TFII-I at the Inr and USF element suggest a possible 
communication link between the basal transcriptional apparatus and minimally one 
group of regulatory transcription factors, i.e. the HLH regulatory proteins (Roeder, 
1991; Roy et al., 1991). 
Additional evidence of TFII-I interaction with HLH proteins and concomitant 
transcriptional regulation is further evident with the nuclear proto-oncoprotein Myc. 
In vitro studies indicate TFII-I and Myc interactions have an inhibitory effect on 
transcription in the presence of promoters containing an Inr but lacking an E-box 130 
element (Roy et al., 1993b). However, in the presence of an E-box element and a 
second HLH nuclear proto-oncoprotein, Max, Myc + Max heterodimers activate 
transcription (Amati et al., 1992), whereas Max homodimers have an antagonistic effect 
(Kretzner et al., 1992; Amati et al., 1992). The ability of these transcription factors to 
interact with multiple nucleotide binding elements as well as combine in various ways 
to either up or down regulate transcription provides insight into the complexities faced 
when investigating transcriptional regulation, i.e. transcription factors may not 
participate strictly as a positive or negative regulators. 
The upstream region of the PC gene contains a remarkable 10 putative TFII-I 
elements. This decamer of elements commences at -790 and repeats every 39 
nucleotides ending at -1148 (Figure 4.8). Furthermore, the observation that an E-box 
core sequence juxtaposed on the downstream side of each TFII-I element is quite 
intriguing. Given the capacity of TFII-I to interact with HLH proteins which bind to E-
box sequences and the presence of a putative Inr element near the transcriptional start 
site, the possibility exists of TFII-I + E-Box proteins interact to regulate transcription of 
PC. Moreover, the importance of transcription factor TFII-I in stabilizing TFIID, thus 
allowing the further assembly of the transcriptional preinitiation complex, suggests 
TFII-I may be a target for transcriptional regulation. Such a role is indicated for TFII-I's 
counterpart, TFIIA, in TATA containing genes (Meisterernst and Roeder, 1991). 
The high number of TFII-I elements may suggest to two possible scenarios: 
(1) Sequential and/or cooperative binding may regulate the rate of transcription through 
the PC gene. The presence of several elements suggests PC may be very sensitive to 
various stresses placed on the organism. Stress could be in the form of an overnight fast 
to long term starvation, vigorous exercise as encountered in the adrenaline induced fight 
or flight response, exposure to environmental contaminates, such as TCDD, which 
interfere with metabolic processes, and metabolic disease such as diabetes. Studies of 
PC activity in heart and skeletal muscles of the rat revealed stress generated by exercise 131 
stimulates PC activity in these tissues (Lancha et al., 1994). With these observations in 
mind and flux through the gluconeogenic pathway primarily occurring in hepatic or 
renal tissue, it would not be unreasonable for metabolic stress to alter PC activity. 
As the severity of the stress increases, more TFII-I would bind and increase the 
flux through PC to produce oxaloacetate for gluconeogenesis and the citric acid cycle. 
It is noteworthy that the rate-limiting gluconeogenic enzyme PEPCK also responds to 
various stresses such as fasting and diabetes (Nandan and Beale, 1992). Moreover, it is 
reasonable to assume that an enzyme that provides the majority of oxaloacetate for two 
critical metabolic pathways in intermediary metabolism must have the capability to 
respond rapidly and with a high degree of control. Multiple TFII-I elements may 
contribute to this ability. Finally, the feasibility of transcription factors bound to the 
juxtaposed E-boxes interacting with bound TFII-I in response to various forms of stress 
should not be overlooked. 
(2) Multiple binding elements may allow for proper spatial positioning between 
bound upstream TFII-I and the Inr of the transcriptional start site. Studies by 
Jitrapakdee et al. (1996) indicate the 5' untranslated region of rat PC gene is divergent, 
possibly due to alternative splicing of transcripts. Depending upon the tissue, the rat PC 
leader sequence ranges from 59 to 222 nucleotides in length. Multiple TFII-I elements 
would allow for proper spatial positioning between the Inr at the transcriptional start site 
and the upstream TFII-I binding element to compensate for varying lengths of the PC 
untranslated region. It is also interesting to note that two of the variable length 
untranslated regions investigated in the rat PC gene differed by only 37 nucleotides; the 
spacing between the upstream PC TFII-I elements is 39 bases. It is possible that the 
similarity in spacing is physiologically relevant for the proper spatial alignment of the 
upstream TFII-I elements to regulated transcriptional initiation. 132 
5.3.12 E-Box Element 
The E-box element was first identified as any of three protein binding sites 
within the enhancer region of the heavy chain immunoglobin gene (Church et al., 1985; 
Ephrussi et al., 1985). The terms "E-motif' and "E- element" are synonymous for this 
trio of binding sequences originally referred to as [1E1, 42, and 43. Subsequent 
studies detected specific nuclear protein factors NF-41, NF-42, and NF-43 which 
bound their respective elements (Lenardo et al., 1987; Sen and Baltimore, 1986; 
Weinberger et al., 1986) in both lymphoid and nonlymphoid cell lines. Further studies 
revealed other factors capable of binding sequences very similar to those of the heavy 
chain immunoglobin gene. For example, the Nir box and the Far box of the rat insulin I 
gene are comprised of nucleotide sequences similar to that of the 41, 42, and µE3 
element and bind factors which may be similar or identical to NF-41, NF-42, or 
NF-43 (Moss et al., 1988). 
Of particular interest is the investigations of Murre et al. (1989a) involving 
characterization of the cloned factors E12 and E47. Their work demonstrated E12 and 
E47 bound to the icE2 sequence TGCAGGTGT, containing the E-element core 
consensus sequence CANNTG, within the immunoglobin kappa chain enhancer. Upon 
sequence analysis of the factors' cDNAs, an apparent amphipathic helix-loop-helix 
motif became apparent. Site directed mutagenesis studies in which either or both of the 
helices were removed eliminated DNA binding potential, thus providing evidence for 
the capacity of nuclear proteins containing a helix-loop-helix (HLH) motif to bind 
DNA. Furthermore, Murre's group discovered that approximately 60 amino acids of the 
amphipathic helices had high homology to a segment found in Drosophila daughterless, 
twist, and achaete-scute genes as well as mammalian MyoD and human N, L, and c-myc 
proteins. Further studies by Murre et al. (1989b) demonstrated homodimer and 
heterodimer formation between many of the heterologous HLH proteins previously 
mentioned. 133 
Although many HLH factors bind the E-box core consensus sequence 
CANNTG, many studies have focused primarily on the ability of the muscle-specific 
regulatory factor MyoD to modulate transcription. These investigations have provided 
many insights to protein-E-box interactions and gene regulation. Investigations of 
myosin light gene expression revealed the requirement of multiple E-box elements for 
gene expression (Wentworth et al., 1991). Mutational analysis of these elements 
illustrated one E-element is required for activity. However, this element by itself is 
inactive; at least one other E-element is needed to affect transcriptional initiation. Other 
genes also require the binding of MyoD factors to multiple E-elements for regulation of 
gene expression. The enhancer region of the chicken acetylcholine receptor a-subunit 
gene contains two E boxes, both which must be bound by MyoD factors for 
transcription to optimally occur (Piette et al., 1990). Furthermore, the binding of two or 
more sites necessary for transcriptional activation ensues in a cooperative manner as 
demonstrated by activation of a chloramphenicol acetyltransferase reporter gene activity 
in transfected C3H/10T1/2 cells (Weintraub et al., 1990). 
Although many genes require multiple E-elements for transcriptional regulation, 
the involvement of a single E-element altering gene transcription does occur. However, 
these solitary elements, like their multiple counterparts, do not have the ability to 
function in a solo capacity. Analysis of the fast skeletal troponin I gene in differentiated 
skeletal muscle cells of quail reveals expression of this contractile protein requires 
interaction between a single E-box bound by muscle specific factors and two ubiquitous 
transcription factors bound to their respective elements. An additional example of a 
single bound E-box cooperating with other sequence-specific regulatory factors as a 
prerequisite for gene regulation take place in the expression of the human cardiac a­
actin gene (Sartorelli et al., 1990). The minimal requirements for expression of this 
tissue specific gene requires the interaction of MyoD1, Sp 1 and the CArG-box binding 
factor. 134 
The 1.3 kb nucleotide sequence upstream of the PC transcriptional start site 
contains up to 16 putative E-box consensus (CANNTG) sequences positioned 
throughout the region (Table 5.1). As previously eluded to in section 5.3.11, ten of 
these elements are adjoined to TFII-I elements. The remaining elements are positioned 
independent of other factor binding elements save two. One which overlaps two 
nucleotides at the upstream end of the NF-1 element positioned at -229 to -243 and the 
other overlaps two nucleotides at the 5' end of the GRE located at -590 to -595. The 
juxtaposition of the E-and TFII-I elements suggests the potential for protein-protein 
interactions influencing transcriptional regulation. The capability of transcription 
factors from different families to interact and alter transcription is commonly referred to 
as crosstalk or cross-coupling (reviewed in Miner and Yamamoto, 1991 and Schule and 
Evans, 1991). Given the critical requirement of TFII-I for complete assembly of a 
functional RNA polymerase II complex and ultimately transcriptional initiation of 
TATA-less genes, crosstalk between proteins binding TFII-I and E-elements to regulate 
transcription would not be unreasonable. 
An interesting molecular aspect of TCDD exposure is the mechanism by which 
TCDD influences transcriptional activity. The liganded Ah receptor (AhR) must form a 
heterodimer complex with the transcription factor ARNT prior to binding a specific 
response element (Mason et al., 1994). Although this mechanism is reminiscent of 
steroid receptor binding, the AhR and ARNT proteins do not belong to the zinc finger 
superfamily of steroid receptors. Instead both the AhR and ARNT are HLH proteins 
(Burbach et al., 1992 and Hoffman et al., 1991, respectively). However, even though 
the AhR-ARNT heterodimer consists of two HLH proteins, this complex does not bind 
E-elements (Whitelaw et al., 1993). This pair of HLH proteins bind the unique dioxin 
responsive element (DRE) TNGCGTG (Yao and Denison, 1992). Intriguingly, the 
ARNT protein, when it forms a homodimer, does bind the E-element (Sogawa et al., 
1995; Antonsson et al., 1995). The work of Sogawa et al. suggests the CAC halves of 135 
the DRE and the E-element is recognized by ARNT. Of the sixteen putative E-elements 
in the upstream sequence of PC, thirteen, including all E-elements juxtaposed to TFII-I 
elements, contain this trinucleotide sequence (Table 5.1). Based on these observations, 
it is reasonable to consider the potential for TFII-I-ARNT homodimer interactions 
influencing transcriptional regulation of PC. 
In TCDD exposed C57BL/6J male mice PC levels are reduced. This reduction 
is a consequence of curtailed transcriptional initiation. Similar studies using the 
congenic strain of C57BL/6J mice, bred to possess a B6N Ah locus coding for low 
ligand affinity AhRs, require TCDD exposure levels 60 times greater to elicit a similar 
response (Ryu et al., 1995). The altered response is consistent with having low affinity 
AhRs and is usually interpreted to indicated AhR involvement for the response. 
However, it is conceivable this response is a result of PC gene regulatory sequence 
differences associated with the segregation of a B6N PC gene locus along with the AhR 
locus. Sequence comparison of approximately 1.3 kb upstream of the transcriptional 
start site reveals both strain have virtually identical regulatory regions. Furthermore, 
this region is noticeably deficient in DREs. These observations, along with the 
capability of ARNT homodimers to bind E-elements, suggested a squelching and 
physical blockage of the transcriptional apparatus as a means for TCDD repression of 
PC mRNA transcription. 
5.4 Transient Transfection Assays 
The finding of multiple E-box elements contained within the 1.3 kb upstream 
region of the PC gene and the ability of ARNT homodimers to bind these elements 
suggests a possible means of PC regulation involving ARNT. A proposed model in 
which ARNT homodimers positively regulated PC transcription is shown in Figure 5.1. 
In this illustration, ARNT homodimer binding to E-elements would upregulate PC 
transcription. A similar mode of transcription factor complex binding to multiple 136 
Table 5.1 Sequence and location of the E-elements within 
the upstream region of the PC gene 
Sequence
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CACCTG
 
CAGGTG
 
CATCTG
 
CAGCTG
 
CAAGTG
 
CAGCTG
 
Location 
-1179 to -1174 
-1140 to -1135 
-1101 to -1096 
-1062 to -1057 
-1023 to -1018 
'984 to -979 
'945 to -940 
'906 to -901 
'867 to -862 
'828 to -823 
789 to 784 
709 to 704 
-634 to -629 
-599 to 
47 to 242 
09 to -204 137 
Figure 5.1 Proposed squelching model for the regulation of PC gene expression. 
Homodimers of ARNT upregulate gene expression by binding to the E-elements 
located in the upstream region of the PC gene. Upon exposure to TCDD, accumulation 
of liganded Ah receptor-ARNT heterodimeric complexes squelch the availability of 
ARNT for homodimer formation. The reduction in the population of ARNT 
homodimers, and resultant unbound E-elements, facilitate the downregulation of PC 
gene expression. 138 
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elements enhancing transcription occurs in expression of murine cytochrome P450 
1A1(CYP1A1) gene. The binding of TCDD liganded Ah receptor-ARNT heterodimer 
complexes to any of five upstream dioxin response elements produces an increase in 
transcription (Fujii-Kuriyama et al., 1992). However, unlike the induction of CYP IA1 
where TCDD exposure induces transcription, intoxication with TCDD negatively alters 
PC transcription. Exposure to TCDD would facilitate liganded Ah receptor-ARNT 
heterodimer formation thereby sequestering ARNT and promote the subsequent 
reduction of homodimer formation thereby diminishing initiation of PC gene 
transcription. The ability of a transcription factor to titrate (squelch) the availability of 
another transcription factor, preventing it from interacting with its respective DNA 
element, to alter transcriptional activity appears to occur in lower eukaryotes. Gill and 
Ptashne (1988) demonstrated squelching with the yeast transcription factor GAL4, 
where it inhibits the transcription of certain genes lacking a GAL4 binding site. The 
capacity of liganded Ah receptor to form heterodimers with ARNT and possibly alter 
cellular ARNT homodimer formation as well as the in vivo experiments in which TCDD 
exposure in C57BL/6J Ahbib mice lowered PC mRNA may implicate squelching as a 
means to alter PC transcription. 
Transient transfection of DNA sequences into cell culture is an accepted way to 
study the ability of a nucleotide sequence to regulate transcription. This approach was 
employed to test the potential of ARNT to regulate PC through E-element interactions 
as well as ARNT mediated PC expression in the presence of TCDD. To use this 
method, the 1.3 kb upstream sequence of the PC gene was spatially inserted 5' of a 
luciferase reporter gene. This construct was used in transfection assays in Hepal cic7 
cell cultures. The unexpected increase in luciferase activity in transiently transfected 
cells exposed to TCDD implicates TCDD mediated interactions involving the upstream 
region of the PC gene. Similarly, TCDD exposed cells co-transfected with a plasmid 140 
encoding the ARNT protein also produced increases in luciferase activity, albeit at 
lower levels than TCDD exposed cells transfected only with the PC/luciferase 
plasmid construct. These results show that increases in expression of ARNT counteract, 
at least in part, the TCDD mediated induction of PC/luciferase transcription. 
Re-evaluation of the sequence 1.3 kb upstream of the PC gene, in particular the 
relative positioning of the E-element in relation to multiple TFII-I elements, suggests an 
explanation for the observations seen in the transient transfection studies. The 
juxtaposition of the E-elements and TFII-I elements suggests the possibility of protein-
protein interactions similar to those of composite elements. Composite elements are 
nucleotide sequences where regulatory transcription factors from different families bind 
and interact (crosstalk) with one another. This results in unique modes of 
transcriptional regulation. 
Interfamily transcription factor interactions at a composite element occurs 
between the leucine zipper transcription factor AP-1 and the zinc finger glucocorticoid 
receptor (Diamond et aL, 1990). The AP-1 transcription factor is comprised of either 
homodimers of c-Jun or heterodimers of c-Jun and c-Fos. Studies by Diamond's group 
(1990) identified a 25-base pair element, denoted as a composite glucocorticoid 
response element (cGRE), upstream of the mouse proliferin gene which binds both the 
glucocorticoid receptor as well as AP-1. Insertion of up to three copies of the proliferin 
cGRE upstream of a chloramphenicol acetyltransferase (CAT) reporter gene, followed 
by transient co-transfection with a glucocorticoid receptor expression vector into CV-1 
cells revealed binding of dexamethasone liganded glucocorticoid receptor lowered CAT 
activity several fold. When co-transfected with a c-Jun encoding plasmid into HeLa cell 
cultures, exposure to dexamethasone increased CAT activity. Conversely, transient co­
transfections with glucocorticoid receptor, c-Jun and c-Fos encoding plasmids in the 
presence of dexamethasone suppresses CAT activity. Furthermore, cross-linking 
studies by Diamond et al. (1990) demonstrated that the glucocorticoid receptor binds to 141 
both c-Jun and the cGRE. In addition, the ratio, not the absolute levels, of c-Jun and 
c-Fos were the critical component in determining whether CAT activity was enhanced 
or reduced. A proposed model for such a regulatory mechanism for PC is shown in 
Figure 5.2. ARNT homodimers bind to the E-box portion of the composite element 
with concomitant protein-protein interactions occurring with TFII-I bound to its 
respective sequence. In the proposed mechanism, bound ARNT homodimers function 
in a negative capacity, thus keeping the transcription of PC at a basal level. Exposure to 
TCDD and the subsequent liganding to the Ah receptor titrates the ARNT homodimer 
population by forming Ah receptor-ARNT heterodimers. The sequential removal of 
ARNT systematically relieves repression and consequentially increases PC 
transcription. Increases in ARNT shifts the cellular ARNT-Ah receptor ratio in such a 
manner as to permit limited homodimer formation, followed by limited reduction in PC 
transcription. 
Subtle similarities between the proposed ARNT-TFII-I composite model and the 
cGRE site of the proliferin gene lend support to a model of PC regulation via 
transcription factor cross-talk. The glucocorticoid receptor and ARNT are both 
components of intracellular receptor signaling pathways, albeit ARNT homodimers are 
not known to interact directly with any signaling molecules. However, ARNT, when 
partnered with liganded Ah receptor, forms an intracellular heterodimer receptor 
complex capable of binding specific DNA response elements and regulating gene 
transcription. In the proposed model, the formation of Ah receptor-ARNT complex 
would relieve the repressional control imparted by ARNT homodimers, i.e. exposure to 
TCDD would alter PC transcriptional rates through the Ah receptor intracellular 
signaling pathway even though the upstream region lacks dioxin response elements. 
A second similarity is noticeable when comparing AP-1 to ARNT. AP-1 is a 
composite of either a c-Jun homodimer or a c-Jun+c-Fos heterodimer. Positive or 
negative transcriptional regulation of the proliferin gene is controlled by which form of 142 
Figure 5.2 Proposed composite element model for the regulation of PC gene 
expression. Transcription factor TFII-I and an ARNT homodimer bind to a composite 
element, thereby keeping expression of PC to a basal level. Subsequent to TCDD 
exposure, formation of liganded Ah receptor-ARNT heterodimeric complexes occur, 
thereby reducing the availability of ARNT for homodimeric interactions. This results in 
the relief of the repressional effect imposed on PC gene expression by the composite 
element bound ARNT homodimer. 143 
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AP-1 interacts with the glucocorticoid receptor at the cGRE; AP-1 homodimers enhance 
transcription while AP-1 heterodimers repress transcription. In the proposed model, 
ARNT can either be in a homodimer configuration or form a heterodimer with liganded 
Ah receptor. When ARNT is in the homodimer configuration, protein-protein 
interaction with TFII-I governs transcription of PC, holding transcription to a basal level 
of expression. Upon exposure to TCDD, the liganded Ah receptor forms a heterodimer 
with ARNT. With ARNT in a heterodimer configuration, transcription is permitted to 
increase above basal levels of expression. As with AP-1, the configuration of ARNT, 
i.e. homodimer vs. heterodimer, may influence transcriptional activity. However, unlike 
the c-Jun+c-Fos heterodimer which has the capacity to bind to the cGRE and interact 
with the glucocorticoid receptor, the Ah receptor+ARNT heterodimer does not bind the 
E-element and subsequently would not interact with bound TFII-I. Nevertheless, the 
formation of heterodimers would alter transcription, much like the heterodimers of AP-1 
alter proliferin transcription, albeit indirectly through the squelching of available 
ARNT. The similarity of action between the proposed composite PC element and the 
cGRE of the proliferin gene (Diamond et al., 1990) lends support for this mode of 
transcriptional control of PC in Hepa lc 1 c7 cell cultures. Additional support is evident 
in the similarity of the Ah receptor squelching available ARNT with the squelching 
ability of GAL4 in yeast (Gill and Ptashne, 1988). 
Another interesting aspect of the proposed TFII-I-ARNT composite element 
model is its multiplicity; a total of ten putative sites may be available for transcription 
factor interactions. The E-element sequence, CACCTG, is 83% homologous to the 
consensus element CACGTG identified by Sogawa et al. (1995) and Antonsson et al. 
(1995). Consensus elements are sequences which are most favorable for relatively 
stable binding of transcription factors. Slight deviations from the consensus sequence 
may reduce binding affinity, thereby resulting in a temporal interaction between the 
transcription factor and the element. Such transient interactions allow the response of a 145 
gene to modulate transcription in a sensitive, precise and transitory manner as a result of 
subtle changes in signaling patterns. The position of PC at the "crossroads" of 
intermediary metabolism, thus interlinking the metabolic major pathways, requires the 
capability of high fidelity response to the ever-changing metabolic stresses placed on an 
organism. The multiplicity and the nucleotide sequence arrangement of the putative 
composite sites upstream of the PC gene may contribute to PC transcriptional responses 
to the ever-changing fluxes of intermediary metabolism. Similarly, multiple copies of 
TFII-I-ARNT composite sites would recognize subtle changes in the Ah receptor-
ARNT cellular ratio, thus heightening sensitivity of PC transcriptional regulation in 
response to signals transduced through the Ah receptor signaling pathway. It is worth 
noting multiple copies of DNA binding elements are present in upstream region of 
genes whose transcriptional activity is impacted by exposure to TCDD. A specific 
example is the murine cytochrome P450 gene 1A1 (CYP1A1) with five dioxin response 
elements capable of binding ligand Ah receptor+ARNT complexes (Fujii-Kuriyama et 
aL, 1992). The sensitivity of genes to TCDD can be appreciated by the estimation of 
KD concentrations for ligand-receptor interactions as low as 1 pM (reviewed in Safe, 
1995). Based on these observations and acknowledging the integral role PC plays in 
intermediary metabolism, the proposed involvement of ten composite elements in the 
high precision regulation of PC is reasonable. 
In the transcriptional regulation of proliferin, the ratio of the intracellular 
transcription factors c-Jun and c-Fos, not the absolute levels, determine whether AP-1 
interaction at the cGRE will alter transcription positively or negatively (Diamond et al., 
1990). When Hepal cic7 cells cultures were co-transfected with an ARNT encoding 
plasmid, the intracellular Ah receptor ARNT ratio was altered. Luciferase activity in 
lysates of co-transfected Hepa lc 1 c7 cell cultures exposed to TCDD was elevated, 
although not to the extent of TCDD exposed cell cultures transfected only with the 
PC/luciferase construct. In the proposed model, the availability of additional ARNT as 146 
a consequence of co-transfection, permits the formation of additional ARNT 
homodimers in the presence of TCDD. These extra homodimer complexes would 
compensate for the loss of ARNT homodimers due to heterodimer formation with 
liganded Ah receptor with concomitant reduction in PC-luciferase transcriptional 
activity. However the reduction in activity does not return to basal levels. This 
observation suggests the alteration of intracellular ARNT pools due to co-transfection 
can only partially compensate for the increases in transcription subsequent to TCDD 
exposure. 
It is also of interest to consider the physiological role of these regulatory zones 
in view of the proposed model in the absence of TCDD. An aspect to consider is 
nutritional in nature. Although TCDD binds to the Ah receptor with high affinity, it is 
not alone in the ability to do so. Other ligands capable of binding the Ah receptor, some 
with affinities similar to that of TCDD, exist in the food chain. An example is indolo­
[3,2b]carbazole, a derivative of the cruciferous plant compound indole-3-carbinol. 
Studies by Kleman et al. (1994) show this indole containing compound interacts with 
murine and human Ah receptors with affinities rivaling that of TCDD. Other indole 
containing molecules also bind the Ah receptor. Rannug et al. (1987) demonstrated the 
ability of certain oxidized derivatives of the essential amino acid tryptophan, also bind 
the Ah receptor with high affinity. Other nutritional compounds capable of binding the 
Ah receptor include heterocyclic amines formed during cooking of protein-rich foods 
(Kleman et al., 1992) and the rutaecarpine alkaloids of the Rutacae plant family (Ginner 
et al., 1989). The capacity of certain food-related compounds to bind to the Ah receptor 
would, based on the proposed model, result in the induction of PC transcription. The 
potential energy in food, when consumed, is converted into a more usable form of 
potential energy, i.e. glycogen, lipids, and ATP. Flux through PC contributes to the 
pathways involved in the synthesis of these physiologically usable potential energies, 
namely gluconeogenesis, glyceroneogenesis, fatty acid synthesis, and the citric acid 147 
cycle. With PC's intimate link to the major pathways of intermediary metabolism, it is 
reasonable to conclude that short term upregulation of PC may be stimulated by various 
compounds in an organism's diet. 
5.5 Tertiary Structure Analysis of the Upstream Region of the PC Gene 
An interesting aspect of the upstream region of the PC gene becomes evident 
upon tertiary structure analysis (Figure 5.3a,b,c). The ability of DNA to curve or bend 
is an intrinsic property of the molecule which is sequence dependent (reviewed in 
Crothers et al., 1990; Hagerman, 1990). As such, transcription factor elements that are 
linearly separated by a substantial distance may be brought into a more favorable 
proximity for possible protein-protein interactions. For example, the linear distance 
from the putative PC Inr element to the composite sites ranges from 2700 to 3900 A 
(assuming B-DNA configuration with a helical rise of 3.4 A per residue). The distance 
is reduced 20-30% (1900 to 3100 A) when the sequence dependent tertiary structure is 
imposed. Although the reduced distance between the Inr and the closest composite 
element approaches 2000 A, the distance may be reduced even further as a consequence 
of the following: 1) The curvature of DNA is not rigid; the impact of torsional forces 
as well as flexibility may position the elements closer to one another. 2) Additional 
bending of DNA can occur upon the binding of transcription factors such as Spl. 
3) The PIC complex consists of at least eight different molecules with a molecular mass 
approaching 950 kDa while the ARNT homodimer and TFII-I of the composite element 
are approximately 300 kDa. When combined, the two complexes would form a massive 
complex nearing 1300 kDa. The size of this complex, coupled with 1) and 2) could 
ultimately culminate in protein-protein interactions between the bound Inr and 
composite element(s). Another intriguing aspect is the sequence imposed tertiary 
structure encompassing the composite elements (Figure 5.3b,c). A novel spiral structure 
is evident. The spiraling is such that nine of the elements are positioned in a manner to 148 
Figure 5.3 Tertiary structural analysis of the sequenced upstream regulatory region of 
the hepatic PC gene. The untranslated leader sequence and the upstream region (to 
1359) of the PC gene were analyzed using Long Range DNA Sequencing (LORDS) 
computer software (Dr. P. Shing Ho, Oregon State University). LORDS calculates the 
intrinsic curvature of DNA produced by the nucleotides within a specified DNA 
sequence. Visualization of the predicted tertiary structure was achieved using Insight II 
analyze software (Biosym Technologies, San Diego, CA). (a) The overall tertiary 
structure encompassing the noncoding exon 1 and the adjacent 1.3 kb upstream region 
of the PC gene. Beginning at the 3' end of the region, the color coding for the cis-acting 
elements are as follows: red = Inr; red/pink/white = overlapping Sp 1 and GCF elements; 
green = E-boxes; yellow = NF-1 element; black = HNF-4 element; purple = CREB 
element; gold = GRE elements; pink = UBP-1 element; green/red = E-box/ TFII-I 
composite elements. (b) Enlarged view of tertiary structure of the 10 E-box/TFII-I 
composite elements. Each colored section represents one composite element. Elements 
colored red, green and purple are in phase with their respectively colored element as 
discussed in Chapter 5. The yellow colored composite element, though in phase with 
the red composite elements, is greater than 400A from the nearest neighboring red 
composite element. (c) Composite elements viewed along the helical axis displaying 
the phasing of the composite elements. The coloring of the elements is as in (b). 149 
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form a trio of phased elements, i.e. every third element positioned in line with one 
another (Figure 5.3b,c). In addition, the distance between the phased elements is 
approximately 400 A. This distance is reduced 33% from the linear distance of 600 A 
(assuming a standard B-DNA configuration). Of further interest is the observation that 
the number of nucleotides between phased elements is similar to the nucleotide number 
found in a nucleosome (156 vs. 146 for a nucleosome). In addition, the intrinsic 
curvature of the composite element region provides a favorable environment for 
nucleosome formation (personnel communication, Dr. Kensal van Holde, Oregon State 
University). The formation of a nucleosome would reduce the overall distance between 
the phased elements from 400 A to approximately 65A. Moreover, the number of 
nucleotides between the phased elements would encircle the nucleosome approximately 
1.8 times. As such, the phased elements would no longer be aligned. It is believed that 
chromatin structure, i.e. DNA with a complement of histones, contributes to the 
regulation of transcription (Svaren and Harz, 1997). The formation of nucleosomes in 
the composite element region may play such a role by eliminating the phasing of the 
elements. Binding of ARNT homodimers and /or TFII-I may displace the nucleosomal 
assembly with subsequent realignment of the elements intrinsic intervening curvature. 
It is worth noting that transcription factors often function by producing bends in DNA. 
Here, release from a nucleosome structure, by default, produces "bent" DNA. This in 
itself may be sufficient for transcriptional activation. The lose of nucleosomal structure 
may also permit subsequent binding of additional transcription factors within the 
upstream regulatory region which facilitate protein-protein interactions among the 
phased elements and the Inr. 
5.6 Comparison of C57BL/6J Mice and Hepa 1c1c7 Cell Culture Studies 
Exposure of C57BL/6J(Ah") male mice to sublethal doses of TCDD results in 
a dose and time dependent reduction in PC level/activity and mRNA. To gain insight to 153 
the mechanisms involved in the TCDD induced downregulation of PC transcription, a 
1.3 kb fragment 5' to the transcriptional start site was isolated and sequenced. 
Subsequent to isolation and sequencing, the nucleotide sequence was inserted into a 
luciferase reporter vector and evaluated by transient transfection into Hepa lc 1 c7 cells 
cultures. Transient transfection assays are routinely used to study the proficiency of 
nucleotide sequences in transcriptional activation. By monitoring the response from 
various reporter genes placed under transcriptional control of the nucleotide sequence of 
interest, one can gain insight into a sequence's ability to alter transcription activity. 
However, such assays may not always produce a complete and true representation of 
in vivo gene regulation. Aspects of the system which may effect reporter gene activity 
include the following: 1) A sequence under study may lack specific areas of sequence 
necessary for an in vivo-like response; 2) The topology of transiently transfected 
plasmids may influence protein-protein interactions between bound transcription 
factors; 3) The physiology of the immortalized cell line used for the transient 
transfection does not mirror that of the tissue of origin. These features of transient 
transfection assays may contribute individually or synergistically to the contradictory 
observations seen in the luciferase activity of TCDD exposed transiently transfected 
Hepa lcl c7 cell cultures as compared to TCDD exposed C57BL/6J (Ahb/b) mice. 
The rate of transcriptional initiation is controlled through the interactions of 
transcription factors with nucleotide elements. Elements are classified as either 
promoter elements or enhancer elements. Promoter elements are usually orientation 
specific and located no more than 100 nucleotides upstream of the transcriptional start 
site. Enhancer elements, on the other hand, are orientation independent and are usually 
positioned within 1 kb upstream of the transcriptional start site. However, some genes 
are influenced by enhancer elements located at distances greater than a thousand 
nucleotides. For example, glucocorticoid regulation of the uteroglobin gene in rabbit 
lung appears to occur via three glucocorticoid response elements positioned 154 
approximately 2.6 kb upstream of the transcriptional start site (Cato et al., 1984). 
Another example of regulation of gene expression over relatively long nucleotide 
distances is observed in the upstream region of the rat CYP1A1 gene (Fujii-Kuriyama et 
al., 1992). Five xenobiotic response elements influence transcription of this gene and 
are situated between 537 and 3586 nucleotides upstream of the CYP1A1 transcriptional 
start site. 
The transcriptional regulation of gene expression does not always involve 
transcription factor interactions with nucleotide elements 5' of the transcriptional start 
site. Transcriptional regulatory elements may be positioned 3' to the transcriptional start 
site and within the intronic sequences of a gene. This form of transcription element 
spatial positioning is found in the quail fast skeletal troponin I gene (Lin et al., 1991b). 
Referred to as an internal regulatory element, this regulatory nucleotide element is 
positioned within the first intron and it plays a role in the muscle specific expression of 
the troponin 1 gene. The TCDD induced increase in expression of the PC-luciferase 
reporter gene plasmid in Hepal c 1 c7 cell cultures may reflect the absence of negative 
control elements that are present in the chromosomal PC gene. Additional sequences, 
either upstream or downstream of the 1.3 kb sequence used in these studies, may be 
required to emulate the response observed in animal studies. Nevertheless, both the 
mice and cell culture studies reveal that TCDD exposure alters the flux of metabolites 
through intermediary metabolism pathways. 
The possible lack of sufficient nucleotide sequences to mirror the in vivo 
response displayed by the C57BL/6J (Ahb/b) mice may not be the only factor in PC­
luciferase expression in cell culture studies. Work by Piña et al. (1990) indicate 
plasmid topology may influence regulation of transcription. This group chose a 
chloramphenicol acetyltransferase reporter gene linked to a herpes virus simplex 
thymidine kinase promoter to monitor the capacity of a sequence to regulate 
transcription. Expression of the reporter gene was placed under the control of the 155 
hormone regulatory element region (glucocorticoid and progesterone response 
elements) of the mouse mammary tumor virus positioned 5' of the thymidine kinase 
promoter. Transient transfections into the human mammary tumor cell line T47D were 
performed using closed circular or linear reporter gene construct plasmids. Closed 
circular plasmids maintain a negative supercoiled topology while linearized plasmids do 
not. Results pointed to progestins induced activity only with the negatively supercoiled 
plasmids. Glucocorticoids, however, induced activity independent of this topology. 
Furthermore, insertion of 5 base pairs to increase the distance between hormone binding 
elements reduced the progesterone response in only the cells transfected with 
supercoiled plasmid. Conversely, the glucocorticoid response was increased using the 
same topological environment. Such topological changes in activity were attributed to 
events subsequent to receptor binding, because receptor binding affinity for supercoiled 
and linear DNA is quite similar. 
The negative supercoiling of the PC-luciferase reporter gene plasmid, while not 
contributing to alterations in transcription factor binding affinities, may provide a 
spatial environment favorable for subsequent events necessary for transactivation of 
transcription. It is conceivable that the topology of the supercoiled plasmid spatially 
arranges the composite sites to place them in phase with one another, thereby producing 
a greater response. In addition, super coiling may also facilitate protein-protein 
interactions among other transcription factors and the pre-initiation transcriptional 
complex with concomitant increases in activity. 
A second factor that may influence PC-luciferase activity may be associated 
with the suggestion that negative supercoiling may lower the energy needed for the 
looping out of DNA. Studies by Kamer et al. (1988) indicate looping out of DNA, as a 
consequence of negative supercoiling , may permit binding to operators for the 
prokaryotic lac repressor. It is intriguing to consider the possibility of PC-luciferase 
plasmid negative supercoiling and subsequent looping out of DNA as a means to permit 156 
bound enhancer elements to interact with the transcriptional pre-initiation complex. In 
this regard, the observations of Weintraub et al. (1986) that only plasmids with 
enhancers appear affected by DNA topology are noteworthy. Similarly, the PC­
luciferase plasmid sequence also encompasses proposed enhancers. Based on this line, 
it is reasonable to consider looping out of DNA in the proposed mechanism for the 
induction of the luciferase activity observed in the transient transfection studies. 
The morphology of transfected plasmid DNA may not be the only contributor to 
the differences observed between the cell culture and whole animal studies. 
Physiological deviations exist between immortalized cell cultures and the tissue cells 
they were derived from. In the case of Hepal cic7 cells, disparity in Ah receptor 
concentrations exist when compared to receptor levels found in the hepatocytes of 
origin, i.e. livers of the C57 mouse strain. The Hepa lc 1 c7 cell line expresses Ah 
receptors in concentrations approximately ten fold higher than that found in the livers of 
C57 animals (Pollenz, 1996). Whether these Ah receptor concentrations are a result of 
cell culture conditions or are in actuality physiological levels found in a subset of 
surviving hepatocytes is unknown. Nevertheless, the overall Ah receptor concentration 
in liver hepatocytes of the C57 strain of mice is noticeably lower when compared to 
Hepa 1c1c7 cell cultures. 
Although Hepa lel c7 cell possess higher concentrations of Ah receptors than 
the C57 strains of mice, exposure to TCDD dramatically lowers Ah receptor levels in 
cell cultures. For example, Hepa lc 1 c9 cell cultures exposed to TCDD displayed an 
80% reduction in Ah receptor concentrations of after 6 hours of exposure (Prokipcak 
and Okey, 1990). Similarly, Hepa lel c7 cell cultures also exhibit the same level of 
reduction in Ah receptor concentrations only hours after exposure (Pollenz, 1996). 
These observations are in stark contrast to studies by Sloop and Lucier (1987) in which 
rats exposed to TCDD manifest a 4-5 fold increase in Ah receptor levels. Whether the 
induction evident in rats also occurs in C57 BL/6J (Ah") mice is uncertain. The 157 
contrasting changes in Ah receptor concentrations in TCDD exposed rats versus Hepa 
cell cultures hinders postulation as to how these differences translate to the disparity 
observed in the whole animal and cell culture studies. Even so, these observations 
should not be ignored in subsequent studies in understanding TCDD induced alterations 
of transcriptional activity. 
Another factor which may contribute to the differences between the animal 
studies and cell cultures is pH. Studies by Iynedjian et al. (1975) demonstrated in rats 
experiencing acute metabolic acidosis display increases in PEPCK synthesis in kidney 
cortex tissues. Although induction of liver PEPCK in acidotic rats in not as apparent, 
cell culture studies by Pollock and Long (1989) indicate lowered pH may alter PEPCK 
activity in hepatoma cells. This group used chimeric constructs consisting of the 5' 
flanking regions of the rat PEPCK gene linked to the human growth hormone (HGH) 
gene. Transfection into rat NRK52E renal epithelial cells and rat H4IIE hepatoma cells 
expressed increases in HGH production by several fold when the extracellular pH is 
lowered to 7.0. Lowering extracellular pH appears to impact intracellular pH and lower 
it even further. Studies with the opossum OK cell line demonstrate lowering of 
extracellular pH to 7.0 reduces intracellular pH to less than 6.8 (Sasaki et aL, 1984). It 
is worth noting that metabolic acidosis in humans occurs when blood pH levels drop 
below 7.37. It is interesting to consider whether intracellular pH levels in acidotic 
animals experience the fluxes in pH observed in cell cultures. 
Studies by Graneri et al. (1992) and Attwood and Graneri (1991) suggest 
alterations of pH can impact the binding of ATP and phosphate in the carboxylation 
reaction of PC. It is of interest to consider the impact lactate acidosis, produced as a 
sequela to TCDD exposure, may have on the mechanisms inherent in the carboxylation 
of pyruvate. The extracellular pH of the Hepa 1c1c7 cell cultures is tightly regulated by 
buffered media which can actively interact with the rigorously monitored CO2 levels 158 
within the cell culture incubator to maintain a physiological pH of 7.4. As such, it is not 
unreasonable to consider possible differences in intracellular pH contributing to the 
contrasting results observed in cell cultures and whole animal studies. 159 
Chapter 6 
Summary and Conclusions 
The ubiquitous environmental contaminate 2,3,7,8-tetrachlorodibenzo-p-dioxin, 
more commonly known as TCDD or dioxin, is the most toxic of the 75 synthetic 
organic congeners of chlorinated dibenzo-p-dioxins. The dioxins are formed as an 
unwanted by-product of phenoxy herbicide manufacturing, waste combustion, 
metallurgy, and pulp bleaching. TCDD exposure effects a plethora of adverse cellular 
responses. These include, but are not limited to, carcinogenesis, teratogenesis, 
immunosuppression and reduced fertility. The most conspicuous sign of high dose 
exposure to TCDD is a wasting syndrome in which laboratory species intoxicated with 
TCDD exhibit weight loss within days of exposure. The underlying mechanisms which 
produce the TCDD wasting syndrome are unknown, however a number of relevant 
metabolic pathways are impacted by TCDD. 
Studies in rats have demonstrated that exposure to TCDD produces a reduction 
in PC activity. PC is a pivotal enzyme in intermediary metabolism, catalyzing the 
energy-dependent carboxylation of pyruvate to oxaloacetate for gluconeogenesis and the 
anaplerotic replenishment of the citric acid cycle. The observation that humans afflicted 
with PC deficiency usually die in utero or shortly after birth suggests that no alternative 
pathway is available to compensate for the lose of PC activity. Given these 
observations, the inhibition of PC activity by TCDD brings into question the potential 
damage this compound and similar congeners could induce during late fetal 
development. 
The research presented in this thesis demonstrates that reduction in PC activity 
is not an unique to rats, but also occurs in the C57BL/6J strain of mice. Here, 
characterization of PC protein and mRNA levels indicates that reductions in protein and 160 
ribonucleotide levels closely parallel one another in a dose-dependent manner 
subsequent to a sublethal exposure to TCDD. Furthermore, the reduction in mRNA 
suggests TCDD exposure produces alterations in the transcription regulation of the PC 
gene. The observation that PC deficient individuals experience lactate acidosis 
indicates the increases in serum lactate levels are consistent with the loss of PC activity. 
In mice, isozyme shifts in lactate dehydrogenase occur at a TCDD dose 20 times greater 
than needed to facilitate a reduction in PC activity. As such, these changes are likely to 
be a secondary effect to TCDD exposure, possibly a consequence of the build up of 
excess serum lactate. Although malate dehydrogenase activity is essential for providing 
PC generated carbon units for gluconeogenesis, exposure to TCDD at the doses tested is 
not a factor, for the enzyme's activity remains unchanged. 
Sequence analysis of the upstream region of the PC gene revealed the existence 
of ten putative transcription factor elements with some occurring as tandem repeats. 
Many of these elements are implicated in the regulation of PEPCK. Examples include 
the glucocorticoid response elements, cyclic AMP response element, and hepatic 
nuclear factor 4. In light of the role PC plays in providing substrate for PEPCK, it is 
reasonable for the regulatory regions of both genes to be under coordinate 
transcriptional control. Further studies such as mobility shift assays using hepatic 
nuclear extracts and DNA footprinting assays will be required to provide additional 
evidence that these elements contribute to the regulation of PC. In addition, 
characterization of the proteins bound to these sites will contribute to understanding the 
functionality of the upstream transcription factor elements of the PC gene. The ability 
of a transcription factor to elicit a response is integrally related to its binding affinity for 
cis elements. As such, binding affinity assays for positively identified transcription 
factors will also provide insight in determining the relevance of the putative 
transcription factor elements that influence variable transcriptional regulation of the PC 
gene. 161 
Computer analysis of the tertiary structure of the upstream nucleotide sequence 
reveals the presence of a loop which brings the Inr element into alignment with the 
proposed tandem composite elements. This may facilitate protein-protein interactions 
between these elements. Protein binding and crosslinking studies will provide evidence 
for such an interaction. Analysis of the sequences comprising the proposed composite 
elements provide evidence for a novel spiral tertiary DNA structure. Each spiral 
contains approximately the number of nucleotides that encircle the octet of histones that 
form the nucleosome. Furthermore, the proposed elements are positioned to form three 
in phase groups with each group containing three composite elements. The distance 
between the phased elements is approximately 400A. The close proximity hints of 
possible protein-protein interactions among the elements of a group. Nucleosome 
reconstitution experiments using nucleosome histone particles and the spiral forming 
nucleotide sequences may provide insight as to the ability of the sequences comprising 
the spiral DNA structures to assemble into a phased set of nucleosome particles. 
Protein cross-linking studies along with mobility shift assays will elucidate protein-
protein interactions between the bound phased elements. The ability of transcription 
factor TFII-I to interact with basic helix-loop-helix proteins lends credence to the 
possibility of phased element interactions with the basal transcriptional complex. 
The increases observed in the luciferase activity of TCDD exposed Hepa lc 1 c7 
cells was quite unexpected and contrasts with the animal studies. Additional 
experimentation may provide further insight to the underlying reasons for the increases 
observed in tissue cultures. Even though regulatory enhancer elements are usually 
positioned within 1 kb upstream of the transcriptional start site, its has been observed 
that nucleotide elements as far as 4.8 kb upstream of the hepatic PEPCK gene can affect 
the transcription expression of this gene (Ip et al., 1990). The possibility of additional 
regulatory elements existing further upstream than 1.4 kb is not unlikely. Isolation of 
additional upstream elements which could contribute to the regulation of PC 162 
transcription can be evaluated using PCR and reporter gene technology as described in 
this thesis. It is not unusual for enhancer elements to be positioned downstream of the 
transcriptional start site and within the introns of the gene. Sequence analysis of the 
downstream region of congenic C57BL/6J male mice have revealed the presence of a 
7.5 kb intron positioned between the untranslated leader sequence and the AUG 
translational start site (Ryu, 1996). Here also, the use of reporter gene assays may be 
used to evaluate the presence of sequences capable of binding transcription factors that 
contribute to the regulation of the PC gene. A potential drawback to these studies may 
be the overall size of the sequence needed to potentiate a physiologically relevant 
response. A complete sequence necessary to produce the response may become too 
unwieldy for efficient incorporation into a reporter gene vector and/or be transiently 
transfected into cell cultures. Using smaller segments of sequence may permit analysis 
for potential transcriptional regulation, however the possible requirement for an intact 
sequence to elicit a response similar to that of a complete organism may be necessary. 
It may be useful to further evaluate the putative functionality of the composite 
elements and the ability of ARNT to bind to the E-box half of the composite element 
via transient transfection into the C- strain of Hepa cell cultures. These cells are 
deficient in ARNT function. If transient transfections into the ARNT deficient strain of 
Hepa cells produces a change in reporter gene activity compared to Hepa lc 1 c7 cells, 
this would indicate ARNT involvement with the composite elements. Furthermore, one 
would expect co-transfection with an ARNT encoding vector to return the response 
observed in the transfection studies reported in this thesis. 
Other investigations that may provide further understanding of the differences 
between animal and tissue culture include alterations of the cell culture pH. Changes in 
pH may alter the transcriptional regulation of the PC gene. Such experiments are 
suggested by the observation that alterations in pH are believed to alter the expression 
of the PEPCK gene (lynedjian et al., 1975; Pollock and Long, 1989). Another possible 163 
option is the stable transfection of the sequence into the cell cultures. Unlike transiently 
transfected sequences, stably transfected sequences are incorporated into the genome of 
the host cell which permits actively dividing cells to replicate the sequence thereby 
allowing the sequence to be passed to the daughter cells and subsequent generations. 
The inclusion of the sequence into the genome would result in a physiologically 
relevant environment free of the supercoiling effects imposed by a circular plasmid. 
This should provide a more realistic picture of the capacity of a sequence to regulate 
transcription. 
Cell culture systems have contributed greatly to our understanding of TCDD 
mediated toxicity. However, there are examples of contradictory results occurring 
between whole animal studies and cell cultures. Such differences have been observed in 
immunotoxicity and developmental studies. With these observations in mind, one 
should be cautious when extrapolating the results obtained in cell culture to the whole 
organism. Cell cultures allow for observation of an isolated tissue separate from the 
influence of peripheral organ activity. If a response requires multiorgan involvement, 
the cell culture system may not produce an accurate picture of events. 
In conclusion, the ability of TCDD exposure to alter the expression of PC 
activity in both animals studies and cell culture is evident, albeit the cell culture studies 
do not mirror the animals studies. Further studies are warranted to understand better the 
mechanisms underlying the response observed in the cell cultures. Nevertheless, the 
reduced expression of PC in TCDD exposed C57BL/6J male mice demonstrates that 
this response is not species specific. The complexities of intermediary metabolism as 
well as TCDD toxicity have made it difficult to establish an underlying mechanism(s) 
which facilitate the observed wasting in lethally exposed animals. The research 
presented in this thesis has provided evidence for the reduction PC expression due to 
TCDD exposure in C57BL/6J male mice. In addition, nucleotide sequence analysis has 164 
given insight to transcription factor elements which may contribute to the regulation of 
PC expression. Although reductions in PC may contribute to the wasting syndrome, the 
complexities of TCDD toxicity dictate that these changes are only one piece of a very 
intricate pu771e. 165 
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APPENDIX
 213 
SIGNAL SCAN Analysis of the Sequenced Upstream Region and the Noncoding 
Exon 1 of the PC Gene. 
Element  Position  Strand  Sequence 
3'_enhancer,_HM  -634  ( +)  CATCTG 
alpha-CBF  +36  (+)  CCAAT 
alpha-IRP  +36  (+)  CCAAT 
box_4  -341  (-)  GTCAC 
box_4  -268  (-)  GTCAC 
box_4  -1319  ( +)  GTCAC 
box_4  -641  ( +)  GTCAC 
box_4  -445  (-)  GTCAC 
box_4  -375  (-)  GTCAC 
c-Myb  -419  (+)  ATTGAA 
CAAT  +35  (+)  GCCAAT 
CAC-binding pro  -506  (-)  nnCCCTCAC 
CAC - binding pro  -225  (+)  CCACC 
CAC - binding pro  -1223  ( +)  CCACC 
CAC - binding pro  +52  (-)  CCACC 
CAC - binding pro  -1205  ( +)  CCACC 
CAC - binding pro  -465  (-)  CCACC 
CAC - binding pro  -221  (-)  GGTGG 
CAC - binding pro  -1219  (-)  GGTGG 
CAC - binding pro  +48  (+)  GGTGG 
CAC - binding pro  -1201  (-)  GGTGG 
CAC - binding pro  -469  ( +)  GGTGG 
CACCC- binding_f  -1204  ( +)  CACCC 
CACCC- binding_f  +51  (-)  CACCC 
CACCC- binding_f  +111  (-)  CACCC 
CACCC- binding_f  -1222  ( +)  CACCC 
CACCC- binding_f  -1204  (+)  CACCC 
CAC CC-bindingf  +51  (-)  CACCC 
CACCC- binding_f  +111  (-)  CACCC 
CACCC-binding_f  -1204  (+)  CACCC 
CBF-B  +40  (-)  ATTGG 
CCAAT-binding_f  +40  (-)  ATTGG 
CDP  +36  ( +)  CCAAT 
CP1  +36  (+)  CCAAT 
CP1  +36  ( +)  CCAAT 
CP2  +36  ( +)  CCAAT 
CREB  -448  ( +)  TGACG 
CTF  +40  (-)  ATTGG 
CTF  +35  ( +)  GCCAATG 214 
Element  Position  Strand  Sequence 
F2F  -557  (-)  TAAAAT 
gammaCAC2  -1222  (+)  CACCC 
gammaCAC2  +51  (-)  CACCC 
gammaCAC2  +111  (-)  CACCC 
gammaCAC2  -1220  (+)  CACCC 
GATA-1  -684  (-)  TGATAA 
GATA-1  -677  (+)  TTATCT 
GATA-1  +75  ( +)  TCTATC 
GATA-1  +76  (+)  CTATCA 
GATA-1  +80  (-)  GATAGA 
GATA-2  -672  (-)  AGATAA 
GR  -1293  (-)  TGTCCT 
GR  -595  (+)  TGTCCT 
GR  -1293  (-)  TGTCCT 
GR  -595  (+)  TGTCCT 
GR  -465  ( +)  TGTTCT 
GR  +22  (-)  AGTTCT 
GR  -1334  (-)  ACAACA 
GR  -638  (+)  ACAACA 
GR  -462  ( +)  TGTTCT 
GR  -462  ( +)  TGTTCT 
GR  -462  ( +)  TGTTCT 
GR  -94  (-)  CAGAG 
GR  -1189  (-)  CAGAG 
GR  -573  (-)  CAGAG 
GR  -254  ( +)  TGAACT 
GR  -315  (-)  TGTGCC 
GR  -741  (+)  TGTCCC 
GR  -420  (-)  GACACA 
GR  -736  (-)  GGGACA 
H1TF2  +36  (+)  CCAAT 
H4TF-1  -31  ( +)  GATTTC 
H4TF-2  -1287  ( +)  GGTCC 
H4TF-2  -611  (-)  GGTCC 
H4TF-2  -605  (+)  GGTCC 
LF -A1  -332  (-)  GGGCA 
LF -A1  -104  (-)  GGGCA 
LF -A1  -1222  (-)  GGGCA 
LF -A1  -531  (+)  GGGCA 
MEP-1  -97  (-)  TGCACAC 
myogenin  -325  (+)  TGCCTGG 
NF-1  +36  (+)  CCAAT 
NF-1  -332  (+)  TCCA 215 
Element  Position  Strand  Sequence 
NF-1  -318  (-)  GCCA 
NF-1  -240  (-)  GCCA 
NF-1  -1245  (-)  TCCA 
NF-1  -233  ( +)  TCCA 
NF-1  -226  ( +)  TCCA 
NF-1  -140  (+)  GCCA 
NF-1  -92  (-)  GCCA 
NF-1  -75  ( +)  GCCA 
NF-1  -67  (-)  GCCA 
NF-1  -57  (-)  GCCA 
NF-1  -15  (-)  AGCCAA 
NF-1  -16  (-)  GCCA 
NF-1  -3  (+)  TCCA 
NF-1  +17  (-)  TCCA 
NF-1  +35  (+)  GCCA 
NF-1  +53  (-)  TCCA 
NF-1  +71  (-)  TCCA 
NF-1  +118  (-)  AGCCAA 
NF-1  +117  (-)  GCCA 
NF-1  -1055  (-)  GCCA 
NF-1  -938  (-)  GCCA 
NF-1  -782  (-)  GCCA 
NF-1  -1301  (+)  GCCA 
NF-1  -679  (-)  TCCA 
NF-1  -661  (-)  TCCA 
NF-1  -641  (-)  AGCCAA 
NF-1  -643  (-)  GCCA 
NF-1  -603  (+)  TCCA 
NF-1  -581  (-)  TCCA 
NF-1  -571  (-)  GCCA 
NF-1  -485  (-)  TCCA 
NF-1  -425  (-)  GCCA 
NF-1/L  -321  (+)  TGGCA 
NF-1/L  -243  ( +)  TGGCA 
NF-1/L  -1298  (-)  TGGCA 
NF-1/L  -428  (+)  TGGCA 
NF-1/L  -321  (-)  TGGCA 
NF-1/L  -243  (+)  TGGCA 
NF-1/L  -1298  (-)  TGGCA 
NF-1/L  -428  (+)  TGGCA 
NF-E  +76  (+)  CTATC 
NF-E  -298  ( +)  CTGTC 
NF-E  -742  (+)  CTGTC 216 
Element  Position  Strand  Sequence 
NF-E  -1292  (-)  CTGTC 
NF-E  -643  (-0  CTGTC 
NF-E  -596  (+)  CTGTC 
NF-E  +36  ( +)  CCAAT 
NF-E2  -109  ( +)  CTGCCCC 
NF-Y  +40  (-)  ATTGG 
PEA3  -1332  ( +)  AGGAAA 
Spl  -235  (-)  ATACTGCC 
Spl  -97  (-)  TGCAC 
Spl  -750  (-)  TGCAC 
Spl  -702  (-)  TGCAC 
Spl  -419  (-)  TGCAC 
Spl  -100  (-)  GGCGGG 
Spl  -104  (-)  GGGCAG 
Spl  -531  (+)  GGGCAG 
Spl  -100  (-)  GGCGGG 
Spl  -99  (-)  AGGCGG 
Spl  -50  ( +)  AGGCGG 
Spl  +32  ( +)  GGGGCC 
Spl  -1052  (-)  GGGGCC 
Spl  -935  (-)  GGGGCC 
Spl  -779  (-)  GGGGCC 
Spl  -627  ( +)  GGGGCC 
SRF  +36  ( +)  CCAAT 
unknown  -1256  (-)  CAGA 
unknown  -273  (-)  CAGA 
unknown  -210  (-)  CAGA 
unknown  -174  (-)  CAGA 
unknown  -119  (-)  CAGA 
unknown  -94  (-)  CAGA 
unknown  +32  (-)  CAGA 
unknown  -1189  (-)  CAGA 
unknown  -752  ( +)  CAGA 
unknown  -740  (-)  CAGA 
unknown  -671  (+)  CAGA 
unknown  -629  (-)  CAGA 
unknown  -573  (-)  CAGA 
unknown  -449  (-)  CAGA 
unknown  -427  (-)  CAGA 
unknown  -102  ( +)  GCCTCTC 
unknown  -401  (-)  GCCTCTC 
unknown  -1172  (-)  GTCAG 
unknown  -1133  (-)  GTCAG 217 
Element  Position  Strand  Sequence 
unknown  -1094  (-)  GTCAG 
unknown  -1016  (-)  GTCAG 
unknown  -977  (-)  GTCAG 
unknown  -899  (-)  GTCAG 
unknown  -860  (-)  GTCAG 
unknown  -821  (-)  GTCAG 
unknown  -685  (-)  GATAAG 
unknown  -345  (-)  CATTA 
unknown  -267  ( +)  CATTT 
unknown  -1315  (+)  CATTA 
unknown  -345  (-)  CATTA 
unknown  -267  (+)  CATTT 
unknown  -1315  (+)  CATTA 
unknown  -36  (+)  CCAAT 
unknown  -147  (+)  GCTC 
unknown  -134  (+)  GCTC 
unknown  -55  (-)  GCTC 
unknown  -1194  (+)  GCTC 
unknown  -1165  (+)  GCTC 
unknown  -1146  (-)  GCTC 
unknown  -1147  (+)  GCTC 
unknown  -1126  ( +)  GCTC 
unknown  -1107  (-)  GCTC 
unknown  -1108  ( +)  GCTC 
unknown  -1087  ( +)  GCTC 
unknown  -1068  (-)  GCTC 
unknown  -1069  (+)  GCTC 
unknown  -1048  ( +)  GCTC 
unknown  -1029  (-)  GCTC 
unknown  -1030  ( +)  GCTC 
unknown  -1009  ( +)  GCTC 
unknown  -990  (-)  GCTC 
unknown  -991  ( +)  GCTC 
unknown  -970  (+)  GCTC 
unknown  -951  (-)  GCTC 
unknown  -952  ( +)  GCTC 
unknown  -931  (+)  GCTC 
unknown  -912  (-)  GCTC 
unknown  -913  (+)  GCTC 
unknown  -892  (+)  GCTC 
unknown  -873  (-)  GCTC 
unknown  -874  (+)  GCTC 
unknown  -853  ( +)  GCTC 218 
Element  Position  Strand  Sequence 
unknown  -834  (-)  GCTC 
unknown  -835  (+)  GCTC 
unknown  -814  (+)  GCTC 
unknown  -795  (-)  GCTC 
unknown  -796  ( +)  GCTC 
unknown  -775  (+)  GCTC 
unknown  -756  (-)  GCTC 
unknown  -555  (-)  TTTAAA 
unknown  +36  ( +)  CCAAT 
unknown  +36  ( +)  CCAAT 
unknown  +36  ( +)  CCAAT 
unknown  -350  ( +)  CTAAT 
unknown  -1310  (-)  CTAAT 
unknown  -1305  (-)  CTAAT 
unknown  -410  (-)  CTAAT 
unknown  +36  ( +)  CCAAT 
unknown  +29  (-)  AATACAA 
unknown  -40  (-)  ATTGG 
unknown  -40  (-)  ATTGG 
unknown  -715  (-)  CAGCAA 
unknown  -356  (-)  AGGC 
unknown  -353  (+)  AGGC 
unknown  -321  (-)  AGGC 
unknown  -297  (-)  AGGC 
unknown  -255  (-)  AGGC 
unknown  -149  (+)  AGGC 
unknown  -142  ( +)  AGGC 
unknown  -99  (-)  AGGC 
unknown  -80  (+)  AGGC 
unknown  -55  (-)  AGGC 
unknown  -50  (+)  AGGC 
unknown  -21  (-)  AGGC 
unknown  -8  ( +)  AGGC 
unknown  -3  (-)  AGGC 
unknown  +66  (-)  AGGC 
unknown  -1345  ( +)  AGGC 
unknown  -1167  ( +)  AGGC 
unknown  -1128  ( +)  AGGC 
unknown  -1011  ( +)  AGGC 
unknown  -972  ( +)  AGGC 
unknown  -894  ( +)  AGGC 
unknown  -855  ( +)  AGGC 
unknown  -816  ( +)  AGGC 219 
Element  Position  Strand  Sequence 
unknown  -541  (+)  AGGC 
unknown  -536  (-)  AGGC 
unknown  -503  ( +)  AGGC 
unknown  -440  (-)  AGGC 
unknown  -404  ( +)  AGGC 
unknown  -388  ( +)  AGGC 
unknown  -383  (-)  AGGC 
unknown  -169  (+)  TTCC 
unknown  -151  (-)  TTCC 
unknown  -38  ( +)  TTCC 
unknown  -1211  ( +)  TTCC 
unknown  -1328  (-)  TTCC 
unknown  -660  (-)  TTCC 
unknown  -1353  (+)  TTCC 
unknown  -552  ( +)  TTCC 
unknown  -504  (-)  TTCC 
unknown  -473  (-)  TTCC 
unknown  -1261  (-)  TTCC 
unknown  -321  ( +)  TGGCAC 
unknown  -110  (-)  TGGGTC 
unknown  -1289  ( +)  TGGGTC 
unknown  -609  (-)  TGGGTC 
unknown  -607  ( +)  TGGGTC 
window 10  -593  ( +)  TCCTGC 
window 4  -415  (-)  TCAAT 
a2(I)coll_US1  -36  (+)  CCAAT 
AABS CS2  -389  (-)  GTGNNGYAA 
Ad-conserved-se  -17  (-)  GCCAA 
Ad-conserved-se  -35  ( +)  GCCAA 
Ad-conserved-se  +117  (-)  GCCAA 
Ad-conserved-se  -643  (-)  GCCAA 
Ad-conserved-se  +38  ( +)  AATGA 
Ad-conserved-se  -515  (-)  AATGA 
alpha-INF.2  -734  (-)  AARKGA 
AP-2  -1171  ( +)  CCCCAGGC 
AP-2  -1132  ( +)  CCCCAGGC 
AP-2  -1015  ( +)  CCCCAGGC 
AP-2  -976  ( +)  CCCCAGGC 
AP-2  -898  ( +)  CCCCAGGC 
AP-2  -859  (+)  CCCCAGGC 
AP-2  -820  (+)  CCCCAGGC 
AP-2  -1171  (+)  CCSCRGGC 
AP-2  -1132  ( +)  CCSCRGGC 220 
Element  Position  Strand  Sequence 
AP-2  -1015  (+)  CCSCRGGC 
AP-2  -976  (+)  CCSCRGGC 
AP-2  -898  ( +)  CCSCRGGC 
AP-2  -859  ( +)  CCSCRGGC 
AP-2  -820  (+)  CCSCRGGC 
AP-2  -11  (+)  CCCMNSSS 
AP-2  -1170  (+)  CCCMNSSS 
AP-2  -1131  (+)  CCCMNSSS 
AP-2  -1014  ( +)  CCCMNSSS 
AP-2  -975  (+)  CCCMNSSS 
AP-2  -897  ( +)  CCCMNSSS 
AP-2  -858  (+)  CCCMNSSS 
AP-2  -819  (+)  CCCMNSSS 
AP-4  -594  (-)  CAGCTGTGG 
AP-4  -594  (-)  CAGCTGTGG 
APRT-mouse_US  -107  (+)  GCCCCGCC 
BPV-E2  -1197  (-)  ACCNNNNNNGGT 
BPV-E2  -1197  (-)  ACCNNNNNNGGT 
c-Myb  -649  ( +)  CMG 11R 
CAP-site  -316  (+)  CANYYY 
CAP-site  -302  (+)  CANYYY 
CAP-site  -286  ( +)  CANYYY 
CAP-site  -267  ( +)  CANYYY 
CAP-site  -26  ( +)  CANYYY 
CAP-site  -14  (+)  CANYYY 
CAP-site  +3  (+)  CANYYY 
CAP-site  +111  (-)  CANYYY 
CAP-site  -1204  ( +)  CANYYY 
CAP-site  -1357  (+)  CANYYY 
CAP-site  -1320  (-)  CANYYY 
CAP-site  -1301  (-)  CANYYY 
CAP-site  -754  (-)  CANYYY 
CAP-site  -733  ( +)  CANYYY 
CAP-site  -703  (+)  CANYYY 
CAP-site  -694  ( +)  CANYYY 
CAP-site  -1288  (-)  CANYYY 
CAP-site  -654  ( +)  CANYYY 
CAP-site  -481  (-)  CANYYY 
CAP-site  -466  (-)  CANYYY 
CAP-site  -399  (-)  CANYYY 
CAP-site  -361  ( +)  CANYYY 
CBF  +36  (+)  CCAAT 
CBP  +36  ( +)  CCAAT 221 
Element  Position  Strand  Sequence 
CBP  +36  ( +)  CCAAT 
CCAAT-bf  +36  (+)  CCAAT 
CREB  -444  (-)  CGTCA 
CRF  +40  (-)  ATTGG 
CTF  +35  (+)  GCCAATGA 
CTF  +40  (-)  ATT'GG 
CTF  +36  (+)  CCAAT 
E1A-F  +97  (-)  NGGAYGT 
E2A  -210  (+)  RCAGNTG 
E2A  -204  (-)  RCAGNTG 
E2A  -629  (-)  RCAGNTG 
E2A  -600  ( +)  RCAGNTG 
E2A  -593  (-)  RCAGNTG 
EPBF  +36  ( +)  CCAAT 
gamma-IRE_CS  -345  (-)  CWKKANNY 
gamma-IRE_CS  -255  ( +)  CWKKANNY 
gamma-IRE CS  -244  (-)  CWKKANNY 
gamma-IRE_CS  -240  ( +)  CWKKANNY 
gamma-IRE_CS  -118  ( +)  CWICKANNY 
gamma-IRE_CS  -54  (+)  CWKKANNY 
gamma-IRE_CS  -12  (-)  CWKKANNY 
gamma-IRE_CS  +2  (-)  CWKKANNY 
gamma-IRESS  -49  (-)  CWICKANNY 
gamma-IRE_CS  -1315  ( +)  CWICICANNY 
gamma-IRE_CS  -683  ( +)  CWKKANNY 
gamma-IRE_CS  -665  ( +)  CWKKANNY 
gamma-IRESS  -585  ( +)  CWKKANNY 
gamma-IRE CS  -566  ( +)  CWKKANNY 
gamma-IRE_CS  -547  (-)  CWKKANNY 
gamma-IRE_CS  -379  (-)  CWKKANNY 
GATA-1  +81  (-)  WGATAR 
GATA-1  -682  (-)  WGATAR 
GATA-1  -684  (-)  WGATAR 
GATA-1  -690  (+)  MYWATCWY 
GATA-1  -677  (+)  TTATCTC 
GATA-1  -676  (+)  TATCTC 
GATA-1  -685  (-)  GATAAG 
GCF  -101  (-)  SCGSSSC 
GCF  -88  (-)  SCGSSSC 
GCF  -91  ( +)  SCGSSSC 
GCF  -42  (-)  SCGSSSC 
GCF  -45  ( +)  SCGSSSC 
GMCSF CS  -345  (-)  CATTW 222 
Element  Position  Strand  Sequence 
GMCSF_CS  -267  ( +)  CATTW 
GMCSF_CS  -1315  ( +)  CATTW 
GT-IIB a  -600  ( +)  ACAGCTG 
GT-IIBa  -593  (-)  ACAGCTG 
GT-IIBa  -600  ( +)  ACAGCTG 
GT-IIBa  -593  (-)  ACAGCTG 
H-2RIIBP/T3R-al  +46  (-)  GAGGTC 
HC3  -225  (+)  CCAC CA 
HNF-4  -336  (-)  KGCWARGKYCAY 
hsp70.2  -100  (-)  GGCGGG 
IE1.2  -1326  (-)  CTTTCC 
IE1.2  -502  (-)  CTTTCC 
JCV_repeated_se  +47  ( +)  GGGNGGRR 
junB-US2  +34  ( +)  GGCCAAT 
LBP-1  -1259  ( +)  WCTRG 
LBP-1  -295  (±)  WCTRG 
LBP-1  -200  (+)  WCTRG 
LBP-1  -145  ( +)  WCTRG 
LBP-1  -97  (+)  WCTRG 
LBP-1  -70  (-)  WCTRG 
LBP-1  +6  (+)  WCTRG 
LBP-1  +11  (-)  WCTRG 
LBP-1  +29  (+)  WCTRG 
LBP-1  -684  ( +)  WCTRG 
LBP-1  -607  (-)  WCTRG 
LBP-1  -576  ( +)  WCTRG 
LBP-1  -496  (-)  WCTRG 
LBP-1  -430  (+)  WCTRG 
LBP-1  -1259  (-0  WCTGG 
LBP-1  -97  ( +)  WCTGG 
LBP-1  -70  (-)  WCTGG 
LBP-1  +29  (+)  WCTGG 
LBP-1  -684  (+)  WCTGG 
LBP-1  -607  (-)  WCTGG 
LBP-1  -576  ( +)  WCTGG 
LBP-1  -430  (+)  WCTGG 
LF-A 1  -344  ( +)  TGRMCC 
LF-A 1  -116  ( +)  TGRMCC 
LF-Al  -95  (+)  TGRMCC 
LF -A1  -70  ( +)  TGRMCC 
LF-A 1  +38  (-)  TGRMCC 
LF-Al  -1175  ( +)  TGRMCC 
LF-Al  -1136  (+)  TGRMCC 223 
Element  Position  Strand  Sequence 
LF -A1  -1097  ( +)  TGRMCC 
LF -A1  -1058  (+)  TGRMCC 
LF -A1  -1019  ( +)  TGRMCC 
LF -A1  -980  ( +)  TGRMCC 
LF -A1  -941  (+)  TGRMCC 
LF -A1  -902  ( +)  TGRMCC 
LF -A1  -863  (+)  TGRMCC 
LF-Al  -824  (+)  TGRMCC 
LF -A1  -785  (+)  TGRMCC 
LF-Al  -600  (-)  TGRMCC 
LF-Al  -366  (+)  TGRMCC 
LVa  -153  ( +)  GAACAG 
LVa  -153  ( +)  GAACAG 
Lvc  -192  (-)  CCTGC 
Lvc  -592  (+)  CCTGC 
Lvc  -192  (-)  CCTGC 
Lye  -592  (+)  CCTGC 
MBF-I  -97  (-)  TGCRCRC 
MRE_C S2  -97  (-)  TGCRCNC 
multiple  -468  ( +)  GTGGWWWG 
multiple  -242  (-)  CANNTG 
multiple  -204  (-)  CANNTG 
multiple  -1174  (-)  CANNTG 
multiple  -1135  (-)  CANNTG 
multiple  -1096  (-)  CANNTG 
multiple  -1057  (-)  CANNTG 
multiple  -1018  (-)  CANNTG 
multiple  -979  (-)  CANNTG 
multiple  -940  (-)  CANNTG 
multiple  -901  (-)  CANNTG 
multiple  -862  (-)  CANNTG 
multiple  -823  (-)  CANNTG 
multiple  -784  (-)  CANNTG 
multiple  -704  (-)  CANNTG 
multiple  -629  (-)  CANNTG 
multiple  -594  (-)  CANNTG 
MyoD  -1179  (+)  CACCTG 
MyoD  -1123  ( +)  CACCTG 
MyoD  -1101  ( +)  CACCTG 
MyoD  -1062  ( +)  CACCTG 
MyoD  -1023  ( +)  CACCTG 
MyoD  -984  (+)  CACCTG 
MyoD  -945  (+)  CACCTG 224 
Element  Position  Strand  Sequence 
MyoD  -906  (+)  CACCTG 
MyoD  -867  (+)  CACCTG 
MyoD  -828  (+)  CACCTG 
MyoD  -789  ( +)  CACCTG 
MyoD  -704  (-)  CACCTG 
NF-IL6  -117  (-)  TKNNGNAAK 
NF-IL6  -1334  (+)  TKNNGNAAK 
NF-Y*  +36  ( +)  CCAAT 
NFI  -8  (-)  TGGNNNNNNGCCA 
NRE_B oxl_C S  -400  (-)  ANCCTCTCY 
PEA3  -1207  (-)  AGGAAG 
polyoma.1  -97  (-)  AGAGG 
polyoma.1  -1347  (+)  AGAGG 
polyoma.1  +77  (-)  AGAGG 
polyoma.1  -1327  ( +)  AGAGG 
polyoma.1  -406  (+)  AGAGG 
PU.1  -1333  ( +)  GAGGAA 
PU.1  -1267  (+)  GAGGAA 
PuF  -1218  (-)  GGGTGGG 
Spl  -105  ( +)  CCCGCC 
Spl  -105  (+)  CCCGCC 
Spl  -98  (-)  KRGGCGKRRY 
SV40.11  -1254  (-)  CCCAG 
SV40.11  -159  (+)  CCCAG 
SV40.11  -11  ( +)  CCCAG 
SV40.11  +35  (-)  CCCAG 
SV40.11  -1170  ( +)  CCCAG 
SV40.11  -1131  ( +)  CCCAG 
SV40.11  -1014  (+)  CCCAG 
SV40.11  -975  (+)  CCCAG 
SV40.11  -897  ( +)  CCCAG 
SV40.11  -858  ( +)  CCCAG 
SV40.11  -819  (+)  CCCAG 
SV40.11  -612  ( +)  CCCAG 
T-Ag  -143  ( +)  TAGGC 
T-Ag  -81  (+)  TAGGC 
T-Ag  -542  ( +)  TAGGC 
T-Ag  -98  (-)  GAGGC 
T-Ag  -54  (-)  GAGGC 
T-Ag  -51  ( +)  GAGGC 
T-Ag  -2  (-)  GAGGC 
T-Ag  -1346  ( +)  GAGGC 
T-Ag  -405  ( +)  GAGGC 225 
Element  Position  Strand  Sequence 
T-Ag  -382  (-)  GAGGC 
T-Ag  -1254  ( +)  GGGGC 
T-Ag  -103  (-)  GGGGC 
T-Ag  -39  (-)  GGGGC 
T-Ag  +32  (+)  GGGGC 
T-Ag  -1051  (-)  GGGGC 
T-Ag  -935  (-)  GGGGC 
T-Ag  -779  (-)  GGGGC 
T-Ag  -627  (+)  GGGGC 
T-Ag  -156  (-)  TGGGC 
T-Ag  -64  (-)  TGGGC 
T-Ag  -8  (-)  TGGGC 
T-Ag  -1221  (-)  TGGGC 
T-antigen  -54  (-)  GAGGCC 
T-antigen  -2  (--)  GAGGCC 
T-antigen  -382  (-)  GAGGCC 
TCF-1  -318  ( +)  MAMAG 
TCF-1  -318  (+)  MAMAG 
TCF-1  -172  (-)  MAMAG 
TCF-1  -152  ( +)  MAMAG 
TCF-1  +24  (-)  MAMAG 
TCF-1  -69  (-)  MAMAG 
TCF-1  +93  (-)  MAMAG 
TCF-1  -1336  (-)  MAMAG 
TCF-1  -752  (-)  MAMAG 
TCF-1  -726  (-)  MAMAG 
TCF-1  -627  (-)  MAMAG 
TCF-1  -601  ( +)  MAMAG 
TCF-1  -557  ( +)  MAMAG 
TCF-1  -533  (-)  MAMAG 
TCF-1  -447  (-)  MAMAG 
TCF-1  -391  (+)  MAMAG 
TCF-1  -377  (-)  MAMAG 
TFII-I  -1148  ( +)  AGCTCTCT 
TFII-I  -1109  (+)  AGCTCTCT 
TFII-I  -1070  ( +)  AGCTCTCT 
TFII-I  -1031  (+)  AGCTCTCT 
TFII-I  -992  ( +)  AGCTCTCT 
TFII-I  -953  ( +)  AGCTCTCT 
TFII-I  -914  (+)  AGCTCTCT 
TFII-I  -875  (+)  AGCTCTCT 
TFII-I  -836  ( +)  AGCTCTCT 
TFII-I  -797  (+)  AGCTCTCT 226 
Element  Position  Strand  Sequence 
TFIID  +27  (-)  TACAAA 
TGGCA-BP  -321  ( +)  TGGCA 
TGGCA-BP  -243  ( +)  TGGCA 
TGGCA-BP  -1298  (-)  TGGCA 
TGGCA-BP  -428  ( +)  TGGCA 
UBP1  -100  ( +)  CTCTCTGG 
UBP1  -579  (+)  CTCTCTGG 
UCE.2  -86  (-)  GGCCG 
UCE.2  -441  (-)  GGCCG 
uteroglobin_HS­ -1172  (-)  RYYWSGTG 
uteroglobin_HS­ -1132  (-)  RYYWSGTG 
uteroglobin_HS­ -1094  (-)  RYYWSGTG 
uteroglobin HS­ -1055  (-)  RYYWSGTG 
uteroglobin_HS­ -1016  (-)  RYYWSGTG 
uteroglobin_HS­ -977  (-)  RYYWSGTG 
uteroglobin_HS­ -938  (-)  RYYWSGTG 
uteroglobin_HS­ -899  (-)  RYYWSGTG 
uteroglobinHS­ -860  (-)  RYYWSGTG 
uteroglobin_HS­ -821  (-)  RYYWSGTG 
uteroglobin_HS­ -782  (-)  RYYWSGTG 
v-Myb  -645  (-)  YAACKG 
vaccinia-tern-s  -1234  ( +)  CTATTC 
W-element_CS  +113  (-)  WGNAMCYK 
W-element_CS  -702  (-)  WGNAMCYK 
W-element_CS  -705  ( +)  WGNAMCYK 
W-element_CS  -548  (-)  WGNAMCYK 
WAP_US5  -696  (-)  CCAAGT 
WAP_US6  -554  (-)  TTTAAA 